George A Calin, M.D., Ph.D.

Peer-Reviewed Articles

1. Song, S, Fan, Y, Zou, G, Huo, L, Kumar, J, Li, Y, Wang, R, Dai, E, Jin, J, Scott, AW, Shao, SH, Pizzi, M, Vykoukal, JV, Katayama, H, Hanash, S, Calin, GA, Zhang, X, Lee, MG, Wang, Z, Lo, Y, Gan, Q, Waters, R, Yin, F, Wang, L, Cheng, X, Ajani, JA, Dhar, SS. KAP1 promotes gastric adenocarcinoma progression by activating Hippo/YAP1 signaling via binding to HNRNPAB. Cancer Letters 621, 2025. e-Pub 2025. PMID: 40189014.
2. Veletic, I, Harris, D, Rozovski, U, Bertilaccio, MS, Calin, GA, Takahashi, K, Li, P, Liu, Z, Manshouri, T, Drula, R, Furudate, K, Muftuoglu, M, Hossain, A, Wierda, WG, Keating, M, Estrov, Z. CLL cell-derived exosomes alter the immune and hematopoietic systems. Leukemia 39(6):1380-1394, 2025. e-Pub 2025. PMID: 40186065.
3. Nguyen, G, Noh, MH, Kang, JM, Miller, AA, Huang, M, Kim, J, Lee, JY, Chung, S, Wang, H, Calin, GA, Ju, C, Eltzschig, H, Banasavadi-Siddegowda, Y, Zhao, Z, Yoo, JY, Lee, TJ. Simultaneous Targeting of Tumor Cells and Tumor-Associated Macrophages To Reprogram Glioblastoma Using Trypsinized Extracellular Vesicles Carrying Tumor Suppressive MicroRNA. Nano Letters 25(20):8414-8422, 2025. e-Pub 2025. PMID: 40357748.
4. Pathania, AS, Murugan, A, Zahid, A, Chava, H, Coulter, DW, Calin, GA, Challagundla, KB. SAP30, a novel autophagy regulatory gene in neuroblastoma. Molecular Therapy Oncology 33(1), 2025. e-Pub 2025. PMID: 40190355.
5. Visal, TH, Bayraktar, R, Den Hollander, P, Attathikhun, MA, Zhou, T, Wang, J, Shen, L, Minciuna, CE, Chen, M, Barrientos Toro, E, Batra, H, Raso, G, Yang, F, Parra Cuentas, ER, Sahin, AA, Calin, GA, Mani, S. Accumulation of CD38 in Hybrid Epithelial/Mesenchymal Cells Promotes Immune Remodeling and Metastasis in Breast Cancer. Cancer Research 85(5):894-911, 2025. e-Pub 2025. PMID: 39853244.
6. Bayraktar, R, Tang, Y, Dragomir, M, Ivan, C, Peng, X, Fabris, L, Zhang, J, Carugo, A, Aneli, S, Liu, J, Chen, MM, Srinivasan, S, Sahnoune, I, Bayraktar, E, Akdemir, KC, Chen, M, Narayanan, P, Huang, W, Ott, LF, Eterovic, AK, Villarreal, OE, Mohammad, MM, Peoples, M, Walsh, D, Hernandez, JA, Morgan, M, Shaw, KR, Davis, JS, Menter, DG, Tam, CS, Yeh, P, Dawson, SJ, Rassenti, LZ, Kipps, TJ, Kunej, T, Estrov, Z, Joosse, SA, Pagani, L, Alix-Panabières, C, Pantel, K, Ferajoli, A, Futreal, A, Wistuba, II, Radovich, M, Kopetz, S, Keating, M, Draetta, G, Mattick, JS, Liang, H, Calin, GA. The mutational landscape and functional effects of noncoding ultraconserved elements in human cancers. Science Advances 11(8), 2025. e-Pub 2025. PMID: 39970212.
7. Fan, Y, Song, S, Pizzi, M, Zou, G, Vykoukal, JV, Yoshimura, K, Jin, J, Calin, GA, Waters, R, Gan, Q, Wang, L, Hanash, S, Dhar, SS, Ajani, JA. Exosomal Galectin-3 promotes peritoneal metastases in gastric adenocarcinoma via microenvironment alterations. iScience 28(1), 2025. e-Pub 2025. PMID: 39811647.
8. Lu, Y, Wang, K, Peng, Y, Chen, M, Zhong, L, Huang, L, Cheng, F, Sheng, X, Yang, X, Ouyang, M, Calin, GA, He, Z. Hsa-miR-214-3p inhibits breast cancer cell growth and improves the tumor immune microenvironment by downregulating B7H3. Oncology research 33(1):103-121, 2025. e-Pub 2025. PMID: 39735676.
9. Calina, TG, Perez, E, Grafenhorst, E, Benhamida, J, Schallenberg, S, Popescu, A, Koch, I, Janik, T, Chen, B, Ihlow, J, Roessler, S, Goeppert, B, Sinn, BV, Bahra, M, Calin, GA, Taube, ET, Pelzer, U, Neumann, CC, Horst, D, Knutsen, E, Capper, D, Dragomir, M. DNA methylation classifier to diagnose pancreatic ductal adenocarcinoma metastases from different anatomical sites. Clinical epigenetics 16(1), 2024. e-Pub 2024. PMID: 39523345.
10. Adamoski, D, M. dos Reis, L, Mafra, AP, Corrêa-da-Silva, F, Moraes-Vieira, PM, Berindan-Neagoe, I, Calin, GA, Gomes Dias, SM. HuR controls glutaminase RNA metabolism. Nature communications 15(1), 2024. e-Pub 2024. PMID: 38965208.
11. Anfossi, S, Darbaniyan, F, Quinlan, J, Calin, S, Shimizu, M, Chen, M, Rausseo, P, Winters, M, Bogatenkova, E, Do, K, Martinez, I, Li, Z, Antal, L, Olariu, TR, Wistuba, II, Calin, GA. MicroRNAs are enriched at COVID-19 genomic risk regions, and their blood levels correlate with the COVID-19 prognosis of cancer patients infected by SARS-CoV-2. Molecular cancer 23(1), 2024. e-Pub 2024. PMID: 39434078.
12. Cheng, X, Dai, E, Wu, J, Flores, N, Chu, Y, Wang, R, Dang, M, Xu, Z, Han, G, Liu, Y, Chatterjee, D, Hu, C, Ying, J, Du, Y, Yang, L, Guan, X, Mo, S, Cao, X, Pei, G, Jiang, J, Lu, X, Benitez, AM, Waters, R, Pizzi, M, Shanbhag, N, Fan, Y, Peng, F, Hanash, S, Calin, GA, Futreal, A, Song, S, Yee, C, Mazur, PK, Qin, JJ, Ajani, JA, Wang, L. Atlas of Metastatic Gastric Cancer Links Ferroptosis to Disease Progression and Immunotherapy Response. Gastroenterology 167(7):1345-1357, 2024. e-Pub 2024. PMID: 39097198.
13. Dogra, P, Shinglot, V, Ruiz Ramírez, J, Cave, J, Butner, JD, Schiavone, C, Duda, DG, Kaseb, A, Chung, C, Koay, EJ, Cristini, V, Ozpolat, B, Calin, GA, Wang, Z. Translational modeling-based evidence for enhanced efficacy of standard-of-care drugs in combination with anti-microRNA-155 in non-small-cell lung cancer. Molecular cancer 23(1), 2024. e-Pub 2024. PMID: 39095771.
14. Cavazzoni, A, Salamon, I, Fumarola, C, Gallerani, G, Laprovitera, N, Gelsomino, F, Riefolo, M, Rihawi, K, Porcellini, E, Rossi, T, Mazzeschi, M, Naddeo, M, Serravalle, S, Broseghini, E, Agostinis, F, Déas, O, Roncarati, R, Durante, G, Pace, I, Lauriola, M, Garajova, I, Calin, GA, Bonafè, M, D'Errico, A, Petronini, PG, Cairo, S, Ardizzoni, A, Sales, G, Ferracin, M. Synergic activity of FGFR2 and MEK inhibitors in the treatment of FGFR2-amplified cancers of unknown primary. Molecular Therapy 32(10):3650-3668, 2024. e-Pub 2024. PMID: 39033323.
15. Cavazzoni, A, Cavazzoni, A, Salamon, I, Salamon, I, Fumarola, C, Fumarola, C, Gallerani, G, Gallerani, G, Laprovitera, N, Laprovitera, N, Gelsomino, F, Gelsomino, F, Riefolo, M, Riefolo, M, Rihawi, K, Rihawi, K, Porcellini, E, Porcellini, E, Rossi, T, Rossi, T, Mazzeschi, M, Mazzeschi, M, Naddeo, M, Naddeo, M, Serravalle, S, Serravalle, S, Broseghini, E, Broseghini, E, Agostinis, F, Agostinis, F, Déas, O, Déas, O, Roncarati, R, Roncarati, R, Durante, G, Durante, G, Pace, I, Pace, I, Lauriola, M, Lauriola, M, Garajova, I, Garajova, I, Calin, GA, Calin, GA, Bonafè, M, Bonafè, M, D'Errico, A, D'Errico, A, Petronini, PG, Petronini, PG, Cairo, S, Cairo, S, Ardizzoni, A, Ardizzoni, A, Sales, G, Sales, G, Ferracin, M, Ferracin, M. Synergic activity of FGFR2 and MEK inhibitors in the treatment of FGFR2-amplified cancers of unknown primary. Molecular Therapy 32(10):3650-3668, 2024. e-Pub 2024. PMID: 39033323.
16. Bayraktar, R, Fontana, B, Calin, GA, Németh, K. miRNA Biology in Chronic Lymphocytic Leukemia. Seminars in hematology 61(3):181-193, 2024. e-Pub 2024. PMID: 38724414.
17. Niu Z, Sun P, Zafereo ME, Liu H, Wei P, Wu J, Gross ND, Shete S, Wei Q, Zheng G, Sikora AG, Calin GA, Li G. TGF-β1 and TGF-βR1 variants are associated with clinical outcomes in smoking-related head and neck cancer patients treated with chemoradiation through modulating microRNA-mediated regulation. Cancer Immunol Immunother 73(5):85, 2024. e-Pub 2024. PMID: 38554185.
18. Mohapatra, S, Banerjee, A, Rausseo, P, Dragomir, M, Manyam, GC, Broom, BM, Calin, GA. FuncPEP v2.0. Non-coding RNA 10(2), 2024. e-Pub 2024. PMID: 38668378.
19. Fuentes-Mattei E, Bayraktar R, Manshouri T, Silva AM, Ivan C, Gulei D, Fabris L, Soares do Amaral N, Mur P, Perez C, Torres-Claudio E, Dragomir MP, Badillo-Perez A, Knutsen E, Narayanan P, Golfman L, Shimizu M, Zhang X, Zhao W, Ho WT, Estecio MR, Bartholomeusz G, Tomuleasa C, Berindan-Neagoe I, Zweidler-McKay PA, Estrov Z, Zhao ZJ, Verstovsek S, Calin GA, Redis RS. miR-543 regulates the epigenetic landscape of myelofibrosis by targeting TET1 and TET2. JCI Insight 9(3), 2024. e-Pub 2024. PMID: 38329131.
20. Arasi MB, De Luca G, Chronopoulou L, Pedini F, Petrucci E, Flego M, Stringaro A, Colone M, Pasquini L, Spada M, Lulli V, Perrotta MC, Calin GA, Palocci C, Biffoni M, Felicetti F, Felli N. MiR126-targeted-nanoparticles combined with PI3K/AKT inhibitor as a new strategy to overcome melanoma resistance. Mol Ther 32(1):152-167, 2024. e-Pub 2024. PMID: 37990493.
21. Treekitkarnmongkol, W, Dai, J, Liu, S, Sankaran, D, Nguyen, T, Balasenthil, S, Hurd, MW, Chen, M, Katayama, H, Roy-Chowdhuri, S, Calin, GA, Brand, RE, Lampe, PD, Hu, T, Maitra, A, Koay, EJ, Killary, AM, Sen, S. Blood-Based microRNA Biomarker Signature of Early-Stage Pancreatic Ductal Adenocarcinoma With Lead-Time Trajectory in Prediagnostic Samples. Gastro Hep Advances 3(8):1098-1115, 2024. e-Pub 2024. PMID: 39529638.
22. Cismas S, Pasca S, Crudden C, Trocoli Drakensjo I, Suleymanova N, Zhang S, Gebhard B, Song D, Neo S, Shibano T, Smith TJ, Calin GA, Girnita A, Girnita L. Competing engagement of β-arrestin isoforms balances IGF1R/p53 signaling and controls melanoma cell chemotherapeutic responsiveness. Mol Cancer Res 21(12):1288-1302, 2023. e-Pub 2023. PMID: 37584671.
23. Rodriguez-Aguayo C, Del C Monroig P, Redis RS, Bayraktar E, Almeida MI, Ivan C, Fuentes-Mattei E, Rashed MH, Chavez-Reyes A, Ozpolat B, Mitra R, Sood AK, Calin GA, Lopez-Berestein G. Author Correction: Regulation of hnRNPA1 by microRNAs controls the miR-18a-K-RAS axis in chemotherapy-resistant ovarian cancer. Cell Discov 9(1), 2023. e-Pub 2023. PMID: 37940695.
24. Fan Y, Song S, Li Y, Dhar SS, Jin J, Yoshimura K, Yao X, Wang R, Scott AW, Pizzi MP, Wu J, Ma L, Calin GA, Hanash S, Wang L, Curran M, Ajani JA. Galectin-3 Cooperates with CD47 to Suppress Phagocytosis and T-cell Immunity in Gastric Cancer Peritoneal Metastases. Cancer Res 83(22):3726-3738, 2023. e-Pub 2023. PMID: 37738407.
25. Bayraktar R, Pichler M, Kanlikilicer P, Ivan C, Bayraktar E, Kahraman N, Aslan B, Oguztuzun S, Ulasli M, Arslan A, Calin G, Lopez-Berestein G, Ozpolat B. Correction: MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase. Oncotarget 14:908-909, 2023. e-Pub 2023. PMID: 37921671.
26. Niu Z, Sun P, Liu H, Wei P, Wu J, Huang Z, Gross ND, Shete S, Wei Q, Zafereo ME, Calin GA, Li G. Functional Genetic Variants in TGFβ1 and TGFβR1 in miRNA-Binding Sites Predict Outcomes in Patients with HPV-positive Oropharyngeal Squamous Cell Carcinoma. Clin Cancer Res 29(16):3081-3091, 2023. e-Pub 2023. PMID: 37327315.
27. Wang R, Song S, Qin J, Yoshimura K, Peng F, Chu Y, Li Y, Fan Y, Jin J, Dang M, Dai E, Pei G, Han G, Hao D, Li Y, Chatterjee D, Harada K, Pizzi MP, Scott AW, Tatlonghari G, Yan X, Xu Z, Hu C, Mo S, Shanbhag N, Lu Y, Sewastjanow-Silva M, Fouad Abdelhakeem AA, Peng G, Hanash SM, Calin GA, Yee C, Mazur P, Marsden AN, Futreal A, Wang Z, Cheng X, Ajani JA, Wang L. Evolution of immune and stromal cell states and ecotypes during gastric adenocarcinoma progression. Cancer Cell 41(8):1407-1426.e9, 2023. e-Pub 2023. PMID: 37419119.
28. Zhang Y, Zhao Z, Huang LA, Liu Y, Yao J, Sun C, Li Y, Zhang Z, Ye Y, Yuan F, Nguyen TK, Garlapati NR, Wu A, Egranov SD, Caudle AS, Sahin AA, Lim B, Beretta L, Calin GA, Yu D, Hung MC, Curran MA, Rezvani K, Gan B, Tan Z, Han L, Lin C, Yang L. Molecular mechanisms of snoRNA-IL-15 crosstalk in adipocyte lipolysis and NK cell rejuvenation. Cell Metab 35(8):1457-1473.e13, 2023. e-Pub 2023. PMID: 37329887.
29. Chira S, Ciocan C, Bica C, Calin GA, Berindan-Neagoe I. Artificial miRNAs derived from miR-181 family members have potential in cancer therapy due to an altered spectrum of target mRNAs. FEBS Lett 597(15):1989-2005, 2023. e-Pub 2023. PMID: 37283340.
30. Blandino G, Dinami R, Marcia M, Anastasiadou E, Ryan BM, Palcau AC, Fattore L, Regazzo G, Sestito R, Loria R, Díaz Méndez AB, Cappelletto MC, Pulito C, Monteonofrio L, Calin GA, Sozzi G, Cheong JK, Aharonov R, Ciliberto G. The new world of RNA diagnostics and therapeutics. J Exp Clin Cancer Res 42(1):189, 2023. e-Pub 2023. PMID: 37507791.
31. Amit M, Baruch E, Nagarajan P, Gleber-Netto F, Rao X, Xie T, Akhter S, Adewale A, Islam S, Mattson B, Ferrarotto R, Wong M, Davies M, Jindal S, Basu S, Harwood C, Leigh I, Ajami N, Futreal A, Castillo M, Gunarante P, Goepfert R, Khushalani N, Wang J, Watowich S, Calin G, Migden M, Vermeer P, D'Silva N, Yaniv D, Burks J, Gomez J, Dougherty P, Tsai K, Allison J, Sharma P, Wargo J, Myers J, Gross N. Inflammation induced by tumor-associated nerves promotes resistance to anti-PD-1 therapy in cancer patients and is targetable by IL-6 blockade. Res Sq, 2023. e-Pub 2023. PMID: 37503252.
32. Baruch, EN, Nagarajan, P, Gleber-Netto, FO, Rao, X, Xie, T, Akhter, S, Adewale, A, Shajedul, I, Mattson, BJ, Ferrarotto, R, Wong, MK, Davies, MA, Jindal, S, Basu, S, Harwood, C, Leigh, I, Ajami, NJ, Futreal, A, Castillo, M, Gunaratne, PH, Goepfert, RP, Khushalani, N, Wang, J, Watowich, SS, Calin, GA, Migden, MR, Vermeer, PD, D'Silva, NJ, Yaniv, D, Burks, JK, Gomez, JA, Dougherty, PM, Tsai, KY, Allison, JP, Sharma, P, Wargo, J, Myers, JN, Gross, N, Amit, M. Inflammation induced by tumor-associated nerves promotes resistance to anti-PD-1 therapy in cancer patients and is targetable by interleukin-6 blockade. Research square, 2023. e-Pub 2023. PMID: 37503252.
33. Dragomir MP, Fuentes-Mattei E, Winkle M, Okubo K, Bayraktar R, Knutsen E, Qdaisat A, Chen M, Li Y, Shimizu M, Pang L, Liu K, Liu X, Anfossi S, Zhang H, Koch I, Tran AM, Mohapatra S, Ton A, Kaplan M, Anderson MW, Rothfuss SJ, Silasi R, Keshari RS, Ferracin M, Ivan C, Rodriguez-Aguayo C, Lopez-Berestein G, Georgescu C, Banerjee PP, Basar R, Li Z, Horst D, Vasilescu C, Bertilaccio MTS, Rezvani K, Lupu F, Yeung SC, Calin GA. Anti-miR-93-5p therapy prolongs sepsis survival by restoring the peripheral immune response. J Clin Invest 133(14), 2023. e-Pub 2023. PMID: 37261908.
34. Dragomir MP, Calina TG, Perez E, Schallenberg S, Chen M, Albrecht T, Koch I, Wolkenstein P, Goeppert B, Roessler S, Calin GA, Sers C, Horst D, Roßner F, Capper D. DNA methylation-based classifier differentiates intrahepatic pancreato-biliary tumours. EBioMedicine 93:104657, 2023. e-Pub 2023. PMID: 37348162.
35. Cave, J, Shinglot, V, Butner, JD, Cristini, V, Ozpolat, B, Calin, GA, Dogra, P, Wang, Z. Mechanistic modeling of anti-microRNA-155 therapy combinations in lung cancer 2023:1-4, 2023. e-Pub 2023. PMID: 38083518.
36. Fierro C, Gatti V, La Banca V, De Domenico S, Scalera S, Corleone G, Fanciulli M, De Nicola F, Mauriello A, Montanaro M, Calin GA, Melino G, Peschiaroli A. The long non-coding RNA NEAT1 is a ?Np63 target gene modulating epidermal differentiation. Nat Commun 14(1):3795, 2023. e-Pub 2023. PMID: 37365156.
37. Zhao S, Wang R, Song S, Hao D, Han G, Song X, Zhang J, Pizzi MP, Shanbhag N, Futreal A, Badgwell B, Harada K, Calin G, Vykoukal J, Yu CY, Katayama H, Hanash SM, Wang L, Ajani JA. Proteogenomic landscape of gastric adenocarcinoma peritoneal metastases. iScience 26(6):106913, 2023. e-Pub 2023. PMID: 37305699.
38. Calin GA. Noncoding RNAs: Hope and hype at 30 years. Mol Ther 31(6):1501-1502, 2023. e-Pub 2023. PMID: 37263271.
39. Drula R, Pardini B, Fu X, De Los Santos MC, Jurj A, Pang L, El-Daly SM, Fabris L, Knutsen E, Dragomir MP, Bayraktar R, Li Y, Chen M, Del Vecchio F, Berland L, Dae J, Fan D, Shimizu M, Tran AM, Barzi M, Pioppini C, Gutierrez AM, Ivan C, Meas S, Hall CS, Alahari SK, Berindan-Neagoe I, Fabbri M, Lucci A, Arun B, Anfossi S, Calin GA. 17β-estradiol promotes extracellular vesicle release and selective miRNA loading in ERα-positive breast cancer. Proc Natl Acad Sci U S A 120(23):e2122053120, 2023. e-Pub 2023. PMID: 37252969.
40. Stabile R, Cabezas MR, Verhagen MP, Tucci FA, van den Bosch TPP, De Herdt MJ, van der Steen B, Nigg AL, Chen M, Ivan C, Shimizu M, Koljenovic S, Hardillo JA, Verrijzer CP, Baatenburg de Jong RJ, Calin GA, Fodde R. The deleted in oral cancer (DOC1 aka CDK2AP1) tumor suppressor gene is downregulated in oral squamous cell carcinoma by multiple microRNAs. Cell Death Dis 14(5):337, 2023. e-Pub 2023. PMID: 37217493.
41. Ichihara M, Takahashi H, Nishida N, Ivan C, Okuzaki D, Yokoyama Y, Ohtsuka M, Miyoshi N, Uemura M, Tanaka S, Calin GA, Mori M, Doki Y, Eguchi H, Yamamoto H. Long noncoding RNA 01534 maintains cancer stemness by downregulating endoplasmic reticulum stress response in colorectal cancer. Ann Gastroenterol Surg 7(3):458-470, 2023. e-Pub 2023. PMID: 37152770.
42. Untergasser A, Hellemans J, Pfaffl MW, Ruijter JM, van den Hoff MJB, Dragomir MP, Adamoski D, Dias SMG, Reis RM, Ferracin M, Dias-Neto E, Marsh I, Kubista M, Fabbri M, Goel A, Slabý O, Knutsen E, Chen B, Negrini M, Mimori K, Pichler M, Papatriantafyllou M, Anfossi S, Schmittgen TD, Huggett J, Bustin S, Vandesompele J, Calin GA, dIsClosure) Consortium H(IGOQ. Disclosing quantitative RT-PCR raw data during manuscript submission: a call for action. Mol Oncol 17(5):713-717, 2023. e-Pub 2023. PMID: 36916500.
43. Fan Y, Li Y, Yao X, Jin J, Scott A, Liu B, Wang S, Huo L, Wang Y, Wang R, Pool Pizzi M, Ma L, Shao S, Sewastjanow-Silva M, Waters R, Chatterjee D, Liu B, Shanbhag N, Peng G, Calin GA, Mazur PK, Hanash SM, Ishizawa J, Hirata Y, Nagano O, Wang Z, Wang L, Xian W, McKeon F, Ajani JA, Song S. Epithelial SOX9 drives progression and metastases of gastric adenocarcinoma by promoting immunosuppressive tumour microenvironment. Gut 72(4):624-637, 2023. e-Pub 2023. PMID: 36002248.
44. Shortridge MD, Chaubey B, Zhang HJ, Pavelitz T, Vidadala V, Tang C, Olsen GL, Calin GA, Varani G. Drug-Like Small Molecules That Inhibit Expression of the Oncogenic MicroRNA-21. ACS Chem Biol 18(2):237-250, 2023. e-Pub 2023. PMID: 36727622.
45. Sun C, Ye Y, Tan Z, Liu Y, Li Y, Hu W, Liang K, Egranov SD, Huang LA, Zhang Z, Zhang Y, Yao J, Nguyen TK, Zhao Z, Wu A, Marks JR, Caudle AS, Sahin AA, Gao J, Gammon ST, Piwnica-Worms D, Hu J, Chiao PJ, Yu D, Hung MC, Curran MA, Calin GA, Ying H, Han L, Lin C, Yang L. Tumor-associated nonmyelinating Schwann cell-expressed PVT1 promotes pancreatic cancer kynurenine pathway and tumor immune exclusion. Sci Adv 9(5):eadd6995, 2023. e-Pub 2023. PMID: 36724291.
46. Moore JA, Lehner MJ, Anfossi S, Datar S, Tidwell RS, Campbell M, Shah AY, Ward JF, Karam JA, Wood CG, Pisters LL, Calin GA, Tu SM. Predictive capacity of a miRNA panel in identifying teratoma in post-chemotherapy consolidation surgeries. BJUI Compass 4(1):81-87, 2023. e-Pub 2023. PMID: 36569509.
47. Pirlog R, Nemeth K, Calin GA. Editorial: Non-coding genome and endocrinology: from bench to bedside. Front Endocrinol (Lausanne) 14:1264302, 2023. e-Pub 2023. PMID: 37822601.
48. Jurj A, Qian D, Calin GA, Litchfield K. At the crossroad between checkpoint blockade and big data analyses: identification of novel biomarkers and potential targets. Ann Oncol 33(12):1214-1216, 2022. e-Pub 2022. PMID: 36456103.
49. Zhang Y, Sun C, Li Y, Qin J, Amancherla K, Jing Y, Hu Q, Liang K, Zhang Z, Ye Y, Huang LA, Nguyen TK, Egranov SD, Zhao Z, Wu A, Xi Y, Yao J, Hung MC, Calin GA, Cheng J, Lim B, Lehmann LH, Salem JE, Johnson DB, Curran MA, Yu D, Han L, Darabi R, Yang L, Moslehi JJ, Lin C. Hormonal therapies up-regulate MANF and overcome female susceptibility to immune checkpoint inhibitor myocarditis. Sci Transl Med 14(669):eabo1981, 2022. e-Pub 2022. PMID: 36322628.
50. Vicente DA, Schobel SA, Anfossi S, Hensman H, Lisboa F, Robertson H, Khatri V, Bradley MJ, Shimizu M, Buchman TG, Davis TA, Dente CJ, Kirk AD, Calin GA, Elster EA. Cellular microRNAs correlate with clinical parameters in multiple injury patients. J Trauma Acute Care Surg 93(4):427-438, 2022. e-Pub 2022. PMID: 35797620.
51. Hofman P, Calin GA, Mani SA, Bontoux C, Ilié M, Wistuba II. The Third Joint Meeting on Lung Cancer of the FHU OncoAge (University Côte d'Azur, Nice, France) and the University of Texas MD Anderson Cancer Center (Houston, TX, USA). Understanding New Therapeutic Options and Promising Predictive Biomarkers for Lung Cancer Patients. Cancers (Basel) 14(17), 2022. e-Pub 2022. PMID: 36077862.
52. Vykoukal J, Fahrmann JF, Patel N, Shimizu M, Ostrin EJ, Dennison JB, Ivan C, Goodman GE, Thornquist MD, Barnett MJ, Feng Z, Calin GA, Hanash SM. Contributions of Circulating microRNAs for Early Detection of Lung Cancer. Cancers (Basel) 14(17), 2022. e-Pub 2022. PMID: 36077759.
53. Farooqi AA, Fayyaz S, Poltronieri P, Calin G, Mallardo M. Epigenetic deregulation in cancer: Enzyme players and non-coding RNAs. Semin Cancer Biol 83:197-207, 2022. e-Pub 2020. PMID: 32738290.
54. Chen J, Tang S, Ke S, Cai JJ, Osorio D, Golovko A, Morpurgo B, Guo S, Sun Y, Winkle M, Calin GA, Tian Y. Ablation of long noncoding RNA MALAT1 activates antioxidant pathway and alleviates sepsis in mice. Redox Biol 54:102377, 2022. e-Pub 2022. PMID: 35763934.
55. Pirlog R, Calin GA. KRAS mutations as essential promoters of lymphangiogenesis via extracellular vesicles in pancreatic cancer. J Clin Invest 132(14), 2022. e-Pub 2022. PMID: 35838046.
56. Giordo R, Gulsha R, Kalla S, Calin GA, Lipovich L. LncRNA-Associated Genetic Etiologies Are Shared between Type 2 Diabetes and Cancers in the UAE Population. Cancers (Basel) 14(14), 2022. e-Pub 2022. PMID: 35884374.
57. Klec C, Knutsen E, Schwarzenbacher D, Jonas K, Pasculli B, Heitzer E, Rinner B, Krajina K, Prinz F, Gottschalk B, Ulz P, Deutsch A, Prokesch A, Jahn SW, Lellahi SM, Perander M, Barbano R, Graier WF, Parrella P, Calin GA, Pichler M. ALYREF, a novel factor involved in breast carcinogenesis, acts through transcriptional and post-transcriptional mechanisms selectively regulating the short NEAT1 isoform. Cell Mol Life Sci 79(7):391, 2022. e-Pub 2022. PMID: 35776213.
58. Garzon R, Pichiorri F, Palumbo T, Visentini M, Aqeilan R, Cimmino A, Wang H, Sun H, Volinia S, Alder H, Calin GA, C- L, Andreeff M, Croce CM. Correction to: MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia. Oncogene 41(25):3452-3453, 2022. e-Pub 2022. PMID: 35546352.
59. Lu Z, Mao W, Yang H, Santiago-O'Farrill JM, Rask PJ, Mondal J, Chen H, Ivan C, Liu X, Liu CG, Xi Y, Masuda K, Carrami EM, Chen M, Tang Y, Pang L, Lakomy DS, Calin GA, Liang H, Ahmed AA, Vankayalapati H, Bast RC. SIK2 inhibition enhances PARP inhibitor activity synergistically in ovarian and triple-negative breast cancers. J Clin Invest 132(11), 2022. e-Pub 2022. PMID: 35642638.
60. Butner JD, Dogra P, Chung C, Ruiz-Ramírez J, Nizzero S, Plodinec M, Li X, Pan PY, Chen SH, Cristini V, Ozpolat B, Calin GA, Wang Z. Dedifferentiation-mediated stem cell niche maintenance in early-stage ductal carcinoma in situ progression: insights from a multiscale modeling study. Cell Death Dis 13(5):485, 2022. e-Pub 2022. PMID: 35597788.
61. Yoon JH, Byun H, Ivan C, Calin GA, Jung D, Lee S. lncRNAs UC.145 and PRKG1-AS1 Determine the Functional Output of DKK1 in Regulating the Wnt Signaling Pathway in Gastric Cancer. Cancers (Basel) 14(10), 2022. e-Pub 2022. PMID: 35625973.
62. Németh K, Calin GA. Standardisation of protocols can be crucial in long non-coding RNA research. Br J Cancer 126(6):833-834, 2022. e-Pub 2022. PMID: 34912071.
63. Chen B, Dragomir MP, Yang C, Li Q, Horst D, Calin GA. Targeting non-coding RNAs to overcome cancer therapy resistance. Signal Transduct Target Ther 7(1), 2022. e-Pub 2022. PMID: 35418578.
64. Turk A, Calin GA, Kunej T. MicroRNAs in Leukemias: A Clinically Annotated Compendium. Int J Mol Sci 23(7), 2022. e-Pub 2022. PMID: 35408829.
65. Siqueira E, Obiols-Guardia A, Jorge-Torres OC, Oliveira-Mateos C, Soler M, Ramesh-Kumar D, Setién F, van Rossum D, Pascual-Alonso A, Xiol C, Ivan C, Shimizu M, Armstrong J, Calin GA, Pasterkamp RJ, Esteller M, Guil S. Analysis of the circRNA and T-UCR populations identifies convergent pathways in mouse and human models of Rett syndrome. Mol Ther Nucleic Acids 27:621-644, 2022. e-Pub 2022. PMID: 35036070.
66. Dogra P, Ramírez JR, Butner JD, Peláez MJ, Chung C, Hooda-Nehra A, Pasqualini R, Arap W, Cristini V, Calin GA, Ozpolat B, Wang Z. Translational Modeling Identifies Synergy between Nanoparticle-Delivered miRNA-22 and Standard-of-Care Drugs in Triple-Negative Breast Cancer. Pharm Res 39(3):511-528, 2022. e-Pub 2022. PMID: 35294699.
67. Vicente D, Schobel SA, Anfossi S, Hensman H, Lisboa F, Robertson H, Khatri V, Bradley MJ, Shimizu M, Buchman TG, Davis TA, Dente CJ, Kirk AD, Calin GA, Elster EA. Viral Micro-RNAs Are Detected in the Early Systemic Response to Injury and Are Associated With Outcomes in Polytrauma Patients. Crit Care Med 50(2):296-306, 2022. e-Pub 2021. PMID: 34259445.
68. Li Y, Chen D, Xuan H, Dragomir MP, Calin GA, Meng X, Chen M, Jin H. Construction and validation of prognostic nomogram for metaplastic breast cancer. Bosn J Basic Med Sci 22(1):131-139, 2022. e-Pub 2021. PMID: 34247567.
69. Zambalde EP, Adamoski D, Gradia DF, Rabinovich I, Rodrigues AC, Ivan C, EMSF R, Calin GA, Carvalho de Oliveira J. Transcribed Ultraconserved Regions Are Associated with Clinicopathological Features in Breast Cancer. Biomolecules 12(2), 2022. e-Pub 2022. PMID: 35204715.
70. Zhang MY, Calin G, Deng MD, Au-Yeung RKH, Wang LQ, Chim CS. Epigenetic Silencing of Tumor Suppressor lncRNA NKILA: Implication on NF-κB Signaling in Non-Hodgkin's Lymphoma. Genes (Basel) 13(1), 2022. e-Pub 2022. PMID: 35052468.
71. Dragomir MP, Tudor S, Lacatus M, Stanciulea O, Trandafir B, Diaconu A, Coriu D, Colita A, Droc G, Purnichescu-Purtan R, Calin G, Vasilescu C. TNF-alpha releasing capacity of the whole blood drops after open total splenectomy, but increases after partial/subtotal or minimally invasive splenectomy. Acta Chir Belg 122(5):1-11, 2022. e-Pub 2021. PMID: 33886417.
72. El-Arabey AA, Denizli M, Kanlikilicer P, Bayraktar R, Ivan C, Rashed M, Kabil N, Ozpolat B, Calin GA, Salama SA, Abd-Allah AR, Sood AK, Lopez-Berestein G. CORRIGENDUM: GATA3 as a master regulator for interactions of tumor-associated macrophages with high-grade serous ovarian carcinoma. Cell Signal 89:110147, 2022. e-Pub 2022. PMID: 34772589.
73. Tognon M, Calin GA, Del Valle L. Editorial: Epigenetics and molecular genetics of rare tumors. Front Oncol 12:1049140, 2022. e-Pub 2022. PMID: 36408168.
74. Chen B, Yang C, Dragomir MP, Chi D, Chen W, Horst D, Calin GA, Li Q. Association of proton pump inhibitor use with survival outcomes in cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis. Ther Adv Med Oncol 14:17588359221111703, 2022. e-Pub 2022. PMID: 35860836.
75. Tellez-Gabriel M, Tekpli X, Reine TM, Hegge B, Nielsen SR, Chen M, Moi L, Normann LS, Busund LR, Calin GA, Mælandsmo GM, Perander M, Theocharis AD, Kolset SO, Knutsen E. Serglycin Is Involved in TGF-β Induced Epithelial-Mesenchymal Transition and Is Highly Expressed by Immune Cells in Breast Cancer Tissue. Front Oncol 12:868868, 2022. e-Pub 2022. PMID: 35494005.
76. Mohapatra S, Calin GA. APPLE and translation: When a small peptideproduced from a "non-coding RNA" matters!. Mol Cell 81(21):4349-4351, 2021. e-Pub 2021. PMID: 34739825.
77. Esposito CL, Van Roosbroeck K, Santamaria G, Rotoli D, Sandomenico A, Wierda WG, Ferrajoli A, Ruvo M, Calin GA, de Franciscis V, Catuogno S. Selection of a Nuclease-Resistant RNA Aptamer Targeting CD19. Cancers (Basel) 13(20), 2021. e-Pub 2021. PMID: 34680368.
78. Mohapatra S, Calin G. JAM-ming miR-21. Cell Death Differ 28(10):2837-2839, 2021. e-Pub 2021. PMID: 34226679.
79. Chaftari P, Qdaisat A, Chaftari AM, Maamari J, Li Z, Lupu F, Raad I, Hachem R, Calin G, Yeung SJ. Prognostic Value of Procalcitonin, C-Reactive Protein, and Lactate Levels in Emergency Evaluation of Cancer Patients with Suspected Infection. Cancers (Basel) 13(16), 2021. e-Pub 2021. PMID: 34439240.
80. Li Y, Tan Z, Zhang Y, Zhang Z, Hu Q, Liang K, Jun Y, Ye Y, Li YC, Li C, Liao L, Xu J, Xing Z, Pan Y, Chatterjee SS, Nguyen TK, Hsiao H, Egranov SD, Putluri N, Coarfa C, Hawke DH, Gunaratne PH, Tsai KL, Han L, Hung MC, Calin GA, Namour F, Guéant JL, Muntau AC, Blau N, Sutton VR, Schiff M, Feillet F, Zhang S, Lin C, Yang L. A noncoding RNA modulator potentiates phenylalanine metabolism in mice. Science 373(6555):662-673, 2021. e-Pub 2021. PMID: 34353949.
81. Yeh M, Wang YY, Yoo JY, Oh C, Otani Y, Kang JM, Park ES, Kim E, Chung S, Jeon YJ, Calin GA, Kaur B, Zhao Z, Lee TJ. MicroRNA-138 suppresses glioblastoma proliferation through downregulation of CD44. Sci Rep 11(1):9219, 2021. e-Pub 2021. PMID: 33911148.
82. Tortora F, Calin GA, Cimmino A. Effects of long non-coding RNAs on androgen signaling pathways in genitourinary malignancies. Mol Cell Endocrinol 526:111197, 2021. e-Pub 2021. PMID: 33577974.
83. Butner JD, Wang Z, Elganainy D, Al Feghali KA, Plodinec M, Calin GA, Dogra P, Nizzero S, Ruiz-Ramírez J, Martin GV, Tawbi HA, Chung C, Koay EJ, Welsh JW, Hong DS, Cristini V. A mathematical model for the quantification of a patient's sensitivity to checkpoint inhibitors and long-term tumour burden. Nat Biomed Eng 5(4):297-308, 2021. e-Pub 2021. PMID: 33398132.
84. Calin GA. Quicker and digital: the way on protein biomarkers?. Blood 137(12):1564-1565, 2021. e-Pub 2021. PMID: 33764431.
85. Gorur A, Bayraktar R, Ivan C, Mokhlis HA, Bayraktar E, Kahraman N, Karakas D, Karamil S, Kabil NN, Kanlikilicer P, Aslan B, Tamer L, Wang Z, Cristini V, Lopez-Berestein G, Calin G, Ozpolat B. ncRNA therapy with miRNA-22-3p suppresses the growth of triple-negative breast cancer. Mol Ther Nucleic Acids 23:930-943, 2021. e-Pub 2021. PMID: 33614241.
86. Calin GA. Being Small and Intronic: miRNAs That Count!. Cancer Res 81(5):1212-1213, 2021. e-Pub 2021. PMID: 33822742.
87. Terreri S, Mancinelli S, Ferro M, Vitale MC, Perdonà S, Castaldo L, Gigantino V, Mercadante V, De Cecio R, Aquino G, Montella M, Angelini C, Del Prete E, Aprile M, Ciaramella A, Liguori GL, Costa V, Calin GA, La Civita E, Terracciano D, Febbraio F, Cimmino A. Subcellular Localization of uc.8+ as a Prognostic Biomarker in Bladder Cancer Tissue. Cancers (Basel) 13(4):1-19, 2021. e-Pub 2021. PMID: 33567603.
88. Butner JD, Fuentes D, Ozpolat B, Calin GA, Zhou X, Lowengrub J, Cristini V, Wang Z. Corrections to "A multiscale Agent-Based Model of Ductal Carcinoma in Situ". IEEE Trans Biomed Eng 68(2):736, 2021. e-Pub 2021. PMID: 33476261.
89. Crudden C, Shibano T, Song D, Dragomir MP, Cismas S, Serly J, Nedelcu D, Fuentes-Mattei E, Tica A, Calin GA, Girnita A, Girnita L. Inhibition of G protein-coupled receptor kinase 2 promotes unbiased downregulation of IGF-1 receptor and restrains malignant cell growth. Cancer Res 81(2):501-515, 2021. e-Pub 2020. PMID: 33158816.
90. Torsin LI, Petrescu GED, Sabo AA, Chen B, Brehar FM, Dragomir MP, Calin GA. Editing and Chemical Modifications on Non-Coding RNAs in Cancer: A New Tale with Clinical Significance. Int J Mol Sci 22(2):581, 2021. e-Pub 2021. PMID: 33430133.
91. das Chagas PF, de Sousa GR, Kodama MH, de Biagi Junior CAO, Yunes JA, Brandalise SR, Calin GA, Tone LG, Scrideli CA, de Oliveira JC. Ultraconserved long non-coding RNA uc.112 is highly expressed in childhood T versus B-cell acute lymphoblastic leukemia. Hematol Transfus Cell Ther 43(1):28-34, 2021. e-Pub 2020. PMID: 32014474.
92. Ajani JA, Xu Y, Huo L, Wang R, Li Y, Wang Y, Pizzi MP, Scott A, Harada K, Ma L, Yao X, Jin J, Zhao W, Dong X, Badgwell BD, Shanbhag N, Tatlonghari G, Estrella JS, Roy-Chowdhuri S, Kobayashi M, Vykoukal JV, Hanash SM, Calin GA, Peng G, Lee JS, Johnson RL, Wang Z, Wang L, Song S. YAP1 mediates gastric adenocarcinoma peritoneal metastases that are attenuated by YAP1 inhibition. Gut 70(1):55-66, 2021. e-Pub 2020. PMID: 32345613.
93. Wang R, Dang M, Harada K, Han G, Wang F, Pool Pizzi M, Zhao M, Tatlonghari G, Zhang S, Hao D, Lu Y, Zhao S, Badgwell BD, Blum Murphy M, Shanbhag N, Estrella JS, Roy-Chowdhuri S, Abdelhakeem AAF, Wang Y, Peng G, Hanash S, Calin GA, Song X, Chu Y, Zhang J, Li M, Chen K, Lazar AJ, Futreal A, Song S, Ajani JA, Wang L. Single-cell dissection of intratumoral heterogeneity and lineage diversity in metastastic gastric adenocarcinoma. Nat Med 27(1):141-151, 2021. e-Pub 2021. PMID: 33398161.
94. Zhang X, Calin GA. Profiling Long Non-coding RNA expression Using Custom-Designed Microarray. Methods Mol Biol 2372:43-51, 2021. e-Pub 2021. PMID: 34417742.
95. Rosenlund IA, Calin GA, Dragomir MP, Knutsen E. CRISPR/Cas9 to Silence Long Non-Coding RNAs. Methods Mol Biol 2348:175-187, 2021. e-Pub 2021. PMID: 34160807.
96. Hunt PJ, Kabotyanski KE, Calin GA, Xie T, Myers JN, Amit M. Interrupting Neuron-Tumor Interactions to Overcome Treatment Resistance. Cancers (Basel) 12(12):3741, 2020. e-Pub 2020. PMID: 33322770.
97. Hao D, He S, Harada K, Pizzi MP, Lu Y, Guan P, Chen L, Wang R, Zhang S, Sewastjanow-Silva M, Abdelhakeem A, Shanbhag N, Bhutani M, Han G, Lee JH, Zhao S, Weston B, Blum Murphy M, Waters R, Estrella JS, Roy-Chowdhuri S, Gan Q, Lee JS, Peng G, Hanash SM, Calin GA, Song X, Zhang J, Song S, Wang L, Ajani JA. Integrated genomic profiling and modeling for risk stratification in patients with advanced oesophagogastric adenocarcinoma. Gut 70(11):2055-2065, 2020. e-Pub 2020. PMID: 33334899.
98. Silverman DA, Martinez VK, Dougherty PM, Myers JN, Calin GA, Amit M. Cancer-associated neurogenesis and nerve-cancer crosstalk. Cancer Res 81(6):1431-1440, 2020. e-Pub 2020. PMID: 33334813.
99. Evangelista AF, de Menezes WP, Berardinelli GN, Dos Santos W, Scapulatempo-Neto C, Guimaraes DP, Calin GA, Reis RM. Pyknon-Containing Transcripts Are Downregulated in Colorectal Cancer Tumors, and Loss of PYK44 Is Associated With Worse Patient Outcome. Front Genet, 2020. e-Pub 2020. PMID: 33304384.
100. Zhang MY, Calin GA, Yuen KS, Jin DY, Chim CS. Epigenetic silencing of miR-342-3p in B cell lymphoma and its impact on autophagy. Clin Epigenetics 12(1):150, 2020. e-Pub 2020. PMID: 33076962.
101. Cortez MA, Masrorpour F, Ivan C, Zhang J, Younes AI, Lu Y, Estecio MR, Barsoumian HB, Menon H, da Silva Caetano M, Ramapriyan R, Schoenhals JE, Wang X, Skoulidis F, Wasley MD, Calin G, Hwu P, Welsh JW. Author Correction: Bone morphogenetic protein 7 promotes resistance to immunotherapy. Nat Commun 11(1):5144, 2020. e-Pub 2020. PMID: 33033261.
102. Duceac LD, Calin GA, Eva L, Marcu C, Bogdan Goroftei ER, Dabija MG, Mitrea G, Luca AC, Hanganu E, Gutu C, Stafie L, Banu EA, Grierosu C, Iordache AC. Third-Generation Cephalosporin-Loaded Chitosan Used to Limit Microorganisms Resistance. Materials (Basel) 13(21):4792, 2020. e-Pub 2020. PMID: 33120990.
103. Dragomir MP, Moisoiu V, Manaila R, Pardini B, Knutsen E, Anfossi S, Amit M, Calin GA. A Holistic Perspective: Exosomes Shuttle between Nerves and Immune Cells in the Tumor Microenvironment. J Clin Med 9(11):3529, 2020. e-Pub 2020. PMID: 33142779.
104. Pichler M, Rodriguez-Aguayo C, Nam SY, Dragomir MP, Bayraktar R, Anfossi S, Knutsen E, Ivan C, Fuentes-Mattei E, Lee SK, Ling H, Catela Ivkovic T, Huang G, Huang L, Okugawa Y, Katayama H, Taguchi A, Bayraktar E, Bhattacharya R, Amero P, He WR, Tran AM, Vychytilova-Faltejskova P, Klec C, Bonilla DL, Zhang X, Kapitanovic S, Loncar B, Gafà R, Wang Z, Cristini V, Hanash SM, Bar-Eli M, Lanza G, Slaby O, Goel A, Rigoutsos I, Lopez-Berestein G, Calin GA. Therapeutic potential of FLANC, a novel primate-specific long non-coding RNA in colorectal cancer. Gut 69(10):1818-1831, 2020. e-Pub 2020. PMID: 31988194.
105. Cortez MA, Masrorpour F, Ivan C, Zhang J, Younes AI, Lu Y, Estecio MR, Barsoumian HB, Menon H, Caetano MDS, Ramapriyan R, Schoenhals JE, Wang X, Skoulidis F, Wasley MD, Calin G, Hwu P, Welsh JW. Bone morphogenetic protein 7 promotes resistance to immunotherapy. Nat Commun 11(1):4840, 2020. e-Pub 2020. PMID: 32973129.
106. Dragomir MP, Manyam GC, Ott LF, Berland L, Knutsen E, Ivan C, Lipovich L, Broom BM, Calin GA. FuncPEP: A Database of Functional Peptides Encoded by Non-Coding RNAs. Noncoding RNA 6(4), 2020. e-Pub 2020. PMID: 32977531.
107. Chen B, Dragomir MP, Fabris L, Bayraktar R, Knutsen E, Liu X, Tang C, Li Y, Shimura T, Ivkovic TC, De Los Santos MC, Anfossi S, Shimizu M, Shah MY, Ling H, Shen P, Multani AS, Pardini B, Burks JK, Katayama H, Reineke LC, Huo L, Syed M, Song S, Ferracin M, Oki E, Fromm B, Ivan C, Bhuvaneshwar K, Gusev Y, Mimori K, Menter D, Sen S, Matsuyama T, Uetake H, Vasilescu C, Kopetz S, Parker-Thornburg J, Taguchi A, Hanash SM, Girnita L, Slaby O, Goel A, Varani G, Gagea M, Li C, Ajani JA, Calin GA. The Long Noncoding RNA CCAT2 induces chromosomal instability through BOP1 - AURKB signaling. Gastroenterology. e-Pub 2020. PMID: 32805281.
108. Wang LQ, Kumar S, Calin GA, Li Z, Chim CS. Frequent methylation of the tumour suppressor miR-1258 targeting PDL1: implication in multiple myeloma-specific cytotoxicity and prognostification. Br J Haematol 190(2):249-261, 2020. e-Pub 2020. PMID: 32079038.
109. De Luca G, Cardinali B, Del Mastro L, Lastraioli S, Carli F, Ferrarini M, Calin GA, Garuti A, Mazzitelli C, Zupo S, Dono M. Optimization of a WGA-Free Molecular Tagging-Based NGS Protocol for CTCs Mutational Profiling. Int J Mol Sci 21(12), 2020. e-Pub 2020. PMID: 32575430.
110. Rupaimoole R, Wu SY, Pradeep S, Ivan C, Pecot CV, Gharpure KM, Nagaraja AS, Armaiz-Pena GN, McGuire M, Zand B, Dalton HJ, Filant J, Miller JB, Lu C, Sadaoui NC, Mangala LS, Taylor M, van den Beucken T, Koch E, Rodriguez-Aguayo C, Huang L, Bar-Eli M, Wouters BG, Radovich M, Ivan M, Calin GA, Zhang W, Lopez-Berestein G, Sood AK. Author Correction: Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progression. Nat Commun 11(1):2867, 2020. e-Pub 2020. PMID: 32493919.
111. Chen F, Wu X, Niculite C, Gilca M, Petrusca D, Rogozea A, Rice S, Guo B, Griffin S, Calin GA, Boswell HS, Konig H. Classic and targeted anti-leukaemic agents interfere with the cholesterol biogenesis metagene in acute myeloid leukaemia: Therapeutic implications. J Cell Mol Med. e-Pub 2020. PMID: 32450611.
112. Butner JD, Fuentes D, Ozpolat B, Calin GA, Zhou X, Lowengrub J, Cristini V, Wang Z. A multiscale agent-based model of ductal carcinoma in situ. IEEE Trans Biomed Eng 67(5):1450-1461, 2020. e-Pub 2020. PMID: 31603768.
113. Calin GA. Pseudogenes, RNAs and new reproducibility norms. Elife 9, 2020. e-Pub 2020. PMID: 32314733.
114. El-Arabey AA, Denizli M, Kanlikilicer P, Bayraktar R, Ivan C, Rashed M, Kabil N, Ozpolat B, Calin GA, Salama SA, Abd-Allah AR, Sood AK, Lopez-Berestein G. GATA3 as a master regulator for interactions of tumor-associated macrophages with high-grade serous ovarian carcinoma. Cell Signal 68:109539, 2020. e-Pub 2020. PMID: 31935430.
115. Dragomir MP, Kopetz S, Ajani JA, Calin GA. Non-coding RNAs in GI cancers: from cancer hallmarks to clinical utility. Gut 69(4):748-763, 2020. e-Pub 2020. PMID: 32034004.
116. Panatta E, Lena AM, Mancini M, Smirnov A, Marini A, Delli Ponti R, Botta-Orfila T, Tartaglia GG, Mauriello A, Zhang X, Calin GA, Melino G, Candi E. Long non-coding RNA uc.291 controls epithelial differentiation by interfering with the ACTL6A/BAF complex. EMBO Rep 21(3):e46734, 2020. e-Pub 2020. PMID: 32017402.
117. Anfossi S, Calin GA. When non-coding is not enough. J Exp Med 217(3), 2020. e-Pub 2020. PMID: 32023341.
118. Chari NS, Ivan C, Le X, Li J, Mijiti A, Patel AA, Osman AA, Peterson CB, Williams MD, Pickering CR, Caulin C, Myers JN, Calin GA, Lai SY. Disruption of TP63-miR-27a* feedback loop by mutant TP53 in head and neck cancer. J Natl Cancer Inst 112(3):266-277, 2020. e-Pub 2020. PMID: 31124563.
119. Anfonssi S, Calin GA. Gut microbiota: a new player in regulating immune- and chemo-therapy efficacy. Cancer Drug Resist, 2020. e-Pub 2020. PMID: 33062956.
120. Kanlikilicer P, Bayraktar R, Denizli M, Rashed MH, Ivan C, Aslan B, Mitra R, Karagoz K, Bayraktar E, Zhang X, Rodriguez-Aguayo C, El-Arabey AA, Kahraman N, Baydogan S, Ozkayar O, Gatza ML, Ozpolat B, Calin GA, Sood AK, Lopez-Berestein G. Corrigendum to 'Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer' [EBioMedicine 38 (2018) 100-112]. EBioMedicine 52:102630, 2020. e-Pub 2020. PMID: 31972470.
121. Amit M, Takahashi H, Dragomir MP, Lindemann A, Gleber-Netto FO, Pickering CR, Anfossi S, Osman AA, Cai Y, Wang R, Knutsen E, Shimizu M, Ivan C, Rao X, Wang J, Silverman DA, Tam S, Zhao M, Caulin C, Zinger A, Tasciotti E, Dougherty PM, El-Naggar A, Calin GA, Myers JN. Loss of p53 drives neuron reprogramming in head and neck cancer. Nature 578(7795):449-454, 2020. e-Pub 2020. PMID: 32051587.
122. Pellecchia S, Sepe R, Decaussin-Petrucci M, Ivan C, Shimizu M, Coppola C, Testa D, Calin GA, Fusco A, Pallante P. The Long Non-Coding RNA Prader Willi/Angelman Region RNA5 (PAR5) Is Downregulated in Anaplastic Thyroid Carcinomas Where It Acts as a Tumor Suppressor by Reducing EZH2 Activity. Cancers (Basel) 12(1), 2020. e-Pub 2020. PMID: 31963578.
123. Fuentes-Mattei E, Bayraktar R, Manshouri T, Silva AM, Ivan C, Gulei D, Fabris L, Soares do Amaral N, Mur P, Perez C, Torres-Claudio E, Dragomir MP, Badillo-Perez A, Knutsen E, Narayanan P, Golfman L, Shimizu M, Zhang X, Zhao W, Ho WT, Estecio MR, Bartholomeusz G, Tomuleasa C, Berindan-Neagoe I, Zweidler-McKay PA, Estrov Z, Zhao ZJ, Verstovsek S, Calin GA, Redis RS. miR-543 regulates the epigenetic landscape of myelofibrosis by targeting TET1 and TET2. JCI Insight 5(1), 2020. e-Pub 2020. PMID: 31941838.
124. Rezaeian AH, Khanbabaei H, Calin GA. Therapeutic Potential of the microRNA-ATM Axis in the Management of Tumor Radioresistance. Cancer Res 80(2):139-150, 2020. e-Pub 2020. PMID: 31767626.
125. Wang R, Song S, Harada K, Ghazanfari Amlashi F, Badgwell B, Pizzi MP, Xu Y, Zhao W, Dong X, Jin J, Wang Y, Scott A, Ma L, Huo L, Vicente D, Blum Murphy M, Shanbhag N, Tatlonghari G, Thomas I, Rogers J, Kobayashi M, Vykoukal J, Estrella JS, Roy-Chowdhuri S, Han G, Zhang S, Mao X, Song X, Zhang J, Gu J, Johnson RL, Calin GA, Peng G, Lee JS, Hanash SM, Futreal A, Wang Z, Wang L, Ajani JA. Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response. Gut 69(1):18-31, 2020. e-Pub 2020. PMID: 31171626.
126. Dias MM, Adamoski D, Dos Reis LM, Ascenção CFR, de Oliveira KRS, Mafra ACP, da Silva Bastos AC, Quintero M, de G Cassago C, Ferreira IM, Fidelis CHV, Rocco SA, Bajgelman MC, Stine Z, Berindan-Neagoe I, Calin GA, Ambrosio ALB, Dias SMG. GLS2 is protumorigenic in breast cancers. Oncogene 39(3):690-702, 2020. e-Pub 2020. PMID: 31541193.
127. Terracciano D, Buonerba C, Scafuri L, De Berardinis P, Calin GA, Ferrajoli A, Fabbri M, Cimmino A. Perspective: Cancer Patient Management Challenges During the COVID-19 Pandemic. Front Oncol 10:1556, 2020. e-Pub 2020. PMID: 32984015.
128. Silverman DA, Calin GA, Myers JN, Amit M. Neural reprogramming via microRNAs: the new kid on the p53-deficient block. Mol Cell Oncol 7(4):1756723, 2020. e-Pub 2020. PMID: 32944617.
129. Li Z, Kumar S, Jin DY, Calin GA, Chng WJ, Siu KL, Poon MW, Chim CS. Epigenetic silencing of long non-coding RNA BM742401 in multiple myeloma: impact on prognosis and myeloma dissemination. Cancer Cell Int 20:403, 2020. e-Pub 2020. PMID: 32855620.
130. De Los Santos MC, Dragomir MP, Calin GA. The role of exosomal long non-coding RNAs in cancer drug resistance. Cancer Drug Resist 2:1178-1192, 2019. e-Pub 2019. PMID: 31867576.
131. Oncul S, Amero P, Rodriguez-Aguayo C, Calin GA, Sood AK, Lopez-Berestein G. Long non-coding RNAs in ovarian cancer: expression profile and functional spectrum. RNA Biol:1-12. e-Pub 2019. PMID: 31847695.
132. Calin GA, Fabris L. Molecular aspects of medicine - Editorial 2019. Mol Aspects Med 70:1-2, 2019. e-Pub 2019. PMID: 31735351.
133. Dragomir MP, Tudor S, Okubo K, Shimizu M, Chen M, Giza DE, He WR, Ivan C, Calin GA, Vasilescu C. The non-coding RNome after splenectomy. J Cell Mol Med 23(11):7844-7858, 2019. e-Pub 2019. PMID: 31496026.
134. Habic A, Mattick JS, Calin GA, Krese R, Konc J, Kunej T. Genetic Variations of Ultraconserved Elements in the Human Genome. OMICS 23(11):549-559, 2019. e-Pub 2019. PMID: 31689173.
135. Li Y, Chen M, Pardini B, Dragomir MP, Lucci A, Calin GA. The role of radiotherapy in metaplastic breast cancer: a propensity score-matched analysis of the SEER database. J Transl Med 17(1):318, 2019. e-Pub 2019. PMID: 31547814.
136. Fabbri M, Girnita L, Varani G, Calin GA. Decrypting noncoding RNA interactions, structures, and functional networks. Genome Res 29(9):1377-1388, 2019. e-Pub 2019. PMID: 31434680.
137. Li Z, Wong KY, Calin GA, Chng WJ, Chan GC, Chim CS. Epigenetic silencing of miR-340-5p in multiple myeloma: mechanisms and prognostic impact. Clin Epigenetics 11(1):71, 2019. e-Pub 2019. PMID: 31064412.
138. Van Roosbroeck K, Bayraktar R, Calin S, Bloehdorn J, Dragomir MP, Okubo K, Bertilaccio MTS, Zupo S, You MJ, Gaidano G, Rossi D, Chen SS, Chiorazzi N, Thompson PA, Ferrajoli A, Bertoni F, Stilgenbauer S, Keating MJ, Calin GA. miRNAs involvement in the pathogenesis of Richter's syndrome. Haematologica 104(5):1004-1015, 2019. e-Pub 2019. PMID: 30409799.
139. Calin GA. Preface for GCC Special Issue on non-coding RNAs, non-coding DNAs and genome editing. Genes Chromosomes Cancer 58(4):189-190, 2019. e-Pub 2019. PMID: 30474323.
140. Calin GA, Pardini B. Mir-roring hypoxia in EGFR-TKI tolerance. Nat Metab 1(4):418-419, 2019. e-Pub 2019. PMID: 32694876.
141. Mokhlis HA, Bayraktar R, Kabil NN, Caner A, Kahraman N, Rodriguez-Aguayo C, Zambalde EP, Sheng J, Karagoz K, Kanlikilicer P, Abdel Aziz AAH, Abdelghany TM, Ashour AA, Wong S, Gatza ML, Calin GA, Lopez-Berestein G, Ozpolat B. The Modulatory Role of MicroRNA-873 in the Progression of KRAS-Driven Cancers. Mol Ther Nucleic Acids 14:301-317, 2019. e-Pub 2019. PMID: 30654191.
142. Diniz MG, França JA, Vilas-Boas FAS, de Souza FTA, Calin GA, Gomez RS, de Sousa SF, Gomes CC. The long noncoding RNA KIAA0125 is upregulated in ameloblastomas. Pathol Res Pract 215(3):466-469, 2019. e-Pub 2019. PMID: 30595406.
143. Schwarzenbacher D, Klec C, Pasculli B, Cerk S, Rinner B, Karbiener M, Ivan C, Barbano R, Ling H, Wulf-Goldenberg A, Stanzer S, Rinnerthaler G, Stoeger H, Bauernhofer T, Haybaeck J, Hoefler G, Jahn SW, Parrella P, Calin GA, Pichler M. MiR-1287-5p inhibits triple negative breast cancer growth by interaction with phosphoinositide 3-kinase CB, thereby sensitizing cells for PI3Kinase inhibitors. Breast Cancer Res 21(1):20, 2019. e-Pub 2019. PMID: 30709367.
144. Gulei D, Raduly L, Berindan-Neagoe I, Calin GA. CRISPR based RNA editing: diagnostic applications and therapeutic options. Expert Rev Mol Diagn 19(2):1-6, 2019. e-Pub 2019. PMID: 30632384.
145. Varkaris A, Katsiampoura A, Davis JS, Shah N, Lam M, Frias RL, Ivan C, Shimizu M, Morris J, Menter D, Overman M, Tran H, Heymach J, Chun YS, Vauthey JN, Calin G, Kopetz S. Circulating inflammation signature predicts overall survival and relapse-free survival in metastatic colorectal cancer. Br J Cancer 120(3):340-345, 2019. e-Pub 2019. PMID: 30636774.
146. Mitra K, Feist WN, Anfossi S, Fuentes-Mattei E, Almeida MI, Kim JJ, Calin GA, Warmflash A. S-MiRAGE: A quantitative, secreted RNA-based reporter of gene expression and cell persistence. ACS Synth Biol 8(1):25-33, 2019. e-Pub 2019. PMID: 30550267.
147. Calin GA. The noncoding RNA revolution-three decades and still going strong!. Mol Oncol 13(1):3, 2019. e-Pub 2019. PMID: 30614645.
148. Lujambio A, Portela A, Liz J, Melo SA, Rossi S, Spizzo R, Croce CM, Calin GA, Esteller M. Correction: CpG island hypermethylation-associated silencing of non-coding RNAs transcribed from ultraconserved regions in human cancer. Oncogene 38(5):765-766, 2019. e-Pub 2019. PMID: 30397238.
149. Van Roosbroeck K, Bayraktar R, Calin GA. Measurement of miRNAs in Chronic Lymphocytic Leukemia Patient Samples by Quantitative Reverse Transcription PCR. Methods Mol Biol 1881:267-276, 2019. e-Pub 2019. PMID: 30350212.
150. Kanlikilicer P, Bayraktar R, Denizli M, Rashed MH, Ivan C, Aslan B, Mitra R, Karagoz K, Bayraktar E, Zhang X, Rodriguez-Aguayo C, El-Arabey AA, Kahraman N, Baydogan S, Ozkayar O, Gatza ML, Ozpolat B, Calin GA, Sood AK, Lopez-Berestein G. Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer. EBioMedicine 38:100-112, 2018. e-Pub 2018. PMID: 30487062.
151. Foßelteder J, Calin GA, Pichler M. Long non-coding RNA CCAT2 as a therapeutic target in colorectal cancer. Expert Opin Ther Targets 22(12):1-4, 2018. e-Pub 2018. PMID: 30365347.
152. Abruzzo LV, Herling CD, Calin GA, Oakes C, Barron LL, Banks HE, Katju V, Keating MJ, Coombes KR. Trisomy 12 chronic lymphocytic leukemia expresses a unique set of activated and targetable pathways. Haematologica 103(12):2069-2078, 2018. e-Pub 2018. PMID: 29976738.
153. Shen P, Reineke LC, Knutsen E, Chen M, Pichler M, Ling H, Calin GA. Metformin blocks MYC protein synthesis in colorectal cancer via mTOR-4EBP-eIF4E and MNK-1-eIF4G-eIF4E signaling. Mol Oncol 12(11):1856-1870, 2018. e-Pub 2018. PMID: 30221473.
154. Fu X, Calin GA. miR-122 and hepatocellular carcinoma: from molecular biology to therapeutics. EBioMedicine 37:17-18, 2018. e-Pub 2018. PMID: 30337246.
155. Kabil N, Bayraktar R, Kahraman N, Mokhlis HA, Calin GA, Lopez-Berestein G, Ozpolat B. Thymoquinone inhibits cell proliferation, migration, and invasion by regulating the elongation factor 2 kinase (eEF-2K) signaling axis in triple-negative breast cancer. Breast Cancer Res Treat 171(3):593-605, 2018. e-Pub 2018. PMID: 29971628.
156. Wu X, Tudoran OM, Calin GA, Ivan M. The Many Faces of Long Noncoding RNAs in Cancer. Antioxid Redox Signal 29(9):922-935, 2018. e-Pub 2018. PMID: 28793797.
157. Xiao H, Shiu PKT, Shu J, Santulli G, Gheybi MK, Conn SJ, Bogard B, Hubé F, Taube JH, Mani SA, Song L, Calin GA, Zhang S. The Non-Coding RNA Journal Club: Highlights on Recent Papers-6. Noncoding RNA 4(3), 2018. e-Pub 2018. PMID: 30231579.
158. Dragomir MP, Calin GA. CpG island hypermethylation go circular (RNA). Oncotarget 9(69):33052-33053, 2018. e-Pub 2018. PMID: 30237846.
159. Bayraktar R, Ivan C, Bayraktar E, Kanlikilicer P, Kabil NN, Kahraman N, Mokhlis HA, Karakas D, Rodriguez-Aguayo C, Arslan A, Sheng J, Wong S, Lopez-Berestein G, Calin GA, Ozpolat B. Dual suppressive effect of microRNA-34a on the FOXM1/eEF2-kinase axis regulates triple-negative breast cancer growth and invasion. Clin Cancer Res 24(17):4225-4241, 2018. e-Pub 2018. PMID: 29748184.
160. Monroig-Bosque PDC, Shah MY, Fu X, Fuentes-Mattei E, Ling H, Ivan C, Nouraee N, Huang B, Chen L, Pileczki V, Redis RS, Jung EJ, Zhang X, Lehrer M, Nagvekar R, Mafra ACP, Monroig-Bosque MDM, Irimie A, Rivera C, Dan Dumitru C, Berindan-Neagoe I, Nikonowicz EP, Zhang S, Calin GA. OncomiR-10b hijacks the small molecule inhibitor linifanib in human cancers. Sci Rep 8(1):13106, 2018. e-Pub 2018. PMID: 30166612.
161. Chaganty BKR, Qiu S, Gest A, Lu Y, Ivan C, Calin GA, Weiner LM, Fan Z. Trastuzumab upregulates PD-L1 as a potential mechanism of trastuzumab resistance through engagement of immune effector cells and stimulation of IFNγ secretion. Cancer Lett 430:47-56, 2018. e-Pub 2018. PMID: 29746929.
162. Dragomir MP, Knutsen E, Calin GA. SnapShot: Unconventional miRNA Functions. Cell 174(4):1038-1038.e1, 2018. e-Pub 2018. PMID: 30096304.
163. Malpeli G, Barbi S, Tosadori G, Greco C, Zupo S, Pedron S, Brunelli M, Bertolaso A, Scupoli MT, Krampera M, Kamga PT, Croce CM, Calin GA, Scarpa A, Zamò A. MYC-related microRNAs signatures in non-Hodgkin B-cell lymphomas and their relationships with core cellular pathways. Oncotarget 9(51):29753-29771, 2018. e-Pub 2018. PMID: 30038718.
164. Manga G, Calin GA, Manuc M, Droc G, Tudor S. New Definitions of Sepsis and the Quest for Specific Biomarkers. Are the miRNAs the Answer?. Chirurgia (Bucur) 113(4):464-468, 2018. e-Pub 2018. PMID: 30183576.
165. Calin GA. Featuring the Special Issue Guest Editor. Cancer Lett 423:27, 2018. e-Pub 2018. PMID: 29330106.
166. Del Vecchio F, Lee GH, Hawezi J, Bhome R, Pugh S, Sayan E, Thomas G, Packham G, Primrose J, Pichler M, Mirnezami A, Calin G, Bullock M. Long non-coding RNAs within the tumour microenvironment and their role in tumour-stroma cross-talk. Cancer Lett 421:94-102, 2018. e-Pub 2018. PMID: 29458141.
167. Dragomir M, Chen B, Fu X, Calin GA. Key questions about the checkpoint blockade-are microRNAs an answer?. Cancer Biol Med 15(2):103-115, 2018. e-Pub 2018. PMID: 29951335.
168. Peng Y, Calin GA. Crucial role of non-coding RNAs in disease. Cancer Lett 420:127-128, 2018. e-Pub 2018. PMID: 29425682.
169. Shah MY, Ferracin M, Pileczki V, Chen B, Redis R, Fabris L, Zhang X, Ivan C, Shimizu M, Rodriguez-Aguayo C, Dragomir M, Van Roosbroeck K, Almeida MI, Ciccone M, Nedelcu D, Cortez MA, Manshouri T, Calin S, Muftuoglu M, Banerjee PP, Badiwi MH, Parker-Thornburg J, Multani A, Welsh JW, Estecio MR, Ling H, Tomuleasa C, Dima D, Yang H, Alvarez H, You MJ, Radovich M, Shpall E, Fabbri M, Rezvani K, Girnita L, Berindan-Neagoe I, Maitra A, Verstovsek S, Fodde R, Bueso-Ramos C, Gagea M, Manero GG, Calin GA. Cancer-associated rs6983267 SNP and its accompanying long noncoding RNACCAT2induce myeloid malignancies via unique SNP-specific RNA mutations. Genome Res 28(4):432-447, 2018. e-Pub 2018. PMID: 29567676.
170. Calin GA, Van Roosbroeck K. Preface. Cancer Metastasis Rev 37(1):3-4, 2018. e-Pub 2018. PMID: 29285656.
171. Pop-Bica C, Pintea S, Cojocneanu-Petric R, Del Sal G, Piazza S, Wu ZH, Alencar AJ, Lossos IS, Berindan-Neagoe I, Calin GA. MiR-181 family-specific behavior in different cancers: a meta-analysis view. Cancer Metastasis Rev 37(1):17-32, 2018. e-Pub 2018. PMID: 29327093.
172. Dragomir M, Chen B, Calin GA. Exosomal lncRNAs as new players in cell-to-cell communication. Transl Cancer Res 7(Suppl 2):S243-S252, 2018. e-Pub 2018. PMID: 30148073.
173. Velazquez-Torres G, Shoshan E, Ivan C, Huang L, Fuentes-Mattei E, Paret H, Kim SJ, Rodriguez-Aguayo C, Xie V, Brooks D, Jones SJM, Robertson AG, Calin G, Lopez-Berenstein G, Sood A, Bar-Eli M. A-to-I miR-378a-3p editing can prevent melanoma progression via regulation of PARVA expression. Nat Commun 9(1):461, 2018. e-Pub 2018. PMID: 29386624.
174. Vannini I, Wise PM, Challagundla KB, Plousiou M, Raffini M, Bandini E, Fanini F, Paliaga G, Crawford M, Ferracin M, Ivan C, Fabris L, Davuluri RV, Guo Z, Cortez MA, Zhang X, Chen L, Zhang S, Fernandez-Cymering C, Han L, Carloni S, Salvi S, Ling H, Murtadha M, Neviani P, Gitlitz BJ, Laird-Offringa IA, Nana-Sinkam P, Negrini M, Liang H, Amadori D, Cimmino A, Calin GA, Fabbri M. Publisher Correction: Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs. Nat Commun 9(1):160, 2018. e-Pub 2018. PMID: 29311577.
175. Bellido F, Sowada N, Mur P, Lázaro C, Pons T, Valdés-Mas R, Pineda M, Aiza G, Iglesias S, Soto JL, Urioste M, Caldés T, Balbín M, Blay P, Rueda D, Durán M, Valencia A, Moreno V, Brunet J, Blanco I, Navarro M, Calin GA, Borck G, Puente XS, Capellá G, Valle L. Association Between Germline Mutations in BRF1, a subunit of the RNA Polymerase III Transcription Complex, and Hereditary Colorectal Cancer. Gastroenterology 154(1):181-194.e20, 2018. e-Pub 2018. PMID: 28912018.
176. Jacobs DI, Liu Y, Gabrusiewicz K, Tsavachidis S, Armstrong GN, Zhou R, Wei J, Ivan C, Calin G, Molinaro AM, Rice T, Bracci PM, Hansen HM, Wiencke JK, Wrensch MR, Heimberger AB, Bondy ML. Germline polymorphisms in myeloid-associated genes are not associated with survival in glioma patients. J Neurooncol 136(1):33-39, 2018. e-Pub 2018. PMID: 28965162.
177. Shen J, Hodges TR, Song R, Gong Y, Calin GA, Heimberger AB, Zhao H. Serum HOTAIR and GAS5 levels as predictors of survival in patients with glioblastoma. Mol Carcinog 57(1):137-141, 2018. e-Pub 2018. PMID: 28926136.
178. Anfossi S, Fu X, Nagvekar R, Calin GA. MicroRNAs, Regulatory Messengers Inside and Outside Cancer Cells. Adv Exp Med Biol 1056:87-108, 2018. e-Pub 2018. PMID: 29754176.
179. Marks DL, Olson RL, Urrutia R, Billadeau DD, Roy N, Calin GA, Fabbri M, Koutsioumpa M, Iliopoulos D, Ordog T, Huebert R, Sarmento O, Bamidele AO, Faubion W, Lomberk GL, Siveke J, Ahuja N, Iovanna J, Hlady RA, Robertson K, Kisiel J, Pin CL, Fernandez-Zapico ME. Epigenetics of gastrointestinal diseases: notes from a workshop. Epigenetics 13(4):449-457, 2018. e-Pub 2018. PMID: 30056798.
180. Dragomir M, Calin GA. Corrigendum: Circular RNAs in Cancer - Lessons Learned From microRNAs. Front Oncol 8:307, 2018. e-Pub 2018. PMID: 30280089.
181. Silva AM, Almeida MI, Teixeira JH, Ivan C, Oliveira J, Vasconcelos D, Neves N, Ribeiro-Machado C, Cunha C, Barbosa MA, Calin GA, Santos SG. Profiling the circulating miRnome reveals a temporal regulation of the bone injury response. Theranostics 8(14):3902-3917, 2018. e-Pub 2018. PMID: 30083269.
182. Nassar FJ, Talhouk R, Zgheib NK, Tfayli A, El Sabban M, El Saghir NS, Boulos F, Jabbour MN, Chalala C, Boustany RM, Kadara H, Zhang Z, Zheng Y, Joyce B, Hou L, Bazarbachi A, Calin G, Nasr R. microRNA Expression in Ethnic Specific Early Stage Breast Cancer: an Integration and Comparative Analysis. Sci Rep 7(1):16829, 2017. e-Pub 2017. PMID: 29203780.
183. Vannini I, Wise PM, Challagundla KB, Plousiou M, Raffini M, Bandini E, Fanini F, Paliaga G, Crawford M, Ferracin M, Ivan C, Fabris L, Davuluri RV, Guo Z, Cortez MA, Zhang X, Chen L, Zhang S, Fernandez-Cymering C, Han L, Carloni S, Salvi S, Ling H, Murtadha M, Neviani P, Gitlitz BJ, Laird-Offringa IA, Nana-Sinkam P, Negrini M, Liang H, Amadori D, Cimmino A, Calin GA, Fabbri M. Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs. Nat Commun 8(1):1801, 2017. e-Pub 2017. PMID: 29180617.
184. D'Abundo L, Callegari E, Bresin A, Chillemi A, Elamin BK, Guerriero P, Huang X, Saccenti E, EMAA H, Casciano F, Secchiero P, Zauli G, Calin GA, Russo G, Lee LJ, Croce CM, Marcucci G, Sabbioni S, Malavasi F, Negrini M. Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse model. Oncogene 36(47):6617-6626, 2017. e-Pub 2017. PMID: 28783166.
185. Yuan T, Yang Y, Chen J, Li W, Li W, Zhang Q, Mi Y, Goswami RS, You JQ, Lin D, Qian MD, Calin S, Liang Y, Miranda RN, Calin GA, Zhou X, Ma L, Zweidler-McKay PA, Liu B, Weng AP, Medeiros LJ, Zhang Y, You MJ. Regulation of PI3K signaling in T cell acute lymphoblastic leukemia: A novel PTEN/Ikaros/miR-26b mechanism reveals a critical targetable role for PIK3CD. Leukemia 31(11):2355-2364, 2017. e-Pub 2017. PMID: 28280276.
186. Figueroa J, Phillips LM, Shahar T, Hossain A, Gumin J, Kim H, Bean AJ, Calin GA, Fueyo J, Walters ET, Kalluri R, Verhaak RG, Lang FF. Exosomes from Glioma-Associated Mesenchymal Stem Cells Increase the Tumorigenicity of Glioma Stem-like Cells via Transfer of miR-1587. Cancer Res 77(21):5808-5819, 2017. e-Pub 2017. PMID: 28855213.
187. Amorim MG, Valieris R, Drummond RD, Pizzi MP, Freitas VM, Sinigaglia-Coimbra R, Calin GA, Pasqualini R, Arap W, Silva IT, Dias-Neto E, Nunes DN. A total transcriptome profiling method for plasma-derived extracellular vesicles: applications for liquid biopsies. Sci Rep 7(1):14395, 2017. e-Pub 2017. PMID: 29089558.
188. Suleymanova N, Crudden C, Shibano T, Worrall C, Oprea I, Tica A, Calin GA, Girnita A, Girnita L. Functional antagonism of β-arrestin isoforms balance IGF-1R expression and signalling with distinct cancer-related biological outcomes. Oncogene 36(41):5734-5744, 2017. e-Pub 2017. PMID: 28581517.
189. Berrout J, Kyriakopoulou E, Moparthi L, Hogea AS, Berrout L, Ivan C, Lorger M, Boyle J, Peers C, Muench S, Gomez JE, Hu X, Hurst C, Hall T, Umamaheswaran S, Wesley L, Gagea M, Shires M, Manfield I, Knowles MA, Davies S, Suhling K, Gonzalez YT, Carragher N, Macleod K, Abbott NJ, Calin GA, Gamper N, Zygmunt PM, Timsah Z. TRPA1-FGFR2 binding event is a regulatory oncogenic driver modulated by miRNA-142-3p. Nat Commun 8(1):947, 2017. e-Pub 2017. PMID: 29038531.
190. Kalariya N, Brassil K, Calin G. MicroRNAs: Clinical Trials and Potential Applications?. Clin J Oncol Nurs 21(5):554-559, 2017. e-Pub 2017. PMID: 28945717.
191. Stiegelbauer V, Vychytilova-Faltejskova P, Karbiener M, Pehserl AM, Reicher A, Resel M, Heitzer E, Ivan C, Bullock M, Ling H, Deutsch A, Wulf-Goldenberg A, Adiprasito JB, Stoeger H, Haybaeck J, Svoboda M, Stotz M, Hoefler G, Slaby O, Calin GA, Gerger A, Pichler M. MicroRNA-196b-5p regulates colorectal cancer cell migration and metastases through interaction of HOXB7 and GALNT5. Clin Cancer Res 23(17):5255-5266, 2017. e-Pub 2017. PMID: 28533224.
192. Ozawa T, Matsuyama T, Toiyama Y, Takahashi N, Ishikawa T, Uetake H, Yamada Y, Kusunoki M, Calin G, Goel A. CCAT1 and CCAT2 long noncoding RNAs, located within the 8q.24.21 'gene desert', serve as important prognostic biomarkers in colorectal cancer. Ann Oncol 28(8):1882-1888, 2017. e-Pub 2017. PMID: 28838211.
193. Fuentes-Mattei E, Giza DE, Shimizu M, Ivan C, Manning JT, Tudor S, Ciccone M, Kargin OA, Zhang X, Mur P, do Amaral NS, Chen M, Tarrand JJ, Lupu F, Ferrajoli A, Keating MJ, Vasilescu C, Yeung SJ, Calin GA. Plasma Viral miRNAs Indicate a High Prevalence of Occult Viral Infections. EBioMedicine 20:182-192, 2017. e-Pub 2017. PMID: 28465156.
194. Van Roosbroeck K, Fanini F, Setoyama T, Ivan C, Rodriguez-Aguayo C, Fuentes-Mattei E, Xiao L, Vannini I, Redis RS, D'Abundo L, Zhang X, Nicoloso MS, Rossi S, Gonzalez-Villasana V, Rupaimoole R, Ferracin M, Morabito F, Neri A, Ruvolo PP, Ruvolo VR, Pecot CV, Amadori D, Abruzzo L, Calin S, Wang X, You MJ, Ferrajoli A, Orlowski R, Plunkett W, Lichtenberg TM, Davuluri RV, Berindan-Neagoe I, Negrini M, Wistuba II, Kantarjian HM, Sood AK, Lopez-Berestein G, Keating MJ, Fabbri M, Calin GA. Combining anti-miR-155 with chemotherapy for the treatment of lung cancers. Clin Cancer Res 23(11):2891-2904, 2017. e-Pub 2017. PMID: 27903673.
195. Marini A, Lena AM, Panatta E, Ivan C, Han L, Liang H, Annicchiarico-Petruzzelli M, Di Daniele N, Calin GA, Candi E, Melino G. Ultraconserved long non-coding RNA uc.63 in breast cancer. Oncotarget 8(22):35669-35680, 2017. e-Pub 2017. PMID: 27447964.
196. Bucay N, Sekhon K, Yang T, Majid S, Shahryari V, Hsieh C, Mitsui Y, Deng G, Tabatabai ZL, Yamamura S, Calin GA, Dahiya R, Tanaka Y, Saini S. MicroRNA-383 located in frequently deleted chromosomal locus 8p22 regulates CD44 in prostate cancer. Oncogene 36(19):2667-2679, 2017. e-Pub 2017. PMID: 27893706.
197. Silva AM, Almeida MI, Teixeira JH, Maia AF, Calin GA, Barbosa MA, Santos SG. Dendritic Cell-derived Extracellular Vesicles mediate Mesenchymal Stem/Stromal Cell recruitment. Sci Rep 7(1):1667, 2017. e-Pub 2017. PMID: 28490808.
198. Ling H, Girnita L, Buda O, Calin GA. Non-coding RNAs: the cancer genome dark matter that matters!. Clin Chem Lab Med 55(5):705-714, 2017. e-Pub 2017. PMID: 27988500.
199. Rigoutsos I, Lee SK, Nam SY, Anfossi S, Pasculli B, Pichler M, Jing Y, Rodriguez-Aguayo C, Telonis AG, Rossi S, Ivan C, Catela Ivkovic T, Fabris L, Clark PM, Ling H, Shimizu M, Redis RS, Shah MY, Zhang X, Okugawa Y, Jung EJ, Tsirigos A, Huang L, Ferdin J, Gafà R, Spizzo R, Nicoloso MS, Paranjape AN, Shariati M, Tiron A, Yeh JJ, Teruel-Montoya R, Xiao L, Melo SA, Menter D, Jiang ZQ, Flores ER, Negrini M, Goel A, Bar-Eli M, Mani SA, Liu CG, Lopez-Berestein G, Berindan-Neagoe I, Esteller M, Kopetz S, Lanza G, Calin GA. N-BLR, a primate-specific non-coding transcript leads to colorectal cancer invasion and migration. Genome Biol 18(1):98, 2017. e-Pub 2017. PMID: 28535802.
200. Pichler M, Stiegelbauer V, Vychytilova-Faltejskova P, Ivan C, Ling H, Winter E, Zhang X, Goblirsch M, Wulf-Goldenberg A, Ohtsuka M, Haybaeck J, Svoboda M, Okugawa Y, Gerger A, Hoefler G, Goel A, Slaby O, Calin GA. Genome-wide microRNA analysis identifies miR-188-3p as novel prognostic marker and molecular factor involved in colorectal carcinogenesis. Clin Cancer Res 23(5):1323-1333, 2017. e-Pub 2017. PMID: 27601590.
201. Rashed MH, Kanlikilicer P, Rodriguez-Aguayo C, Pichler M, Bayraktar R, Bayraktar E, Ivan C, Filant J, Silva A, Aslan B, Denizli M, Mitra R, Ozpolat B, Calin GA, Sood AK, Abd-Ellah MF, Helal GK, Berestein GL. Exosomal miR-940 maintains SRC-mediated oncogenic activity in cancer cells: a possible role for exosomal disposal of tumor suppressor miRNAs. Oncotarget 8(12):20145-20164, 2017. e-Pub 2017. PMID: 28423620.
202. Bayraktar R, Pichler M, Kanlikilicer P, Ivan C, Bayraktar E, Kahraman N, Aslan B, Oguztuzun S, Ulasli M, Arslan A, Calin G, Lopez-Berestein G, Ozpolat B. MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase. Oncotarget 8(7):11641-11658, 2017. e-Pub 2017. PMID: 28036267.
203. Lee NK, Lee JH, Ivan C, Ling H, Zhang X, Park CH, Calin GA, Lee SK. MALAT1 promoted invasiveness of gastric adenocarcinoma. BMC Cancer 17(1):46, 2017. e-Pub 2017. PMID: 28077118.
204. Redis RS, Calin GA. SnapShot: Non-coding RNAs and Metabolism. Cell Metab 25(1):220-220.e1, 2017. e-Pub 2017. PMID: 28076764.
205. Bottai G, Diao L, Baggerly KA, Paladini L, Gyorffy B, Raschioni C, Pusztai L, Calin GA, Santarpia L. Integrated MicroRNA-mRNA Profiling Identifies Oncostatin M as a Marker of Mesenchymal-Like ER-Negative/HER2-Negative Breast Cancer. Int J Mol Sci 18(1), 2017. e-Pub 2017. PMID: 28106823.
206. Rodriguez-Aguayo C, Monroig PDC, Redis RS, Bayraktar E, Almeida MI, Ivan C, Fuentes-Mattei E, Rashed MH, Chavez-Reyes A, Ozpolat B, Mitra R, Sood AK, Calin GA, Lopez-Berestein G. Regulation of hnRNPA1 by microRNAs controls the miR-18a-K-RAS axis in chemotherapy-resistant ovarian cancer. Cell Discov 3:17029, 2017. e-Pub 2017. PMID: 28904816.
207. Vasilescu C, Dragomir M, Tanase M, Giza D, Purnichescu-Purtan R, Chen M, Yeung SJ, Calin GA. Circulating miRNAs in sepsis-A network under attack: An in-silico prediction of the potential existence of miRNA sponges in sepsis. PLoS One 12(8):e0183334, 2017. e-Pub 2017. PMID: 28820886.
208. Bras JP, Silva AM, Calin GA, Barbosa MA, Santos SG, Almeida MI. miR-195 inhibits macrophages pro-inflammatory profile and impacts the crosstalk with smooth muscle cells. PLoS One 12(11):e0188530, 2017. e-Pub 2017. PMID: 29166412.
209. Van Roosbroeck K, Calin GA. Cancer Hallmarks and MicroRNAs: The Therapeutic Connection. Adv Cancer Res 135:119-149, 2017. e-Pub 2017. PMID: 28882220.
210. Kanlikilicer P, Rashed MH, Bayraktar R, Mitra R, Ivan C, Aslan B, Zhang X, Filant J, Silva AM, Rodriguez-Aguayo C, Bayraktar E, Pichler M, Ozpolat B, Calin GA, Sood AK, Lopez-Berestein G. Ubiquitous release of exosomal tumor suppressor miR-6126 from ovarian cancer cells. Cancer Res 76(24):7194-7207, 2016. e-Pub 2016. PMID: 27742688.
211. Ohtsuka M, Ling H, Ivan C, Pichler M, Matsushita D, Goblirsch M, Stiegelbauer V, Shigeyasu K, Zhang X, Chen M, Vidhu F, Bartholomeusz GA, Toiyama Y, Kusunoki M, Doki Y, Mori M, Song S, Gunther JR, Krishnan S, Slaby O, Goel A, Ajani JA, Radovich M, Calin GA. H19 Noncoding RNA, an Independent Prognostic Factor, Regulates Essential Rb-E2F and CDK8-β-Catenin Signaling in Colorectal Cancer. EBioMedicine 13:113-124, 2016. e-Pub 2016. PMID: 27789274.
212. Vasilescu C, Tanase M, Dragomir M, Calin GA. From mobility to crosstalk. A model of intracellular miRNAs motion may explain the RNAs interaction mechanism on the basis of target subcellular localization. Math Biosci 280:50-61, 2016. e-Pub 2016. PMID: 27498347.
213. Anfossi S, Calin GA. Hodgkin Lymphoma Cells Have a Specific Long Noncoding RNA Expression Pattern. Am J Pathol 186(9):2251-3, 2016. e-Pub 2016. PMID: 27456130.
214. Fabris L, Berton S, Citron F, D'Andrea S, Segatto I, Nicoloso MS, Massarut S, Armenia J, Zafarana G, Rossi S, Ivan C, Perin T, Vaidya JS, Avanzo M, Roncadin M, Schiappacassi M, Bristow RG, Calin G, Baldassarre G, Belletti B. Radiotherapy-induced miR-223 prevents relapse of breast cancer by targeting the EGF pathway. Oncogene 35(37):4914-26, 2016. e-Pub 2016. PMID: 26876200.
215. Dragomir M, Petrescu DGE, Manga GE, Calin GA, Vasilescu C, -. Patients After Splenectomy: Old Risks and New Perspectives. Chirurgia (Bucur) 111(5):393-399, 2016. e-Pub 2016. PMID: 27819637.
216. Visone R, Pallante P, Vecchione A, Cirombella R, Ferracin M, Ferraro A, Volinia S, Coluzzi S, Leone V, Borbone E, Liu CG, Petrocca F, Troncone G, Calin GA, Scarpa A, Colato C, Tallini G, Santoro M, Croce CM, Fusco A. Specific microRNAs are downregulated in human thyroid anaplastic carcinomas. Oncogene 35(39):5214, 2016. e-Pub 2016. PMID: 27345412.
217. Debeb BG, Lacerda L, Anfossi S, Diagaradjane P, Chu K, Bambhroliya A, Huo L, Wei C, Larson RA, Wolfe AR, Xu W, Smith DL, Li L, Ivan C, Allen PK, Wu W, Calin GA, Krishnamurthy S, Zhang XH, Buchholz TA, Ueno NT, Reuben JM, Woodward WA. miR-141-Mediated Regulation of Brain Metastasis From Breast Cancer. J Natl Cancer Inst 108(8), 2016. e-Pub 2016. PMID: 27075851.
218. de Melo Maia B, Rodrigues IS, Akagi EM, Soares do Amaral N, Ling H, Monroig P, Soares FA, Calin GA, Rocha RM. MiR-223-5p works as an oncomiR in vulvar carcinoma by TP63 suppression. Oncotarget 7(31):49217-49231, 2016. e-Pub 2016. PMID: 27359057.
219. Rupaimoole R, Ivan C, Yang D, Gharpure KM, Wu SY, Pecot CV, Previs RA, Nagaraja AS, Armaiz-Pena GN, McGuire M, Pradeep S, Mangala LS, Rodriguez-Aguayo C, Huang L, Bar-Eli M, Zhang W, Lopez-Berestein G, Calin GA, Sood AK. Hypoxia-upregulated microRNA-630 targets Dicer, leading to increased tumor progression. Oncogene 35(33):4312-20, 2016. e-Pub 2016. PMID: 26725326.
220. Jiang J, Azevedo-Pouly AC, Redis RS, Lee EJ, Gusev Y, Allard D, Sutaria DS, Badawi M, Elgamal OA, Lerner MR, Brackett DJ, Calin GA, Schmittgen TD. Globally increased ultraconserved noncoding RNA expression in pancreatic adenocarcinoma. Oncotarget 7(33):53165-53177, 2016. e-Pub 2016. PMID: 27363020.
221. Naga Prasad SV, Duan ZH, Gupta MK, Surampudi VS, Volinia S, Calin GA, Kotwal A, Moravec CS, Starling RC, Perez DM, Sen S, Wu Q, Plow EF, Croce CM, Karnik S. A unique microRNA profile in end-stage heart failure indicates alterations in specific cardiovascular signaling networks. J Biol Chem 291(29):14914, 2016. e-Pub 2016. PMID: 27422978.
222. Redis RS, Calin GA. The interplay between lnRNAs, SNPs, and protein complexes - what does it mean for cancer metabolism?. Mol Cell Oncol 3(4):e1166308, 2016. e-Pub 2016. PMID: 27652320.
223. Ling H, Pickard K, Ivan C, Isella C, Ikuo M, Mitter R, Spizzo R, Bullock M, Braicu C, Pileczki V, Vincent K, Pichler M, Stiegelbauer V, Hoefler G, Almeida MI, Hsiao A, Zhang X, Primrose J, Packham G, Liu K, Bojja K, Gafà R, Xiao L, Rossi S, Song JH, Vannini I, Fanini F, Kopetz S, Zweidler-McKay P, Wang X, Ionescu C, Irimie A, Fabbri M, Lanza G, Hamilton SR, Berindan-Neagoe I, Medico E, Mirnezami A, Calin GA, Nicoloso MS. The clinical and biological significance of MIR-224 expression in colorectal cancer metastasis. Gut 65(6):977-89, 2016. e-Pub 2016. PMID: 25804630.
224. Rozovski U, Hazan-Halevy I, Calin G, Harris D, Li P, Liu Z, Keating MJ, Estrov Z. Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome. J Vis Exp(112), 2016. e-Pub 2016. PMID: 27341356.
225. Wei J, Nduom EK, Kong LY, Hashimoto Y, Xu S, Gabrusiewicz K, Ling X, Huang N, Qiao W, Zhou S, Ivan C, Fuller GN, Gilbert MR, Overwijk W, Calin GA, Heimberger AB. MiR-138 exerts anti-glioma efficacy by targeting immune checkpoints. Neuro Oncol 18(5):639-48, 2016. e-Pub 2016. PMID: 26658052.
226. Vitale C, Falchi L, Ten Hacken E, Gao H, Shaim H, Van Roosbroeck K, Calin G, O'Brien S, Faderl S, Wang X, Wierda WG, Rezvani K, Reuben JM, Burger JA, Keating MJ, Ferrajoli A. Ofatumumab and Lenalidomide for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia: Correlation Between Responses and Immune Characteristics. Clin Cancer Res 22(10):2359-67, 2016. e-Pub 2016. PMID: 26733610.
227. Lupini L, Pepe F, Ferracin M, Braconi C, Callegari E, Pagotto S, Spizzo R, Zagatti B, Lanuti P, Fornari F, Ghasemi R, Mariani-Costantini R, Bolondi L, Gramantieri L, Calin GA, Sabbioni S, Visone R, Veronese A, Negrini M. Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma. Oncotarget 7(21):31361-71, 2016. e-Pub 2016. PMID: 27120784.
228. Kong LY, Wei J, Fuller GN, Schrand B, Gabrusiewicz K, Zhou S, Rao G, Calin G, Gilboa E, Heimberger AB. Tipping a favorable CNS intratumoral immune response using immune stimulation combined with inhibition of tumor-mediated immune suppression. Oncoimmunology 5(5):e1117739, 2016. e-Pub 2016. PMID: 27467917.
229. Chaluvally-Raghavan P, Jeong KJ, Pradeep S, Silva AM, Yu S, Liu W, Moss T, Rodriguez-Aguayo C, Zhang D, Ram P, Liu J, Lu Y, Lopez-Berestein G, Calin GA, Sood AK, Mills GB. Direct Upregulation of STAT3 by MicroRNA-551b-3p Deregulates Growth and Metastasis of Ovarian Cancer. Cell Rep 15(7):1493-504, 2016. e-Pub 2016. PMID: 27160903.
230. Van Roosbroeck K, Calin GA. When kissing (disease) counts. Blood 127(16):1947-8, 2016. e-Pub 2016. PMID: 27103742.
231. Bueno MJ, Pérez de Castro I, Gómez de Cedrón M, Santos J, Calin GA, Cigudosa JC, Croce CM, Fernández-Piqueras J, Malumbres M. Genetic and Epigenetic Silencing of MicroRNA-203 Enhances ABL1 and BCR-ABL1 Oncogene Expression. Cancer Cell 29(4):607-608, 2016. e-Pub 2016. PMID: 27070707.
232. Olivieri M, Ferro M, Terreri S, Durso M, Romanelli A, Avitabile C, De Cobelli O, Messere A, Bruzzese D, Vannini I, Marinelli L, Novellino E, Zhang W, Incoronato M, Ilardi G, Staibano S, Marra L, Franco R, Perdonà S, Terracciano D, Czerniak B, Liguori GL, Colonna V, Fabbri M, Febbraio F, Calin GA, Cimmino A. Long non-coding RNA containing ultraconserved genomic region 8 promotes bladder cancer tumorigenesis. Oncotarget 7(15):20636-54, 2016. e-Pub 2016. PMID: 26943042.
233. Sun Y, Liu Y, Cogdell D, Calin GA, Sun B, Kopetz S, Hamilton SR, Zhang W. Examining plasma microRNA markers for colorectal cancer at different stages. Oncotarget 7(10):11434-49, 2016. e-Pub 2016. PMID: 26863633.
234. Almeida MI, Calin GA. The miR-143/miR-145 cluster and the tumor microenvironment: unexpected roles. Genome Med 8(1):29, 2016. e-Pub 2016. PMID: 26988859.
235. Dwivedi SK, Mustafi SB, Mangala LS, Jiang D, Pradeep S, Rodriguez-Aguayo C, Ling H, Ivan C, Mukherjee P, Calin GA, Lopez-Berestein G, Sood AK, Bhattacharya R. Therapeutic evaluation of microRNA-15a and microRNA-16 in ovarian cancer. Oncotarget 7(12):15093-104, 2016. e-Pub 2016. PMID: 26918603.
236. Nduom EK, Wei J, Yaghi NK, Huang N, Kong LY, Gabrusiewicz K, Ling X, Zhou S, Ivan C, Chen JQ, Burks JK, Fuller GN, Calin GA, Conrad CA, Creasy C, Ritthipichai K, Radvanyi L, Heimberger AB. PD-L1 expression and prognostic impact in glioblastoma. Neuro Oncol 18(2):195-205, 2016. e-Pub 2016. PMID: 26323609.
237. Redis RS, Vela LE, Lu W, Ferreira de Oliveira J, Ivan C, Rodriguez-Aguayo C, Adamoski D, Pasculli B, Taguchi A, Chen Y, Fernandez AF, Valledor L, Van Roosbroeck K, Chang S, Shah M, Kinnebrew G, Han L, Atlasi Y, Cheung LH, Huang GY, Monroig P, Ramirez MS, Catela Ivkovic T, Van L, Ling H, Gafà R, Kapitanovic S, Lanza G, Bankson JA, Huang P, Lai SY, Bast RC, Rosenblum MG, Radovich M, Ivan M, Bartholomeusz G, Liang H, Fraga MF, Widger WR, Hanash S, Berindan-Neagoe I, Lopez-Berestein G, Ambrosio ALB, Gomes Dias SM, Calin GA. Allele-Specific Reprogramming of Cancer Metabolism by the Long Non-coding RNA CCAT2. Mol Cell 61(4):640, 2016. e-Pub 2016. PMID: 28934601.
238. Redis RS, Vela LE, Lu W, Ferreira de Oliveira J, Ivan C, Rodriguez-Aguayo C, Adamoski D, Pasculli B, Taguchi A, Chen Y, Fernandez AF, Valledor L, Van Roosbroeck K, Chang S, Shah M, Kinnebrew G, Han L, Atlasi Y, Cheung LH, Huang GY, Monroig P, Ramirez MS, Catela Ivkovic T, Van L, Ling H, Gafà R, Kapitanovic S, Lanza G, Bankson JA, Huang P, Lai SY, Bast RC, Rosenblum MG, Radovich M, Ivan M, Bartholomeusz G, Liang H, Fraga MF, Widger WR, Hanash S, Berindan-Neagoe I, Lopez-Berestein G, Ambrosio ALB, Gomes Dias SM, Calin GA. Allele-Specific Reprogramming of Cancer Metabolism by the Long Non-coding RNA CCAT2. Mol Cell 61(4):520-34, 2016. e-Pub 2016. PMID: 26853146.
239. Melo SA, Ropero S, Moutinho C, Aaltonen LA, Yamamoto H, Calin GA, Rossi S, Fernandez AF, Carneiro F, Oliveira C, Ferreira B, Liu CG, Villanueva A, Capella G, Schwartz S, Shiekhattar R, Esteller M. Retraction: A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function. Nat Genet 48(2):221, 2016. e-Pub 2016. PMID: 26813765.
240. Cortez MA, Ivan C, Valdecanas D, Wang X, Peltier HJ, Ye Y, Araujo L, Carbone DP, Shilo K, Giri DK, Kelnar K, Martin D, Komaki R, Gomez DR, Krishnan S, Calin GA, Bader AG, Welsh JW. PDL1 Regulation by p53 via miR-34. J Natl Cancer Inst 108(1), 2016. e-Pub 2016. PMID: 26577528.
241. Almeida MI, Silva AM, Vasconcelos DM, Almeida CR, Caires H, Pinto MT, Calin GA, Santos SG, Barbosa MA. miR-195 in human primary mesenchymal stromal/stem cells regulates proliferation, osteogenesis and paracrine effect on angiogenesis. Oncotarget 7(1):7-22, 2016. e-Pub 2016. PMID: 26683705.
242. Zhang X, Lopez-Berestein G, Sood AK, Calin GA. Profiling Long Noncoding RNA Expression Using Custom-Designed Microarray. Methods Mol Biol 1402:33-41, 2016. e-Pub 2016. PMID: 26721482.
243. Ciccone M, Calin GA. MicroRNAs in chronic lymphocytic leukemia: An old disease with new genetic insights. Microrna 5(2):106-112, 2016. e-Pub 2016. PMID: 27568792.
244. de la Parra C, Castillo-Pichardo L, Cruz-Collazo A, Cubano L, Redis R, Calin GA, Dharmawardhane S. Soy Isoflavone Genistein-Mediated Downregulation of miR-155 Contributes to the Anticancer Effects of Genistein. Nutr Cancer 68(1):1-11, 2016. e-Pub 2016. PMID: 26771440.
245. Rupaimoole R, Lee J, Haemmerle M, Ling H, Previs RA, Pradeep S, Wu SY, Ivan C, Ferracin M, Dennison JB, Millward NM, Nagaraja AS, Gharpure KM, McGuire M, Sam N, Armaiz-Pena GN, Sadaoui NC, Rodriguez-Aguayo C, Calin GA, Drapkin RI, Kovacs J, Mills GB, Zhang W, Lopez-Berestein G, Bhattacharya PK, Sood AK. Long Noncoding RNA Ceruloplasmin Promotes Cancer Growth by Altering Glycolysis. Cell Rep 13(11):2395-402, 2015. e-Pub 2015. PMID: 26686630.
246. Cortez MA, Valdecanas D, Niknam S, Peltier HJ, Diao L, Giri U, Komaki R, Calin GA, Gomez DR, Chang JY, Heymach JV, Bader AG, Welsh JW. In Vivo Delivery of miR-34a Sensitizes Lung Tumors to Radiation Through RAD51 Regulation. Mol Ther Nucleic Acids 4:e270, 2015. e-Pub 2015. PMID: 26670277.
247. de Melo Maia B, Ling H, Monroig P, Ciccone M, Soares FA, Calin GA, Rocha RM. Design of a miRNA sponge for the miR-17 miRNA family as a therapeutic strategy against vulvar carcinoma. Mol Cell Probes 29(6):420-6, 2015. e-Pub 2015. PMID: 26297962.
248. De Mattos-Arruda L, Bottai G, Nuciforo PG, Di Tommaso L, Giovannetti E, Peg V, Losurdo A, Pérez-Garcia J, Masci G, Corsi F, Cortés J, Seoane J, Calin GA, Santarpia L. MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients. Oncotarget 6(35):37269-80, 2015. e-Pub 2015. PMID: 26452030.
249. Ciccone M, Calin GA. MicroRNAs in Myeloid Hematological Malignancies. Curr Genomics 16(5):336-348, 2015. e-Pub 2015. PMID: 27047254.
250. Ye X, Fan F, Bhattacharya R, Bellister S, Boulbes DR, Wang R, Xia L, Ivan C, Zheng X, Calin GA, Wang J, Lu X, Ellis LM. VEGFR-1 Pseudogene Expression and Regulatory Function in Human Colorectal Cancer Cells. Mol Cancer Res 13(9):1274-82, 2015. e-Pub 2015. PMID: 26041938.
251. Pichler M, Calin GA. MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients. Br J Cancer 113(4):569-73, 2015. e-Pub 2015. PMID: 26158421.
252. Salameh A, Lee AK, Cardó-Vila M, Nunes DN, Efstathiou E, Staquicini FI, Dobroff AS, Marchiò S, Navone NM, Hosoya H, Lauer RC, Wen S, Salmeron CC, Hoang A, Newsham I, Lima LA, Carraro DM, Oliviero S, Kolonin MG, Sidman RL, Do KA, Troncoso P, Logothetis CJ, Brentani RR, Calin GA, Cavenee WK, Dias-Neto E, Pasqualini R, Arap W. PRUNE2 is a human prostate cancer suppressor regulated by the intronic long noncoding RNA PCA3. Proc Natl Acad Sci U S A 112(27):8403-8, 2015. e-Pub 2015. PMID: 26080435.
253. García-Cruz R, Camats M, Calin GA, Liu CG, Volinia S, Taccioli C, Croce CM, Bach-Elias M. The role of p19 and p21 H-Ras proteins and mutants in miRNA expression in cancer and a Costello syndrome cell model. BMC Med Genet 16(1):46, 2015. e-Pub 2015. PMID: 26138095.
254. Karjalainen K, Jaalouk DE, Bueso-Ramos C, Bover L, Sun Y, Kuniyasu A, Driessen WH, Cardó-Vila M, Rietz C, Zurita AJ, O'Brien S, Kantarjian HM, Cortes JE, Calin GA, Koivunen E, Arap W, Pasqualini R. Targeting IL11 Receptor in Leukemia and Lymphoma: A Functional Ligand-Directed Study and Hematopathology Analysis of Patient-Derived Specimens. Clin Cancer Res 21(13):3041-51, 2015. e-Pub 2015. PMID: 25779950.
255. Bucur O, Almasan A, Zubarev R, Friedman M, Nicolson GL, Sumazin P, Leabu M, Nikolajczyk BS, Avram D, Kunej T, Calin GA, Godwin AK, Adami HO, Zaphiropoulos PG, Richardson DR, Schmitt-Ulms G, Westerblad H, Keniry M, Grau GE, Carbonetto S, Stan RV, Popa-Wagner A, Takhar K, Baron BW, Galardy PJ, Yang F, Data D, Fadare O, Yeo KJ, Gabreanu GR, Andrei S, Soare GR, Nelson MA, Liehn EA. An updated h-index measures both the primary and total scientific output of a researcher. Discoveries (Craiova) 3(3), 2015. e-Pub 2015. PMID: 26504901.
256. Challagundla KB, Wise PM, Neviani P, Chava H, Murtadha M, Xu T, Kennedy R, Ivan C, Zhang X, Vannini I, Fanini F, Amadori D, Calin GA, Hadjidaniel M, Shimada H, Jong A, Seeger RC, Asgharzadeh S, Goldkorn A, Fabbri M. Exosome-Mediated Transfer of microRNAs Within the Tumor Microenvironment and Neuroblastoma Resistance to Chemotherapy. J Natl Cancer Inst 107(7), 2015. e-Pub 2015. PMID: 25972604.
257. Aslan B, Monroig P, Hsu MC, Pena GA, Rodriguez-Aguayo C, Gonzalez-Villasana V, Rupaimoole R, Nagaraja AS, Mangala S, Han HD, Yuca E, Wu SY, Ivan C, Moss TJ, Ram PT, Wang H, Gol-Chambers A, Ozkayar O, Kanlikilicer P, Fuentes-Mattei E, Kahraman N, Pradeep S, Ozpolat B, Tucker S, Hung MC, Baggerly K, Bartholomeusz G, Calin G, Sood AK, Lopez-Berestein G. The ZNF304-integrin axis protects against anoikis in cancer. Nat Commun 6:7351, 2015. e-Pub 2015. PMID: 26081979.
258. Ferrajoli A, Ivan C, Ciccone M, Shimizu M, Kita Y, Ohtsuka M, D'Abundo L, Qiang J, Lerner S, Nouraee N, Rabe KG, Rassenti LZ, Van Roosbroeck K, Manning JT, Yuan Y, Zhang X, Shanafelt TD, Wierda WG, Sabbioni S, Tarrand JJ, Estrov Z, Radovich M, Liang H, Negrini M, Kipps TJ, Kay NE, Keating M, Calin GA. Epstein-Barr Virus MicroRNAs are Expressed in Patients with Chronic Lymphocytic Leukemia and Correlate with Overall Survival. EBioMedicine 2(6):572-82, 2015. e-Pub 2015. PMID: 26288818.
259. Nouraee N, Mowla SJ, Calin GA. Tracking miRNAs' footprints in tumor-microenvironment interactions: Insights and implications for targeted cancer therapy. Genes Chromosomes Cancer 54(6):335-52, 2015. e-Pub 2015. PMID: 25832733.
260. Schwarzenbacher D, Stiegelbauer V, Deutsch A, Ress AL, Aigelsreiter A, Schauer S, Wagner K, Langsenlehner T, Resel M, Gerger A, Ling H, Ivan C, Calin GA, Hoefler G, Rinner B, Pichler M. Low spinophilin expression enhances aggressive biological behavior of breast cancer. Oncotarget 6(13):11191-202, 2015. e-Pub 2015. PMID: 25857299.
261. Gonzalez-Villasana V, Fuentes-Mattei E, Ivan C, Dalton HJ, Rodriguez-Aguayo C, Fernandez-de Thomas RJ, Aslan B, Del C Monroig P, Velazquez-Torres G, Previs RA, Pradeep S, Kahraman N, Wang H, Kanlikilicer P, Ozpolat B, Calin G, Sood AK, Lopez-Berestein G. Rac1/Pak1/p38/MMP-2 Axis Regulates Angiogenesis in Ovarian Cancer. Clin Cancer Res 21(9):2127-37, 2015. e-Pub 2015. PMID: 25595279.
262. Bullock MD, Pickard K, Mitter R, Sayan AE, Primrose JN, Ivan C, Calin GA, Thomas GJ, Packham GK, Mirnezami AH. Stratifying risk of recurrence in stage II colorectal cancer using deregulated stromal and epithelial microRNAs. Oncotarget 6(9):7262-79, 2015. e-Pub 2015. PMID: 25788261.
263. Li X, Liu Y, Granberg KJ, Wang Q, Moore LM, Ji P, Gumin J, Sulman EP, Calin GA, Haapasalo H, Nykter M, Shmulevich I, Fuller GN, Lang FF, Zhang W. Two mature products of MIR-491 coordinate to suppress key cancer hallmarks in glioblastoma. Oncogene 34(13):1619-28, 2015. e-Pub 2015. PMID: 24747968.
264. Nunes DN, Dias-Neto E, Cardó-Vila M, Edwards JK, Dobroff AS, Giordano RJ, Mandelin J, Brentani HP, Hasselgren C, Yao VJ, Marchiò S, Pereira CA, Passetti F, Calin GA, Sidman RL, Arap W, Pasqualini R. Synchronous down-modulation of miR-17 family members is an early causative event in the retinal angiogenic switch. Proc Natl Acad Sci U S A 112(12):3770-5, 2015. e-Pub 2015. PMID: 25775553.
265. Londin E, Loher P, Telonis AG, Quann K, Clark P, Jing Y, Hatzimichael E, Kirino Y, Honda S, Lally M, Ramratnam B, Comstock CE, Knudsen KE, Gomella L, Spaeth GL, Hark L, Katz LJ, Witkiewicz A, Rostami A, Jimenez SA, Hollingsworth MA, Yeh JJ, Shaw CA, McKenzie SE, Bray P, Nelson PT, Zupo S, Van Roosbroeck K, Keating MJ, Calin GA, Yeo C, Jimbo M, Cozzitorto J, Brody JR, Delgrosso K, Mattick JS, Fortina P, Rigoutsos I. Analysis of 13 cell types reveals evidence for the expression of numerous novel primate- and tissue-specific microRNAs. Proc Natl Acad Sci U S A 112(10):E1106-15, 2015. e-Pub 2015. PMID: 25713380.
266. Kleivi Sahlberg K, Bottai G, Naume B, Burwinkel B, Calin GA, Børresen-Dale AL, Santarpia L. A Serum MicroRNA Signature Predicts Tumor Relapse and Survival in Triple Negative Breast Cancer Patients. Clin Cancer Res 21(5):1207-14, 2015. e-Pub 2015. PMID: 25547678.
267. Zuo Z, Maiti S, Hu S, Loghavi S, Calin GA, Garcia-Manero G, Kantarjian HM, Medeiros LJ, Cooper LJ, Bueso-Ramos CE. Plasma circulating-microRNA profiles are useful for assessing prognosis in patients with cytogenetically normal myelodysplastic syndromes. Mod Pathol 28(3):373-82, 2015. e-Pub 2015. PMID: 25216221.
268. Shoshan E, Mobley AK, Braeuer RR, Kamiya T, Huang L, Vasquez ME, Salameh A, Lee HJ, Kim SJ, Ivan C, Velazquez-Torres G, Nip KM, Zhu K, Brooks D, Jones SJ, Birol I, Mosqueda M, Wen YY, Eterovic AK, Sood AK, Hwu P, Gershenwald JE, Robertson AG, Calin GA, Markel G, Fidler IJ, Bar-Eli M. Reduced adenosine-to-inosine miR-455-5p editing promotes melanoma growth and metastasis. Nat Cell Biol 17(3):311-21, 2015. e-Pub 2015. PMID: 25686251.
269. Zhang S, Lu Z, Unruh AK, Ivan C, Baggerly KA, Calin GA, Li Z, Bast RC, Le XF. Clinically Relevant microRNAs in Ovarian Cancer. Mol Cancer Res 13(3):393-401, 2015. e-Pub 2015. PMID: 25304686.
270. Van Roosbroeck K, Verstovsek S, Calin GA. Long non-coding rnas in primary myelofibrosis: the dark matter in hematopoietic progenitor cells?. Leuk Lymphoma 56(2):1-6, 2015. e-Pub 2015. PMID: 25093380.
271. Sato-Kuwabara Y, Melo SA, Soares FA, Calin GA. The fusion of two worlds: Non-coding RNAs and extracellular vesicles - diagnostic and therapeutic implications (Review). Int J Oncol 46(1):17-27, 2015. e-Pub 2015. PMID: 25338714.
272. Braicu C, Tomuleasa C, Monroig P, Cucuianu A, Berindan-Neagoe I, Calin GA. Exosomes as divine messengers: are they the Hermes of modern molecular oncology?. Cell Death Differ 22(1):34-45, 2015. e-Pub 2015. PMID: 25236394.
273. Bullock MD, Silva AM, Calin GA. Estrogen and Breast Cancer: can less mean more?. Cell Cycle 14(14):0, 2015. e-Pub 2015. PMID: 26090587.
274. Monroig-Bosque Pdel C, Rivera CA, Calin GA. MicroRNAs in cancer therapeutics: "from the bench to the bedside". Expert Opin Biol Ther 15(10):1381-5, 2015. e-Pub 2015. PMID: 26372796.
275. Sawada G, Niida A, Hirata H, Komatsu H, Uchi R, Shimamura T, Takahashi Y, Kurashige J, Matsumura T, Ueo H, Takano Y, Ueda M, Sakimura S, Shinden Y, Eguchi H, Sudo T, Sugimachi K, Yamasaki M, Tanaka F, Tachimori Y, Kajiyama Y, Natsugoe S, Fujita H, Tanaka Y, Calin G, Miyano S, Doki Y, Mori M, Mimori K. An Integrative Analysis to Identify Driver Genes in Esophageal Squamous Cell Carcinoma. PLoS One 10(10):e0139808, 2015. e-Pub 2015. PMID: 26465158.
276. Giza DE, Calin GA. microRNA and Chronic Lymphocytic Leukemia. Adv Exp Med Biol 889:23-40, 2015. e-Pub 2015. PMID: 26658994.
277. Berindan-Neagoe I, Calin GA. Molecular Pathways: microRNAs, Cancer Cells, and Microenvironment. Clin Cancer Res 20(24):6247-53, 2014. e-Pub 2014. PMID: 25512634.
278. Kunej T, Obsteter J, Pogacar Z, Horvat S, Calin GA. The decalog of long non-coding RNA involvement in cancer diagnosis and monitoring. Crit Rev Clin Lab Sci 51(6):344-57, 2014. e-Pub 2014. PMID: 25123609.
279. Melo SA, Sugimoto H, O'Connell JT, Kato N, Villanueva A, Vidal A, Qiu L, Vitkin E, Perelman LT, Melo CA, Lucci A, Ivan C, Calin GA, Kalluri R. Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis. Cancer Cell 26(5):707-21, 2014. e-Pub 2014. PMID: 25446899.
280. Ciccone M, Ferrajoli A, Keating MJ, Calin GA. SnapShot: Chronic Lymphocytic Leukemia. Cancer Cell 26(5):770-770.e1, 2014. e-Pub 2014. PMID: 25517752.
281. Bottai G, Pasculli B, Calin GA, Santarpia L. Targeting the microRNA-regulating DNA damage/repair pathways in cancer. Expert Opin Biol Ther 14(11):1-17, 2014. e-Pub 2014. PMID: 25190496.
282. Giza DE, Vasilescu C, Calin GA. Key principles of miRNA involvement in human diseases. Discoveries (Craiova) 2(4):e34, 2014. e-Pub 2014. PMID: 26317116.
283. Ress AL, Stiegelbauer V, Schwarzenbacher D, Deutsch A, Perakis S, Ling H, Ivan C, Calin GA, Rinner B, Gerger A, Pichler M. Spinophilin expression determines cellular growth, cancer stemness and 5-flourouracil resistance in colorectal cancer. Oncotarget 5(18):8492-502, 2014. e-Pub 2014. PMID: 25261368.
284. Gee HE, Ivan C, Calin GA, Ivan M. HypoxamiRs and Cancer: From Biology to Targeted Therapy. Antioxid Redox Signal 21(8):1220-38, 2014. e-Pub 2014. PMID: 24111776.
285. Giza DE, Vasilescu C, Calin GA. MicroRNAs and ceRNAs: therapeutic implications of RNA networks. Expert Opin Biol Ther 14(9):1285-93, 2014. e-Pub 2014. PMID: 24941322.
286. Ruvolo PP, Ruvolo VR, Jacamo R, Burks JK, Zeng Z, Duvvuri SR, Zhou L, Qiu Y, Coombes KR, Zhang N, Yoo SY, Pan R, Hail N, Konopleva M, Calin G, Kornblau SM, Andreeff M. The protein phosphatase 2A regulatory subunit B55α is a modulator of signaling and microRNA expression in acute myeloid leukemia cells. Biochim Biophys Acta 1843(9):1969-77, 2014. e-Pub 2014. PMID: 24858343.
287. Negrini M, Cutrona G, Bassi C, Fabris S, Zagatti B, Colombo M, Ferracin M, D'Abundo L, Saccenti E, Matis S, Lionetti M, Agnelli L, Gentile M, Recchia AG, Bossio S, Reverberi D, Rigolin G, Calin GA, Sabbioni S, Russo G, Tassone P, Morabito F, Ferrarini M, Neri A. microRNAome expression in chronic lymphocytic leukemia: comparison with normal B-cell subsets and correlations with prognostic and clinical parameters. Clin Cancer Res 20(15):4141-53, 2014. e-Pub 2014. PMID: 24916701.
288. Cortez MA, Valdecanas D, Zhang X, Zhan Y, Bhardwaj V, Calin GA, Komaki R, Giri DK, Quini CC, Wolfe T, Peltier HJ, Bader AG, Heymach JV, Meyn RE, Welsh JW. Therapeutic delivery of miR-200c enhances radiosensitivity in lung cancer. Mol Ther 22(8):1494-503, 2014. e-Pub 2014. PMID: 24791940.
289. Xu S, Wei J, Wang F, Kong LY, Ling XY, Nduom E, Gabrusiewicz K, Doucette T, Yang Y, Yaghi NK, Fajt V, Levine JM, Qiao W, Li XG, Lang FF, Rao G, Fuller GN, Calin GA, Heimberger AB. Effect of miR-142-3p on the M2 macrophage and therapeutic efficacy against murine glioblastoma. J Natl Cancer Inst 106(8), 2014. e-Pub 2014. PMID: 24974128.
290. Cui B, Chen L, Zhang S, Mraz M, Fecteau JF, Yu J, Ghia EM, Zhang L, Bao L, Rassenti LZ, Messer K, Calin GA, Croce CM, Kipps TJ. MicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemia. Blood 124(4):546-54, 2014. e-Pub 2014. PMID: 24914134.
291. Liz J, Portela A, Soler M, Gómez A, Ling H, Michlewski G, Calin GA, Guil S, Esteller M. Regulation of pri-miRNA processing by a long noncoding RNA transcribed from an ultraconserved region. Mol Cell 55(1):138-47, 2014. e-Pub 2014. PMID: 24910097.
292. Pichler M, Calin GA. Long noncoding RNA in neuroblastoma: new light on the (old) N-Myc story. J Natl Cancer Inst 106(7), 2014. e-Pub 2014. PMID: 24906400.
293. Kita Y, Vincent K, Natsugoe S, Berindan-Neagoe I, Calin GA. Epigenetically regulated microRNAs and their prospect in cancer diagnosis. Expert Rev Mol Diagn 14(6):673-83, 2014. e-Pub 2014. PMID: 24914586.
294. Shah MY, Calin GA. MicroRNAs as therapeutic targets in human cancers. Wiley Interdiscip Rev RNA 5(4):537-48, 2014. e-Pub 2014. PMID: 24687772.
295. Wu SY, Lopez-Berestein G, Calin GA, Sood AK. RNAi therapies: drugging the undruggable. Sci Transl Med 6(240):240ps7, 2014. e-Pub 2014. PMID: 24920658.
296. Martens-Uzunova ES, Böttcher R, Croce CM, Jenster G, Visakorpi T, Calin GA. Long noncoding RNA in prostate, bladder, and kidney cancer. Eur Urol 65(6):1140-51, 2014. e-Pub 2014. PMID: 24373479.
297. Ferreira AF, Moura LG, Tojal I, Ambrósio L, Pinto-Simões B, Hamerschlak N, Calin GA, Ivan C, Covas DT, Kashima S, Castro FA. ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance. Blood Cells Mol Dis 53(1-2):47-55, 2014. e-Pub 2014. PMID: 24629639.
298. Liu X, Robinson SN, Setoyama T, Tung SS, D'Abundo L, Shah MY, Yang H, Yvon E, Shah N, Yang H, Konopleva M, Garcia-Manero G, McNiece I, Rezvani K, Calin GA, Shpall EJ, Parmar S. FOXP3 is a direct target of miR15a/16 in umbilical cord blood regulatory T cells. Bone Marrow Transplant 49(6):793-9, 2014. e-Pub 2014. PMID: 24710569.
299. Rayner K, Dimmeler S, Calin GA, Thum T, Raizman JE, Diamandis EP. Novel biomarkers for acute myocardial infarction: is microRNA the new kid on the block?. Clin Chem 60(6):812-7, 2014. e-Pub 2014. PMID: 24212084.
300. Pichler M, Ress AL, Winter E, Stiegelbauer V, Karbiener M, Schwarzenbacher D, Scheideler M, Ivan C, Jahn SW, Kiesslich T, Gerger A, Bauernhofer T, Calin GA, Hoefler G. MiR-200a regulates epithelial to mesenchymal transition-related gene expression and determines prognosis in colorectal cancer patients. Br J Cancer 110(6):1614-21, 2014. e-Pub 2014. PMID: 24504363.
301. Armenia J, Fabris L, Lovat F, Berton S, Segatto I, D'Andrea S, Ivan C, Cascione L, Calin GA, Croce CM, Colombatti A, Vecchione A, Belletti B, Baldassarre G. Contact inhibition modulates intracellular levels of miR-223 in a p27kip1-dependent manner. Oncotarget 5(5):1185-97, 2014. e-Pub 2014. PMID: 24727437.
302. Schwarzenbach H, Nishida N, Calin GA, Pantel K. Clinical relevance of circulating cell-free microRNAs in cancer. Nat Rev Clin Oncol 11(3):145-56, 2014. e-Pub 2014. PMID: 24492836.
303. Zhou Y, Wan G, Spizzo R, Ivan C, Mathur R, Hu X, Ye X, Lu J, Fan F, Xia L, Calin GA, Ellis LM, Lu X. miR-203 induces oxaliplatin resistance in colorectal cancer cells by negatively regulating ATM kinase. Mol Oncol 8(1):83-92, 2014. e-Pub 2014. PMID: 24145123.
304. Maia BM, Rocha RM, Calin GA. Clinical significance of the interaction between non-coding RNAs and the epigenetics machinery: challenges and opportunities in oncology. Epigenetics 9(1):75-80, 2014. e-Pub 2014. PMID: 24121593.
305. Bottoni A, Calin GA. MicroRNAs as Main Players in the Pathogenesis of Chronic Lymphocytic Leukemia. Microrna 2(3):158-64, 2014. e-Pub 2014. PMID: 25069439.
306. Braicu C, Catana C, Calin GA, Berindan-Neagoe I. NCRNA Combined Therapy as Future Treatment Option for Cancer. Curr Pharm Des 20(42):6565-74, 2014. e-Pub 2014. PMID: 25341933.
307. Rupaimoole R, Wu SY, Pradeep S, Ivan C, Pecot CV, Gharpure KM, Nagaraja AS, Armaiz-Pena GN, McGuire M, Zand B, Dalton HJ, Filant J, Miller JB, Lu C, Sadaoui NC, Mangala LS, Taylor M, van den Beucken T, Koch E, Rodriguez-Aguayo C, Huang L, Bar-Eli M, Wouters BG, Radovich M, Ivan M, Calin GA, Zhang W, Lopez-Berestein G, Sood AK. Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progression. Nat Commun 5:5202, 2014. e-Pub 2014. PMID: 25351346.
308. Chen M, Calin GA, Meng QH. Circulating microRNAs as Promising Tumor Biomarkers. Adv Clin Chem 67:189-214, 2014. e-Pub 2014. PMID: 25735862.
309. Ru Y, Kechris KJ, Tabakoff B, Hoffman P, Radcliffe RA, Bowler R, Mahaffey S, Rossi S, Calin GA, Bemis L, Theodorescu D. The multiMiR R package and database: integration of microRNA-target interactions along with their disease and drug associations. Nucleic Acids Res 42(17):e133, 2014. e-Pub 2014. PMID: 25063298.
310. Galasso M, Dama P, Previati M, Sandhu S, Palatini J, Coppola V, Warner S, Sana ME, Zanella R, Abujarour R, Desponts C, Teitell MA, Garzon R, Calin G, Croce CM, Volinia S. A large scale expression study associates uc.283-plus lncRNA with pluripotent stem cells and human glioma. Genome Med 6(10):76, 2014. e-Pub 2014. PMID: 25352916.
311. Gañán-Gómez I, Wei Y, Yang H, Pierce S, Bueso-Ramos C, Calin G, Boyano-Adánez Mdel C, García-Manero G. Overexpression of miR-125a in myelodysplastic syndrome CD34+ cells modulates NF-κB activation and enhances erythroid differentiation arrest. PLoS One 9(4):e93404, 2014. e-Pub 2014. PMID: 24690917.
312. Nassar FJ, El Sabban M, Zgheib NK, Tfayli A, Boulos F, Jabbour M, El Saghir NS, Talhouk R, Bazarbachi A, Calin GA, Nasr R. miRNA as potential biomarkers of breast cancer in the Lebanese population and in young women: a pilot study. PLoS One 9(9):e107566, 2014. e-Pub 2014. PMID: 25232827.
313. Crippa E, Lusa L, De Cecco L, Marchesi E, Calin GA, Radice P, Manoukian S, Peissel B, Daidone MG, Gariboldi M, Pierotti MA. miR-342 regulates BRCA1 expression through modulation of ID4 in breast cancer. PLoS One 9(1):e87039, 2014. e-Pub 2014. PMID: 24475217.
314. Tudor S, Giza DE, Lin HY, Fabris L, Yoshiaki K, D'Abundo L, Toale KM, Shimizu M, Ferracin M, Challagundla KB, Cortez MA, Fuentes-Mattei E, Tulbure D, Gonzalez C, Henderson J, Row M, Rice TW, Ivan C, Negrini M, Fabbri M, Morris JS, Yeung SC, Vasilescu C, Calin GA. Cellular and Kaposi's sarcoma-associated herpes virus microRNAs in sepsis and surgical trauma. Cell Death Dis 5:e1559, 2014. e-Pub 2014. PMID: 25476907.
315. Anfossi S, Giordano A, Gao H, Cohen EN, Tin S, Wu Q, Garza RJ, Debeb BG, Alvarez RH, Valero V, Hortobagyi GN, Calin GA, Ueno NT, Woodward WA, Reuben JM. High serum miR-19a levels are associated with inflammatory breast cancer and are predictive of favorable clinical outcome in patients with metastatic HER2+ inflammatory breast cancer. PLoS One 9(1):e83113, 2014. e-Pub 2014. PMID: 24416156.
316. Silla T, Kepp K, Tai ES, Goh L, Davila S, Catela Ivkovic T, Calin GA, Voorhoeve PM. Allele frequencies of variants in ultra conserved elements identify selective pressure on transcription factor binding. PLoS One 9(11):e110692, 2014. e-Pub 2014. PMID: 25369454.
317. Ferdin J, Nishida N, Wu X, Nicoloso MS, Shah MY, Devlin C, Ling H, Shimizu M, Kumar K, Cortez MA, Ferracin M, Bi Y, Yang D, Czerniak B, Zhang W, Schmittgen TD, Voorhoeve MP, Reginato MJ, Negrini M, Davuluri RV, Kunej T, Ivan M, Calin GA. HINCUTs in cancer: hypoxia-induced noncoding ultraconserved transcripts. Cell Death Differ 20(12):1675-87, 2013. e-Pub 2013. PMID: 24037088.
318. Santarpia L, Calin GA, Adam L, Ye L, Fusco A, Giunti S, Thaller C, Paladini L, Zhang X, Jimenez C, Trimarchi F, El-Naggar AK, Gagel RF. A miRNA signature associated with human metastatic medullary thyroid carcinoma. Endocr Relat Cancer 20(6):809-23, 2013. e-Pub 2013. PMID: 24127332.
319. Nishimura M, Jung EJ, Shah MY, Lu C, Spizzo R, Shimizu M, Han HD, Ivan C, Rossi S, Zhang X, Nicoloso MS, Wu SY, Almeida MI, Bottsford-Miller J, Pecot CV, Zand B, Matsuo K, Shahzad MM, Jennings NB, Rodriguez-Aguayo C, Lopez-Berestein G, Sood AK, Calin GA. Therapeutic synergy between microRNA and siRNA in ovarian cancer treatment. Cancer Discov 3(11):1302-15, 2013. e-Pub 2013. PMID: 24002999.
320. Wan G, Hu X, Liu Y, Han C, Sood AK, Calin GA, Zhang X, Lu X. A novel non-coding RNA lncRNA-JADE connects DNA damage signalling to histone H4 acetylation. EMBO J 32(21):2833-47, 2013. e-Pub 2013. PMID: 24097061.
321. Gumireddy K, Li A, Yan J, Setoyama T, Johannes GJ, Orom UA, Tchou J, Liu Q, Zhang L, Speicher DW, Calin GA, Huang Q. Identification of a long non-coding RNA-associated RNP complex regulating metastasis at the translational step. EMBO J 32(20):2672-84, 2013. e-Pub 2013. PMID: 23974796.
322. Manyam G, Ivan C, Calin GA, Coombes KR. targetHub: a programmable interface for miRNA-gene interactions. Bioinformatics 29(20):2657-8, 2013. e-Pub 2013. PMID: 24013925.
323. Redis RS, Sieuwerts AM, Look MP, Tudoran O, Ivan C, Spizzo R, Zhang X, de Weerd V, Shimizu M, Ling H, Buiga R, Pop V, Irimie A, Fodde R, Bedrosian I, Martens JW, Foekens JA, Berindan-Neagoe I, Calin GA. CCAT2, a novel long non-coding RNA in breast cancer: expression study and clinical correlations. Oncotarget 4(10):1748-62, 2013. e-Pub 2013. PMID: 24077681.
324. Nishida N, Mimori K, Mori M, Calin GA. EGFR gets in the way of microRNA biogenesis. Cell Res 23(10):1157-8, 2013. e-Pub 2013. PMID: 23835474.
325. Ferrajoli A, Shanafelt TD, Ivan C, Shimizu M, Rabe KG, Nouraee N, Ikuo M, Ghosh AK, Lerner S, Rassenti LZ, Xiao L, Hu J, Reuben JM, Calin S, You MJ, Manning JT, Wierda WG, Estrov Z, O'Brien S, Kipps TJ, Keating MJ, Kay NE, Calin GA. Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B-chronic lymphocytic leukemia. Blood 122(11):1891-9, 2013. e-Pub 2013. PMID: 23821659.
326. Ling H, Spizzo R, Atlasi Y, Nicoloso M, Shimizu M, Redis RS, Nishida N, Gafà R, Song J, Guo Z, Ivan C, Barbarotto E, De Vries I, Zhang X, Ferracin M, Churchman M, van Galen JF, Beverloo BH, Shariati M, Haderk F, Estecio MR, Garcia-Manero G, Patijn GA, Gotley DC, Bhardwaj V, Shureiqi I, Sen S, Multani AS, Welsh J, Yamamoto K, Taniguchi I, Song MA, Gallinger S, Casey G, Thibodeau SN, Le Marchand L, Tiirikainen M, Mani SA, Zhang W, Davuluri RV, Mimori K, Mori M, Sieuwerts AM, Martens JW, Tomlinson I, Negrini M, Berindan-Neagoe I, Foekens JA, Hamilton SR, Lanza G, Kopetz S, Fodde R, Calin GA. CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer. Genome Res 23(9):1446-61, 2013. e-Pub 2013. PMID: 23796952.
327. Wu X, Bhayani MK, Dodge CT, Nicoloso MS, Chen Y, Yan X, Adachi M, Thomas L, Galer CE, Jiffar T, Pickering CR, Kupferman ME, Myers JN, Calin GA, Lai SY. Coordinated targeting of the EGFR signaling axis by microRNA-27a*. Oncotarget 4(9):1388-98, 2013. e-Pub 2013. PMID: 23963114.
328. Wei J, Wang F, Kong LY, Xu S, Doucette T, Ferguson SD, Yang Y, McEnery K, Jethwa K, Gjyshi O, Qiao W, Levine NB, Lang FF, Rao G, Fuller GN, Calin GA, Heimberger AB. miR-124 inhibits STAT3 signaling to enhance T cell-mediated immune clearance of glioma. Cancer Res 73(13):3913-26, 2013. e-Pub 2013. PMID: 23636127.
329. Jin L, Wessely O, Marcusson EG, Ivan C, Calin GA, Alahari SK. Prooncogenic Factors miR-23b and miR-27b Are Regulated by Her2/Neu, EGF, and TNF-α in Breast Cancer. Cancer Res 73(9):2884-96, 2013. e-Pub 2013. PMID: 23338610.
330. Atlasi Y, Noori R, Gaspar C, Franken P, Sacchetti A, Rafati H, Mahmoudi T, Decraene C, Calin GA, Merrill BJ, Fodde R. Wnt Signaling Regulates the Lineage Differentiation Potential of Mouse Embryonic Stem Cells through Tcf3 Down-Regulation. PLoS Genet 9(5):e1003424, 2013. e-Pub 2013. PMID: 23658527.
331. Van Roosbroeck K, Pollet J, Calin GA. miRNAs and long noncoding RNAs as biomarkers in human diseases. Expert Rev Mol Diagn 13(2):183-204, 2013. e-Pub 2013. PMID: 23477558.
332. Monroig PD, Calin GA. MicroRNA and Epigenetics: Diagnostic and Therapeutic Opportunities. Curr Pathobiol Rep 1(1):43-52, 2013. e-Pub 2013. PMID: 23515489.
333. Tsongalis GJ, Calin G, Cordelier P, Croce C, Monzon F, Szafranska-Schwarzbach AE. MicroRNA Analysis: Is It Ready for Prime Time?. Clin Chem 59(2):343-7, 2013. e-Pub 2013. PMID: 22935643.
334. Shah MY, Calin GA. The Mix of Two Worlds: Non-Coding RNAs and Hormones. Nucleic Acid Ther 23(1):2-8, 2013. e-Pub 2013. PMID: 23051203.
335. Hudson RS, Yi M, Volfovsky N, Prueitt RL, Esposito D, Volinia S, Liu CG, Schetter AJ, Van Roosbroeck K, Stephens RM, Calin GA, Croce CM, Ambs S. Transcription signatures encoded by ultraconserved genomic regions in human prostate cancer. Mol Cancer 12:13, 2013. e-Pub 2013. PMID: 23409773.
336. Braicu C, Calin GA, Berindan-Neagoe I. MicroRNAs and Cancer Therapy - from Bystanders to Major Players. Curr Med Chem 20(29):3561-73, 2013. e-Pub 2013. PMID: 23834177.
337. Rozovski U, Calin GA, Setoyama T, D'Abundo L, Harris DM, Li P, Liu Z, Grgurevic S, Ferrajoli A, Faderl S, Burger JA, O'Brien S, Wierda WG, Keating MJ, Estrov Z. Signal transducer and activator of transcription (STAT)-3 regulates microRNA gene expression in chronic lymphocytic leukemia cells. Mol Cancer 12:50, 2013. e-Pub 2013. PMID: 23725032.
338. Li P, Grgurevic S, Liu Z, Harris D, Rozovski U, Calin GA, Keating MJ, Estrov Z. Signal transducer and activator of transcription-3 induces MicroRNA-155 expression in chronic lymphocytic leukemia. PLoS One 8(6):e64678, 2013. e-Pub 2013. PMID: 23750211.
339. Wang LQ, Kwong YL, Kho CS, Wong KF, Wong KY, Ferracin M, Calin GA, Chim CS. Epigenetic inactivation of miR-9 family microRNAs in chronic lymphocytic leukemia--implications on constitutive activation of NFκB pathway. Mol Cancer 12:173, 2013. e-Pub 2013. PMID: 24373626.
340. Pecot CV, Rupaimoole R, Yang D, Akbani R, Ivan C, Lu C, Wu S, Han HD, Shah MY, Rodriguez-Aguayo C, Bottsford-Miller J, Liu Y, Kim SB, Unruh A, Gonzalez-Villasana V, Huang L, Zand B, Moreno-Smith M, Mangala LS, Taylor M, Dalton HJ, Sehgal V, Wen Y, Kang Y, Baggerly KA, Lee JS, Ram PT, Ravoori MK, Kundra V, Zhang X, Ali-Fehmi R, Gonzalez-Angulo AM, Massion PP, Calin GA, Lopez-Berestein G, Zhang W, Sood AK. Tumour angiogenesis regulation by the miR-200 family. Nat Commun 4:2427, 2013. e-Pub 2013. PMID: 24018975.
341. Nouraee N, Calin GA. MicroRNAs as cancer biomarkers. Microrna 2(2):102-17, 2013. e-Pub 2013. PMID: 25070780.
342. Nouraee N, Van Roosbroeck K, Vasei M, Semnani S, Samaei NM, Naghshvar F, Omidi AA, Calin GA, Mowla SJ. Expression, tissue distribution and function of miR-21 in esophageal squamous cell carcinoma. PLoS One 8(9):e73009, 2013. e-Pub 2013. PMID: 24039846.
343. Taube JH, Malouf GG, Lu E, Sphyris N, Vijay V, Ramachandran PP, Ueno KR, Gaur S, Nicoloso MS, Rossi S, Herschkowitz JI, Rosen JM, Issa JP, Calin GA, Chang JT, Mani SA. Epigenetic silencing of microRNA-203 is required for EMT and cancer stem cell properties. Sci Rep 3:2687, 2013. e-Pub 2013. PMID: 24045437.
344. Vasilescu C, Olteanu M, Flondor P, Calin GA. Fractal-like kinetics of intracellular enzymatic reactions: a chemical framework of endotoxin tolerance and a possible non-specific contribution of macromolecular crowding to cross-tolerance. Theor Biol Med Model 10:55, 2013. e-Pub 2013. PMID: 24034421.
345. Godnic I, Zorc M, Jevsinek Skok D, Calin GA, Horvat S, Dovc P, Kovac M, Kunej T. Genome-wide and species-wide in silico screening for intragenic MicroRNAs in human, mouse and chicken. PLoS One 8(6):e65165, 2013. e-Pub 2013. PMID: 23762306.
346. Redis RS, Calin S, Yang Y, You MJ, Calin GA. Cell-to-cell miRNA transfer: From body homeostasis to therapy. Pharmacol Ther 136(2):169-74, 2012. e-Pub 2012. PMID: 22903157.
347. Spizzo R, Almeida MI, Colombatti A, Calin GA. Long non-coding RNAs and cancer: a new frontier of translational research?. Oncogene 31(43):4577-87, 2012. e-Pub 2012. PMID: 22266873.
348. Chen L, Calin GA, Zhang S. Novel Insights of Structure-based Modeling for RNA-targeted Drug Discovery. J Chem Inf Model 52(10):2741-53, 2012. e-Pub 2012. PMID: 22947071.
349. Almeida MI, Reis RM, Calin GA. Decoy activity through microRNAs: the therapeutic implications. Expert Opin Biol Ther 12(9):1153-9, 2012. e-Pub 2012. PMID: 22650365.
350. Lin M, Gu J, Eng C, Ellis LM, Hildebrandt MA, Lin J, Huang M, Calin GA, Wang D, Dubois RN, Hawk ET, Wu X. Genetic Polymorphisms in MicroRNA-Related Genes as Predictors of Clinical Outcomes in Colorectal Adenocarcinoma Patients. Clin Cancer Res 18(14):3982-91, 2012. e-Pub 2012. PMID: 22661538.
351. Calin GA, Konopleva M. Small gene, big number, many effects. Blood 120(2):240-1, 2012. e-Pub 2012. PMID: 22791772.
352. Jung EJ, Santarpia L, Kim J, Esteva FJ, Moretti E, Buzdar AU, Di Leo A, Le XF, Bast RC, Park ST, Pusztai L, Calin GA. Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patients. Cancer 118(10):2603-14, 2012. e-Pub 2012. PMID: 22370716.
353. Kunej T, Godnic I, Horvat S, Zorc M, Calin GA. Cross Talk Between MicroRNA and Coding Cancer Genes. Cancer J 18(3):223-31, 2012. e-Pub 2012. PMID: 22647358.
354. Redis RS, Berindan-Neagoe I, Pop VI, Calin GA. Non-coding RNAs as theranostics in human cancers. J Cell Biochem 113(5):1451-9, 2012. e-Pub 2012. PMID: 22213511.
355. Zhang P, Bill K, Liu J, Young E, Peng T, Bolshakov S, Hoffman A, Song Y, Demicco EG, Terrada DL, Creighton CJ, Anderson ML, Lazar AJ, Calin GG, Pollock RE, Lev D. MiR-155 Is a Liposarcoma Oncogene That Targets Casein Kinase-1α and Enhances β-Catenin Signaling. Cancer Res 72(7):1751-62, 2012. e-Pub 2012. PMID: 22350414.
356. Almeida MI, Nicoloso MS, Zeng L, Ivan C, Spizzo R, Gafà R, Xiao L, Zhang X, Vannini I, Fanini F, Fabbri M, Lanza G, Reis RM, Zweidler-McKay PA, Calin GA. Strand-Specific miR-28-5p and miR-28-3p Have Distinct Effects in Colorectal Cancer Cells. Gastroenterology 142(4):886-896.e9, 2012. e-Pub 2012. PMID: 22240480.
357. Bhayani MK, Calin GA, Lai SY. Functional relevance of miRNA sequences in human disease. Mutat Res 731(1-2):14-9, 2012. e-Pub 2012. PMID: 22085809.
358. Rivetti di Val Cervo P, Lena AM, Nicoloso M, Rossi S, Mancini M, Zhou H, Saintigny G, Dellambra E, Odorisio T, Mahé C, Calin GA, Candi E, Melino G. p63-microRNA feedback in keratinocyte senescence. Proc Natl Acad Sci U S A 109(4):1133-8, 2012. e-Pub 2012. PMID: 22228303.
359. Zorc M, Skok DJ, Godnic I, Calin GA, Horvat S, Jiang Z, Dovc P, Kunej T. Catalog of microRNA seed polymorphisms in vertebrates. PLoS One 7(1):e30737, 2012. e-Pub 2012. PMID: 22303453.
360. Le XF, Almeida MI, Mao W, Spizzo R, Rossi S, Nicoloso MS, Zhang S, Wu Y, Calin GA, Bast RC. Modulation of MicroRNA-194 and Cell Migration by HER2-Targeting Trastuzumab in Breast Cancer. PLoS One 7(7):e41170, 2012. e-Pub 2012. PMID: 22829924.
361. Almeida MI, Reis RM, Calin GA. MicroRNA history: Discovery, recent applications, and next frontiers. Mutat Res 717(1-2):1-8, 2011. e-Pub 2011. PMID: 21458467.
362. Kunej T, Godnic I, Ferdin J, Horvat S, Dovc P, Calin GA. Epigenetic regulation of microRNAs in cancer: An integrated review of literature. Mutat Res 717(1-2):77-84, 2011. e-Pub 2011. PMID: 21420983.
363. Bartley AN, Yao H, Barkoh BA, Ivan C, Mishra BM, Rashid A, Calin GA, Luthra R, Hamilton SR. Complex Patterns of Altered MicroRNA Expression during the Adenoma-Adenocarcinoma Sequence for Microsatellite-stable Colorectal Cancer. Clin Cancer Res 17(23):7283-93, 2011. e-Pub 2011. PMID: 21948089.
364. Olaru AV, Ghiaur G, Yamanaka S, Luvsanjav D, An F, Popescu I, Alexandrescu S, Allen S, Pawlik TM, Torbenson M, Georgiades C, Roberts LR, Gores GJ, Ferguson-Smith A, Almeida MI, Calin GA, Mezey E, Selaru FM. A microRNA downregulated in human cholangiocarcinoma controls cell cycle through multiple targets involved in the G1/S checkpoint. Hepatology 54(6):2089-98, 2011. e-Pub 2011. PMID: 21809359.
365. Wang Y, Scheiber MN, Neumann C, Calin GA, Zhou D. MicroRNA Regulation of Ionizing Radiation-Induced Premature Senescence. Int J Radiat Oncol Biol Phys 81(3):839-48, 2011. e-Pub 2011. PMID: 21093163.
366. Ling H, Zhang W, Calin GA. Principles of microRNA involvement in human cancers. Chin J Cancer 30(11):739-48, 2011. e-Pub 2011. PMID: 22035854.
367. Setoyama T, Zhang X, Natsugoe S, Calin GA. microRNA-10b: a new marker or the marker of pancreatic ductal adenocarcinoma?. Clin Cancer Res 17(17):5527-9, 2011. e-Pub 2011. PMID: 21816909.
368. Munker R, Calin GA. MicroRNA profiling in cancer. Clin Sci (Lond) 121(4):141-58, 2011. e-Pub 2011. PMID: 21526983.
369. Cortez MA, Bueso-Ramos C, Ferdin J, Lopez-Berestein G, Sood AK, Calin GA. MicroRNAs in body fluids-the mix of hormones and biomarkers. Nat Rev Clin Oncol 8(8):467-77, 2011. e-Pub 2011. PMID: 21647195.
370. Zuo Z, Calin GA, de Paula HM, Medeiros LJ, Fernandez MH, Shimizu M, Garcia-Manero G, Bueso-Ramos CE. Circulating microRNAs let-7a and miR-16 predict progression-free survival and overall survival in patients with myelodysplastic syndrome. Blood 118(2):413-5, 2011. e-Pub 2011. PMID: 21602527.
371. Shao M, Rossi S, Chelladurai B, Shimizu M, Ntukogu O, Ivan M, Calin GA, Matei D. PDGF induced microRNA alterations in cancer cells. Nucleic Acids Res 39(10):4035-4047, 2011. e-Pub 2011. PMID: 21266476.
372. Zheng H, Song F, Zhang L, Yang D, Ji P, Wang Y, Almeida M, Calin GA, Hao X, Wei Q, Zhang W, Chen K. Genetic variants at the miR-124 binding site on the cytoskeleton-organizing IQGAP1 gene confer differential predisposition to breast cancer. Int J Oncol 38(4):1153-61, 2011. e-Pub 2011. PMID: 21318219.
373. Melo S, Villanueva A, Moutinho C, Davalos V, Spizzo R, Ivan C, Rossi S, Setien F, Casanovas O, Simo-Riudalbas L, Carmona J, Carrere J, Vidal A, Aytes A, Puertas S, Ropero S, Kalluri R, Croce CM, Calin GA, Esteller M. Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing. Proc Natl Acad Sci U S A 108(11):4394-9, 2011. e-Pub 2011. PMID: 21368194.
374. Lee SK, Calin GA. Non-coding RNAs and cancer: new paradigms in oncology. Discov Med 11(58):245-54, 2011. e-Pub 2011. PMID: 21447283.
375. Almeida MI, Reis RM, Calin GA. BRCA1, microRNAs and cancer predisposition: challenging the dogma. Cell Cycle 10(3):377, 2011. e-Pub 2011. PMID: 21270524.
376. Rossi S, Tsirigos A, Amoroso A, Mascellani N, Rigoutsos I, Calin GA, Volinia S. OMiR: Identification of associations between OMIM diseases and microRNAs. Genomics 97(2):71-6, 2011. e-Pub 2011. PMID: 20974243.
377. Yang H, Fang Z, Wei Y, Hu Y, Calin GA, Kantarjian HM, Garcia-Manero G. Levels of miR-29b do not predict for response in patients with acute myelogenous leukemia treated with the combination of 5-azacytidine, valproic acid, and ATRA. Am J Hematol 86(2):237-8, 2011. e-Pub 2011. PMID: 21264920.
378. Fabbri M, Bottoni A, Shimizu M, Spizzo R, Nicoloso MS, Rossi S, Barbarotto E, Cimmino A, Adair B, Wojcik SE, Valeri N, Calore F, Sampath D, Fanini F, Vannini I, Musuraca G, Dell'Aquila M, Alder H, Davuluri RV, Rassenti LZ, Negrini M, Nakamura T, Amadori D, Kay NE, Rai KR, Keating MJ, Kipps TJ, Calin GA, Croce CM. Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia. JAMA 305(1):59-67, 2011. e-Pub 2011. PMID: 21205967.
379. Raia R, Calin GA. Non-coding RNAs and cancer: MicroRNAs and beyond. Journal of Nucleic Acids Investigation 2(1):27-30, 2011. e-Pub 2011.
380. Ferdin J, Kunej T, Calin GA. MicroRNA: Genomic Association with Cancer Predisposition. J Assoc Genet Technol 37(1):11-9, 2011. e-Pub 2011. PMID: 21430351.
381. Shah MY, Calin GA. MicroRNAs miR-221 and miR-222: a new level of regulation in aggressive breast cancer. Genome Med 3(8):56, 2011. e-Pub 2011. PMID: 21888691.
382. Lujambio A, Portela A, Liz J, Melo SA, Rossi S, Spizzo R, Croce CM, Calin GA, Esteller M. CpG island hypermethylation-associated silencing of non-coding RNAs transcribed from ultraconserved regions in human cancer. Oncogene 29(48):6390-401, 2010. e-Pub 2010. PMID: 20802525.
383. Iuliano R, Palmieri D, He H, Iervolino A, Borbone E, Pallante P, Cianflone A, Nagy R, Alder H, Calin GA, Trapasso F, Giordano C, Croce CM, de la Chapelle A, Fusco A. Role of PTPRJ genotype in the risk for papillary thyroid carcinoma. Endocr Relat Cancer 17(4):1001-6, 2010. e-Pub 2010. PMID: 20823296.
384. Cortez MA, Nicoloso MS, Shimizu M, Rossi S, Gopisetty G, Molina JR, Carlotti C, Tirapelli D, Neder L, Brassesco MS, Scrideli CA, Tone LG, Georgescu MM, Zhang W, Puduvalli V, Calin GA. miR-29b and miR-125a regulate podoplanin and suppress invasion in glioblastoma. Genes Chromosomes Cancer 49(11):981-90, 2010. e-Pub 2010. PMID: 20665731.
385. Tili E, Michaille JJ, Liu CG, Alder H, Taccioli C, Volinia S, Calin GA, Croce CM. GAM/ZFp/ZNF512B is central to a gene sensor circuitry involving cell-cycle regulators, TGFβ effectors, Drosha and microRNAs with opposite oncogenic potentials. Nucleic Acids Res 38(21):7673-7688, 2010. e-Pub 2010. PMID: 20639536.
386. Melo SA, Moutinho C, Ropero S, Calin GA, Rossi S, Spizzo R, Fernandez AF, Davalos V, Villanueva A, Montoya G, Yamamoto H, Schwartz S, Esteller M. A genetic defect in exportin-5 traps precursor microRNAs in the nucleus of cancer cells. Cancer Cell 18(4):303-15, 2010. e-Pub 2010. PMID: 20951941.
387. Urdinguio RG, Fernandez AF, Lopez-Nieva P, Rossi S, Huertas D, Kulis M, Liu CG, Croce CM, Calin GA, Esteller M. Disrupted microRNA expression caused by Mecp2 loss in a mouse model of Rett syndrome. Epigenetics 5(7):656-63, 2010. e-Pub 2010. PMID: 20716963.
388. Jung EJ, Calin GA. The Meaning of 21 in the MicroRNA world: perfection rather than destruction?. Cancer Cell 18(3):203-5, 2010. e-Pub 2010. PMID: 20832748.
389. Rossi S, Shimizu M, Barbarotto E, Nicoloso MS, Dimitri F, Sampath D, Fabbri M, Lerner S, Barron LL, Rassenti LZ, Jiang L, Xiao L, Hu J, Secchiero P, Zauli G, Volinia S, Negrini M, Wierda W, Kipps TJ, Plunkett W, Coombes KR, Abruzzo LV, Keating MJ, Calin GA. microRNA fingerprinting of CLL patients with chromosome 17p deletion identify a miR-21 score that stratifies early survival. Blood 116(6):945-52, 2010. e-Pub 2010. PMID: 20393129.
390. Lu C, Han HD, Mangala LS, Ali-Fehmi R, Newton CS, Ozbun L, Armaiz-Pena GN, Hu W, Stone RL, Munkarah A, Ravoori MK, Shahzad MM, Lee JW, Mora E, Langley RR, Carroll AR, Matsuo K, Spannuth WA, Schmandt R, Jennings NB, Goodman BW, Jaffe RB, Nick AM, Kim HS, Guven EO, Chen YH, Li LY, Hsu MC, Coleman RL, Calin GA, Denkbas EB, Lim JY, Lee JS, Kundra V, Birrer MJ, Hung MC, Lopez-Berestein G, Sood AK. Regulation of tumor angiogenesis by EZH2. Cancer Cell 18(2):185-97, 2010. e-Pub 2010. PMID: 20708159.
391. Rossi S, Kopetz S, Davuluri R, Hamilton SR, Calin GA. MicroRNAs, ultraconserved genes and colorectal cancers. Int J Biochem Cell Biol 42(8):1291-7, 2010. e-Pub 2010. PMID: 19497386.
392. Fornari F, Milazzo M, Chieco P, Negrini M, Calin GA, Grazi GL, Pollutri D, Croce CM, Bolondi L, Gramantieri L. MiR-199a-3p Regulates mTOR and c-Met to Influence the Doxorubicin Sensitivity of Human Hepatocarcinoma Cells. Cancer Res 70(12):5184-93, 2010. e-Pub 2010. PMID: 20501828.
393. Edwards JK, Pasqualini R, Arap W, Calin GA. MicroRNAs and ultraconserved genes as diagnostic markers and therapeutic targets in cancer and cardiovascular diseases. J Cardiovasc Transl Res 3(3):271-9, 2010. e-Pub 2010. PMID: 20560048.
394. Almeida MI, Reis RM, Calin GA. MYC-microRNA-9-metastasis connection in breast cancer. Cell Res 20(6):603-4, 2010. e-Pub 2010. PMID: 20502442.
395. Zhang S, Chen L, Jung EJ, Calin GA. Targeting MicroRNAs With Small Molecules: From Dream to Reality. Clin Pharmacol Ther 87(6):754-8, 2010. e-Pub 2010. PMID: 20428111.
396. Sampath D, Calin GA. Coding and noncoding: the CLL mix. Blood 115(19):3858-9, 2010. e-Pub 2010. PMID: 20466868.
397. Fabbri M, Calin GA. Beyond genomics: interpreting the 93% of the human genome that does not encode proteins. Curr Opin Drug Discov Devel 13(3):350-8, 2010. e-Pub 2010. PMID: 20443168.
398. Volinia S, Galasso M, Costinean S, Tagliavini L, Gamberoni G, Drusco A, Marchesini J, Mascellani N, Sana ME, Abu Jarour R, Desponts C, Teitell M, Baffa R, Aqeilan R, Iorio MV, Taccioli C, Garzon R, Di Leva G, Fabbri M, Catozzi M, Previati M, Ambs S, Palumbo T, Garofalo M, Veronese A, Bottoni A, Gasparini P, Harris CC, Visone R, Pekarsky Y, de la Chapelle A, Bloomston M, Dillhoff M, Rassenti LZ, Kipps TJ, Huebner K, Pichiorri F, Lenze D, Cairo S, Buendia MA, Pineau P, Dejean A, Zanesi N, Rossi S, Calin GA, Liu CG, Palatini J, Negrini M, Vecchione A, Rosenberg A, Croce CM. Reprogramming of miRNA networks in cancer and leukemia. Genome Res 20(5):589-99, 2010. e-Pub 2010. PMID: 20439436.
399. Nicoloso MS, Sun H, Spizzo R, Kim H, Wickramasinghe P, Shimizu M, Wojcik SE, Ferdin J, Kunej T, Xiao L, Manoukian S, Secreto G, Ravagnani F, Wang X, Radice P, Croce CM, Davuluri RV, Calin GA. Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility. Cancer Res 70(7):2789-98, 2010. e-Pub 2010. PMID: 20332227.
400. Ferdin J, Kunej T, Calin GA. Non-coding RNAs: identification of cancer-associated microRNAs by gene profiling. Technol Cancer Res Treat 9(2):123-38, 2010. e-Pub 2010. PMID: 20218735.
401. Almeida MI, Reis RM, Calin GA. MicroRNAs and metastases: The neuroblastoma link. Cancer Biol Ther 9(6):453-4, 2010. e-Pub 2010. PMID: 20139721.
402. Eiring AM, Harb JG, Neviani P, Garton C, Oaks JJ, Spizzo R, Liu S, Schwind S, Santhanam R, Hickey CJ, Becker H, Chandler JC, Andino R, Cortes J, Hokland P, Huettner CS, Bhatia R, Roy DC, Liebhaber SA, Caligiuri MA, Marcucci G, Garzon R, Croce CM, Calin GA, Perrotti D. miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts. Cell 140(5):652-65, 2010. e-Pub 2010. PMID: 20211135.
403. Santarpia L, Nicoloso M, Calin GA. MicroRNAs: a complex regulatory network drives the acquisition of malignant cell phenotype. Endocr Relat Cancer 17(1):F51-75, 2010. e-Pub 2010. PMID: 19843580.
404. Le XF, Merchant O, Bast RC, Calin GA. The Roles of MicroRNAs in the Cancer Invasion-Metastasis Cascade. Cancer Microenviron 3(1):137-47, 2010. e-Pub 2010. PMID: 21209780.
405. Aqeilan RI, Calin GA, Croce CM. miR-15a and miR-16-1 in cancer: discovery, function and future perspectives. Cell Death Differ 17(2):215-20, 2010. e-Pub 2010. PMID: 19498445.
406. Ueda T, Volinia S, Okumura H, Shimizu M, Taccioli C, Rossi S, Alder H, Liu CG, Oue N, Yasui W, Yoshida K, Sasaki H, Nomura S, Seto Y, Kaminishi M, Calin GA, Croce CM. Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol 11(2):136-46, 2010. e-Pub 2010. PMID: 20022810.
407. Wojcik SE, Rossi S, Shimizu M, Nicoloso MS, Cimmino A, Alder H, Herlea V, Rassenti LZ, Rai KR, Kipps TJ, Keating MJ, Croce CM, Calin GA. Non-codingRNA Sequence Variations in Human Chronic Lymphocytic Leukemia and Colorectal Cancer. Carcinogenesis 31(2):208-15, 2010. e-Pub 2010. PMID: 19926640.
408. Spizzo R, Nicoloso MS, Lupini L, Lu Y, Fogarty J, Rossi S, Zagatti B, Fabbri M, Veronese A, Liu X, Davuluri R, Croce CM, Mills G, Negrini M, Calin GA. miR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-alpha in human breast cancer cells. Cell Death Differ 17(2):246-54, 2010. e-Pub 2010. PMID: 19730444.
409. Izzotti A, Calin GA, Steele VE, Cartiglia C, Longobardi M, Croce CM, De Flora S. Chemoprevention of cigarette smoke-induced alterations of MicroRNA expression in rat lungs. Cancer Prev Res (Phila) 3(1):62-72, 2010. e-Pub 2010. PMID: 20051373.
410. Lee SK, Calin GA. Genetic control of mammalian T-cell proliferation with a synthetic RNA regulatory system - illusion or reality?. Genome Med 2(10):77, 2010. e-Pub 2010. PMID: 20959026.
411. Zanesi N, Pekarsky Y, Trapasso F, Calin G, Croce CM. MicroRNAs in mouse models of lymphoid malignancies. J Nucleic Acids Investig 1(1):36-40, 2010. e-Pub 2010. PMID: 21666870.
412. Felli N, Cianetti L, Pelosi E, Carè A, Liu CG, Calin GA, Rossi S, Peschle C, Marziali G, Giuliani A. Hematopoietic differentiation: a coordinated dynamical process towards attractor stable states. BMC Syst Biol 4(1):85, 2010. e-Pub 2010. PMID: 20553595.
413. Garzon R, Heaphy CE, Havelange V, Fabbri M, Volinia S, Tsao T, Zanesi N, Kornblau SM, Marcucci G, Calin GA, Andreeff M, Croce CM. MicroRNA 29b functions in acute myeloid leukemia. Blood 114(26):5331-41, 2009. e-Pub 2009. PMID: 19850741.
414. Fasanaro P, Greco S, Lorenzi M, Pescatori M, Brioschi M, Kulshreshtha R, Banfi C, Stubbs A, Calin GA, Ivan M, Capogrossi MC, Martelli F. An integrated approach for experimental target identification of hypoxia-induced miR-210. J Biol Chem 284(50):35134-43, 2009. e-Pub 2009. PMID: 19826008.
415. Bhattacharya R, Nicoloso M, Arvizo R, Wang E, Cortez A, Rossi S, Calin GA, Mukherjee P. MiR-15a and MiR-16 Control Bmi-1 Expression in Ovarian Cancer. Cancer Res 69(23):9090-5, 2009. e-Pub 2009. PMID: 19903841.
416. Calin GA, Croce CM. Chronic lymphocytic leukemia: interplay between non-coding RNAs and protein-coding genes. Blood 114(23):4761-70, 2009. e-Pub 2009. PMID: 19745066.
417. Vasilescu C, Rossi S, Shimizu M, Tudor S, Veronese A, Ferracin M, Nicoloso MS, Barbarotto E, Popa M, Stanciulea O, Fernandez MH, Tulbure D, Bueso-Ramos CE, Negrini M, Calin GA. MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis. PLoS One 4(10):e7405, 2009. e-Pub 2009. PMID: 19823581.
418. Naga Prasad SV, Duan ZH, Gupta MK, Surampudi VS, Volinia S, Calin GA, Liu CG, Kotwal A, Moravec CS, Starling RC, Perez DM, Sen S, Wu Q, Plow EF, Croce CM, Karnik S. A unique microRNA profile in end-stage heart failure indicates alterations in specific cardiovascular signaling networks. J Biol Chem 284(40):27487-99, 2009. e-Pub 2009. PMID: 19641226.
419. Song F, Zheng H, Liu B, Wei S, Dai H, Zhang L, Calin GA, Hao X, Wei Q, Zhang W, Chen K. An miR-502-binding site single-nucleotide polymorphism in the 3'-untranslated region of the SET8 gene is associated with early age of breast cancer onset. Clin Cancer Res 15(19):6292-300, 2009. e-Pub 2009. PMID: 19789321.
420. Izzotti A, Calin GA, Steele VE, Croce CM, De Flora S. Relationships of microRNA expression in mouse lung with age and exposure to cigarette smoke and light. FASEB J 23(9):3243-50, 2009. e-Pub 2009. PMID: 19465468.
421. Calin GA. MicroRNAs and cancer: what we know and what we still have to learn. Genome Med 1(8):78, 2009. e-Pub 2009. PMID: 19691821.
422. Adam L, Zhong M, Choi W, Qi W, Nicoloso M, Arora A, Calin G, Wang H, Siefker-Radtke A, McConkey D, Bar-Eli M, Dinney C. miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy. Clin Cancer Res 15(16):5060-72, 2009. e-Pub 2009. PMID: 19671845.
423. Gramantieri L, Fornari F, Ferracin M, Veronese A, Sabbioni S, Calin GA, Grazi GL, Croce CM, Bolondi L, Negrini M. MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality. Clin Cancer Res 15(16):5073-81, 2009. e-Pub 2009. PMID: 19671867.
424. Fornari F, Gramantieri L, Giovannini C, Veronese A, Ferracin M, Sabbioni S, Calin GA, Grazi GL, Croce CM, Tavolari S, Chieco P, Negrini M, Bolondi L. MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells. Cancer Res 69(14):5761-7, 2009. e-Pub 2009. PMID: 19584283.
425. Yendamuri S, Calin GA. The role of microRNA in human leukemia: a review. Leukemia 23(7):1257-63, 2009. e-Pub 2009. PMID: 19148134.
426. Negrini M, Nicoloso MS, Calin GA. MicroRNAs and cancer--new paradigms in molecular oncology. Curr Opin Cell Biol 21(3):470-9, 2009. e-Pub 2009. PMID: 19411171.
427. Fabbri M, Valeri N, Calin GA. MicroRNAs and genomic variations: from Proteus tricks to Prometheus gift. Carcinogenesis 30(6):912-7, 2009. e-Pub 2009. PMID: 19293341.
428. Cortez MA, Calin GA. MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases. Expert Opin Biol Ther 9(6):703-711, 2009. e-Pub 2009. PMID: 19426115.
429. Ghosh AK, Shanafelt TD, Cimmino A, Taccioli C, Volinia S, Liu CG, Calin GA, Croce CM, Chan DA, Giaccia AJ, Secreto C, Wellik LE, Lee YK, Mukhopadhyay D, Kay NE. Aberrant regulation of pVHL levels by microRNA promotes the HIF/VEGF axis in CLL B cells. Blood 113(22):5568-74, 2009. e-Pub 2009. PMID: 19336759.
430. Sampath D, Calin GA. miRs: fine-tuning prognosis in CLL. Blood 113(21):5035-6, 2009. e-Pub 2009. PMID: 19470431.
431. Spizzo R, Nicoloso MS, Croce CM, Calin GA. Snap Shot: MicroRNAs in Cancer. Cell 137(3):586-586.e1, 2009. e-Pub 2009. PMID: 19410551.
432. Sampath D, Calin GA, Puduvalli VK, Gopisetty G, Taccioli C, Liu CG, Ewald B, Liu C, Keating MJ, Plunkett W. Specific activation of microRNA106b enables the p73 apoptotic response in chronic lymphocytic leukemia by targeting the ubiquitin ligase, Itch for degradation. Blood 113(16):3744-53, 2009. e-Pub 2009. PMID: 19096009.
433. Calin GA. MiR-sensing chemotherapy resistance in CLL. Blood 113(16):3652-3, 2009. e-Pub 2009. PMID: 19372264.
434. Nicoloso MS, Spizzo R, Shimizu M, Rossi S, Calin GA. MicroRNAs - the micro steering wheel of tumour metastases. Nat Rev Cancer 9(4):293-302, 2009. e-Pub 2009. PMID: 19262572.
435. Melo SA, Ropero S, Moutinho C, Aaltonen LA, Yamamoto H, Calin GA, Rossi S, Fernandez AF, Carneiro F, Oliveira C, Ferreira B, Liu CG, Villanueva A, Capella G, Schwartz S, Shiekhattar R, Esteller M. A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function. Nat Genet 41(3):365-70, 2009. e-Pub 2009. PMID: 19219043.
436. Izzotti A, Calin GA, Arrigo P, Steele VE, Croce CM, De Flora S. Downregulation of microRNA expression in the lungs of rats exposed to cigarette smoke. FASEB J 23(3):806-12, 2009. e-Pub 2009. PMID: 18952709.
437. Rehman SK, Baldassarre G, Calin GA, Nicoloso MS. MicroRNAs: The jack of all trades. Clinical Leukemia 3(1):20-32, 2009. e-Pub 2009.
438. Fabbri M, Croce CM, Calin GA. MicroRNAs in the ontogeny of leukemias and lymphomas. Leuk Lymphoma 50(2):1-11, 2009. e-Pub 2009. PMID: 19160125.
439. Taccioli C, Fabbri E, Visone R, Volinia S, Calin GA, Fong LY, Gambari R, Bottoni A, Acunzo M, Hagan J, Iorio MV, Piovan C, Romano G, Croce CM. UCbase & miRfunc: a database of ultraconserved sequences and microRNA function. Nucleic Acids Res 37(Database Issue):D41-8, 2009. e-Pub 2009. PMID: 18945703.
440. Spizzo R, Calin GA. Multiple Approach to Analyzing the Role of MicroRNAs in Apoptosis. Methods Mol Biol 559:219-45, 2009. e-Pub 2009. PMID: 19609760.
441. Crosby ME, Devlin CM, Glazer PM, Calin GA, Ivan M. Emerging roles of microRNAs in the molecular responses to hypoxia. Curr Pharm Des 15(33):3861-6, 2009. e-Pub 2009. PMID: 19925433.
442. Garzon R, Calin GA, Croce CM. MicroRNAs in Cancer. Annu Rev Med 60:167-79, 2009. e-Pub 2009. PMID: 19630570.
443. Spizzo R, Rushworth D, Guerrero M, Calin GA. RNA inhibition, microRNAs, and new therapeutic agents for cancer treatment. Clin Lymphoma Myeloma 9 Suppl 3:S313-8, 2009. e-Pub 2009. PMID: 19778859.
444. Yang N, Kaur S, Volinia S, Greshock J, Lassus H, Hasegawa K, Liang S, Leminen A, Deng S, Smith L, Johnstone CN, Chen XM, Liu CG, Huang Q, Katsaros D, Calin GA, Weber BL, Bützow R, Croce CM, Coukos G, Zhang L. MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer. Cancer Res 68(24):10307-14, 2008. e-Pub 2008. PMID: 19074899.
445. Fornari F, Gramantieri L, Ferracin M, Veronese A, Sabbioni S, Calin GA, Grazi GL, Giovannini C, Croce CM, Bolondi L, Negrini M. MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma. Oncogene 27(43):5651-61, 2008. e-Pub 2008. PMID: 18521080.
446. Lujambio A, Calin GA, Villanueva A, Ropero S, Sánchez-Céspedes M, Blanco D, Montuenga LM, Rossi S, Nicoloso MS, Faller WJ, Gallagher WM, Eccles SA, Croce CM, Esteller M. A microRNA DNA methylation signature for human cancer metastasis. Proc Natl Acad Sci U S A 105(36):13556-61, 2008. e-Pub 2008. PMID: 18768788.
447. Deng S, Calin GA, Croce CM, Coukos G, Zhang L. Mechanisms of microRNA deregulation in human cancer. Cell Cycle 7(17):2643-6, 2008. e-Pub 2008. PMID: 18719391.
448. Prueitt RL, Yi M, Hudson RS, Wallace TA, Howe TM, Yfantis HG, Lee DH, Stephens RM, Liu CG, Calin GA, Croce CM, Ambs S. Expression of microRNAs and protein-coding genes associated with perineural invasion in prostate cancer. Prostate 68(11):1152-64, 2008. e-Pub 2008. PMID: 18459106.
449. Ambs S, Prueitt RL, Yi M, Hudson RS, Howe TM, Petrocca F, Wallace TA, Liu CG, Volinia S, Calin GA, Yfantis HG, Stephens RM, Croce CM. Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer. Cancer Res 68(15):6162-70, 2008. e-Pub 2008. PMID: 18676839.
450. Rossi S, Sevignani C, Nnadi SC, Siracusa LD, Calin GA. Cancer-associated genomic regions (CAGRs) and noncoding RNAs: bioinformatics and therapeutic implications. Mamm Genome 19(7-8):526-540, 2008. e-Pub 2008. PMID: 18636290.
451. Chen K, Song F, Calin GA, Wei Q, Hao X, Zhang W. Polymorphisms in microRNA targets: a gold mine for molecular epidemiology. Carcinogenesis 29(7):1306-11, 2008. e-Pub 2008. PMID: 18477647.
452. Yendamuri S, Trapasso F, Calin GA. ARLTS1 - a novel tumor suppressor gene. Cancer Lett 264(1):11-20, 2008. e-Pub 2008. PMID: 18375053.
453. Bueno MJ, Pérez de Castro I, Gómez de Cedrón M, Santos J, Calin GA, Cigudosa JC, Croce CM, Fernández-Piqueras J, Malumbres M. Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression. Cancer Cell 13(6):496-506, 2008. e-Pub 2008. PMID: 18538733.
454. Fabbri M, Garzon R, Andreeff M, Kantarjian HM, Garcia-Manero G, Calin GA. MicroRNAs and noncoding RNAs in hematological malignancies: molecular, clinical and therapeutic implications. Leukemia 22(6):1095-105, 2008. e-Pub 2008. PMID: 18323801.
455. Zhang L, Volinia S, Bonome T, Calin GA, Greshock J, Yang N, Liu CG, Giannakakis A, Alexiou P, Hasegawa K, Johnstone CN, Megraw MS, Adams S, Lassus H, Huang J, Kaur S, Liang S, Sethupathy P, Leminen A, Simossis VA, Sandaltzopoulos R, Naomoto Y, Katsaros D, Gimotty PA, DeMichele A, Huang Q, Bützow R, Rustgi AK, Weber BL, Birrer MJ, Hatzigeorgiou AG, Croce CM, Coukos G. Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer. Proc Natl Acad Sci U S A 105(19):7004-9, 2008. e-Pub 2008. PMID: 18458333.
456. Barbarotto E, Secchiero P, Dasgupta A, Fortina P, Calin GA, Hyslop T. MicroRNAs as new players in the genomic galaxy and disease puzzles. Clin Transl Sci 1(1):50-6, 2008. e-Pub 2008. PMID: 20443818.
457. Tili E, Michaille JJ, Calin GA. Expression and function of micro-RNAs in immune cells during normal or disease state. Int J Med Sci 5(2):73-9, 2008. e-Pub 2008. PMID: 18392144.
458. Calin GA, Cimmino A, Fabbri M, Ferracin M, Wojcik SE, Shimizu M, Taccioli C, Zanesi N, Garzon R, Aqeilan RI, Alder H, Volinia S, Rassenti L, Liu X, Liu CG, Kipps TJ, Negrini M, Croce CM. MiR-15a and miR-16-1 cluster functions in human leukemia. Proc Natl Acad Sci U S A 105(13):5166-71, 2008. e-Pub 2008. PMID: 18362358.
459. Kulshreshtha R, Davuluri RV, Calin GA, Ivan M. A microRNA component of the hypoxic response. Cell Death Differ 15(4):667-71, 2008. e-Pub 2008. PMID: 18219318.
460. Garzon R, Volinia S, Liu CG, Fernandez-Cymering C, Palumbo T, Pichiorri F, Fabbri M, Coombes K, Alder H, Nakamura T, Flomenberg N, Marcucci G, Calin GA, Kornblau SM, Kantarjian H, Bloomfield CD, Andreeff M, Croce CM. MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. Blood 111(6):3183-9, 2008. e-Pub 2008. PMID: 18187662.
461. Negrini M, Veronese A, Ferracin M, Zagatti B, Sabbioni S, Corallini A, Calin GA, Croce GM. Investigations on microRNAs in human chronic lymphocytic leukemia and control of cancer-associated molecular pathways. Minerva Biotecnologica 20(1):13-21, 2008. e-Pub 2008.
462. Spizzo R, Nicoloso MS, Calin GA. MicroRNAs as new biomarkers in oncology. Expert Opin Med Diagn 2(2):115-127, 2008. e-Pub 2008. PMID: 23485132.
463. Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, Yanaihara N, Yuen ST, Chan TL, Kwong DL, Au GK, Liu CG, Calin GA, Croce CM, Harris CC. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 299(4):425-36, 2008. e-Pub 2008. PMID: 18230780.
464. Fabbri M, Croce CM, Calin GA. MicroRNAs. Cancer J 14(1):1-6, 2008. e-Pub 2008. PMID: 18303474.
465. Nicoloso MS, Calin GA. MicroRNA involvement in brain tumors: from bench to bedside. Brain Pathol 18(1):122-9, 2008. e-Pub 2008. PMID: 18226107.
466. Liu CG, Spizzo R, Calin GA, Croce CM. Expression profiling of microRNA using oligo DNA arrays. Methods 44(1):22-30, 2008. e-Pub 2008. PMID: 18158129.
467. Sun H, Nicoloso MS, Bhattacharyya A, Calin GA, Davuluri RV. In silico prediction of target SNPs affecting miR-mRNA interaction. Proceedings - 2008 IEEE International Conference on Bioinformatics and Biomedicine Workshops, BIBMW:211-214, 2008. e-Pub 2008.
468. Negrini M, Calin GA. Breast cancer metastasis: a microRNA story. Breast Cancer Res 10(2):203, 2008. e-Pub 2008. PMID: 18373886.
469. Barbarotto E, Calin GA. Potential therapeutic applications of miRNA-based technology in hematological malignancies. Curr Pharm Des 14(21):2040-50, 2008. e-Pub 2008. PMID: 18691114.
470. Liu CG, Calin GA, Volinia S, Croce CM. MicroRNA expression profiling using microarrays. Nat Protoc 3(4):563-78, 2008. e-Pub 2008. PMID: 18388938.
471. Visone R, Pallante P, Vecchione A, Cirombella R, Ferracin M, Ferraro A, Volinia S, Coluzzi S, Leone V, Borbone E, Liu CG, Petrocca F, Troncone G, Calin GA, Scarpa A, Colato C, Tallini G, Santoro M, Croce CM, Fusco A. Specific microRNAs are downregulated in human thyroid anaplastic carcinomas. Oncogene 26(54):7590-5, 2007. e-Pub 2007. PMID: 17563749.
472. Tili E, Michaille JJ, Cimino A, Costinean S, Dumitru CD, Adair B, Fabbri M, Alder H, Liu CG, Calin GA, Croce CM. Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J Immunol 179(8):5082-9, 2007. e-Pub 2007. PMID: 17911593.
473. Fabbri M, Garzon R, Cimmino A, Liu Z, Zanesi N, Callegari E, Liu S, Alder H, Costinean S, Fernandez-Cymering C, Volinia S, Guler G, Morrison CD, Chan KK, Marcucci G, Calin GA, Huebner K, Croce CM. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci U S A 104(40):15805-10, 2007. e-Pub 2007. PMID: 17890317.
474. Iorio MV, Visone R, Di Leva G, Donati V, Petrocca F, Casalini P, Taccioli C, Volinia S, Liu CG, Alder H, Calin GA, Ménard S, Croce CM. MicroRNA signatures in human ovarian cancer. Cancer Res 67(18):8699-707, 2007. e-Pub 2007. PMID: 17875710.
475. Gottardo F, Liu CG, Ferracin M, Calin GA, Fassan M, Bassi P, Sevignani C, Byrne D, Negrini M, Pagano F, Gomella LG, Croce CM, Baffa R. Micro-RNA profiling in kidney and bladder cancers. Urol Oncol 25(5):387-92, 2007. e-Pub 2007. PMID: 17826655.
476. Calin GA, Liu CG, Ferracin M, Hyslop T, Spizzo R, Sevignani C, Fabbri M, Cimmino A, Lee EJ, Wojcik SE, Shimizu M, Tili E, Rossi S, Taccioli C, Pichiorri F, Liu X, Zupo S, Herlea V, Gramantieri L, Lanza G, Alder H, Rassenti L, Volinia S, Schmittgen TD, Kipps TJ, Negrini M, Croce CM. Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas. Cancer Cell 12(3):215-29, 2007. e-Pub 2007. PMID: 17785203.
477. Yendamuri S, Trapasso F, Ferracin M, Cesari R, Sevignani C, Shimizu M, Rattan S, Kuroki T, Dumon KR, Bullrich F, Liu CG, Negrini M, Williams NN, Kaiser LR, Croce CM, Calin GA. Tumor suppressor functions of ARLTS1 in lung cancers. Cancer Res 67(16):7738-45, 2007. e-Pub 2007. PMID: 17699778.
478. Gramantieri L, Ferracin M, Fornari F, Veronese A, Sabbioni S, Liu CG, Calin GA, Giovannini C, Ferrazzi E, Grazi GL, Croce CM, Bolondi L, Negrini M. Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Cancer Res 67(13):6092-9, 2007. e-Pub 2007. PMID: 17616664.
479. Garzon R, Pichiorri F, Palumbo T, Visentini M, Aqeilan R, Cimmino A, Wang H, Sun H, Volinia S, Alder H, Calin GA, Liu CG, Andreeff M, Croce CM. MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia. Oncogene 26(28):4148-57, 2007. e-Pub 2007. PMID: 17260024.
480. Sevignani C, Calin GA, Nnadi SC, Shimizu M, Davuluri RV, Hyslop T, Demant P, Croce CM, Siracusa LD. MicroRNA genes are frequently located near mouse cancer susceptibility loci. Proc Natl Acad Sci U S A 104(19):8017-22, 2007. e-Pub 2007. PMID: 17470785.
481. Petrocca F, Calin GA, Croce CM. In response [2]. Cancer Research 67(9):4534, 2007. e-Pub 2007.
482. Sever NI, Younan S, Wojcik SE, Spizzo R, Fabbri M, Calin GA. Use of miRNA expression profiling to identify novel biomarkers. Personalized Medicine 4(2):147-155, 2007. e-Pub 2007.
483. Kulshreshtha R, Ferracin M, Wojcik SE, Garzon R, Alder H, Agosto-Perez FJ, Davuluri R, Liu CG, Croce CM, Negrini M, Calin GA, Ivan M. A microRNA signature of hypoxia. Mol Cell Biol 27(5):1859-67, 2007. e-Pub 2007. PMID: 17194750.
484. Georgantas RW, Hildreth R, Morisot S, Alder J, Liu CG, Heimfeld S, Calin GA, Croce CM, Civin CI. CD34+ hematopoietic stem-progenitor cell microRNA expression and function: a circuit diagram of differentiation control. Proc Natl Acad Sci U S A 104(8):2750-5, 2007. e-Pub 2007. PMID: 17293455.
485. Bottoni A, Zatelli MC, Ferracin M, Tagliati F, Piccin D, Vignali C, Calin GA, Negrini M, Croce CM, Degli Uberti EC. Identification of differentially expressed microRNAs by microarray: a possible role for microRNA genes in pituitary adenomas. J Cell Physiol 210(2):370-7, 2007. e-Pub 2007. PMID: 17111382.
486. Calin GA, Croce CM. Investigation of microRNA alterations in leukemias and lymphomas. Methods Enzymol 427:193-213, 2007. e-Pub 2007. PMID: 17720486.
487. Lanza G, Ferracin M, Gafà R, Veronese A, Spizzo R, Pichiorri F, Liu CG, Calin GA, Croce CM, Negrini M. mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer. Mol Cancer 6:54, 2007. e-Pub 2007. PMID: 17716371.
488. Pekarsky Y, Santanam U, Cimmino A, Palamarchuk A, Efanov A, Maximov V, Volinia S, Alder H, Liu CG, Rassenti L, Calin GA, Hagan JP, Kipps T, Croce CM. Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181. Cancer Res 66(24):11590-3, 2006. e-Pub 2006. PMID: 17178851.
489. Petrocca F, Iliopoulos D, Qin HR, Nicoloso MS, Yendamuri S, Wojcik SE, Shimizu M, Di Leva G, Vecchione A, Trapasso F, Godwin AK, Negrini M, Calin GA, Croce CM. alterations of the tumor suppressor gene ARLTS1 in ovarian cancer. Cancer Res 66(21):10287-91, 2006. e-Pub 2006. PMID: 17079447.
490. Roldo C, Missiaglia E, Hagan JP, Falconi M, Capelli P, Bersani S, Calin GA, Volinia S, Liu CG, Scarpa A, Croce CM. microRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J Clin Oncol 24(29):4677-84, 2006. e-Pub 2006. PMID: 16966691.
491. Calin GA, Garzon R, Cimmino A, Fabbri M, Croce CM. MicroRNAs and leukemias: how strong is the connection. Leuk Res 30(6):653-5, 2006. e-Pub 2006. PMID: 16330098.
492. Shi B, Prisco M, Calin G, Liu CG, Russo G, Giordano A, Baserga R. Expression profiles of micro RNA in proliferating and differentiating 32D murine myeloid cells. J Cell Physiol 207(3):706-10, 2006. e-Pub 2006. PMID: 16482530.
493. Garzon R, Pichiorri F, Palumbo T, Iuliano R, Cimmino A, Aqeilan R, Volinia S, Bhatt D, Alder H, Marcucci G, Calin GA, Liu CG, Bloomfield CD, Andreeff M, Croce CM. MicroRNA fingerprints during human megakaryocytopoiesis. Proc Natl Acad Sci U S A 103(13):5078-83, 2006. e-Pub 2006. PMID: 16549775.
494. Calin GA, Croce CM, Neuberg D. The authors reply [12]. New England Journal of Medicine 354(11):1205, 2006. e-Pub 2006.
495. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, Calin GA, Liu CG, Croce CM, Harris CC. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9(3):189-98, 2006. e-Pub 2006. PMID: 16530703.
496. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris CC, Croce CM. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 103(7):2257-61, 2006. e-Pub 2006. PMID: 16461460.
497. Calin GA, Cimmino A, Croce CM. The authors reply [3]. New England Journal of Medicine 354(5):525, 2006. e-Pub 2006.
498. Zanesi N, Aqeilan R, Drusco A, Kaou M, Sevignani C, Costinean S, Bortesi L, La Rocca G, Koldovsky P, Volinia S, Mancini R, Calin G, Scott CP, Pekarsky Y, Croce CM. Effect of rapamycin on mouse chronic lymphocytic leukemia and the development of nonhematopoietic malignancies in Emu-TCL1 transgenic mice. Cancer Res 6(2):915-20, 2006. e-Pub 2006. PMID: 16424025.
499. He H, Jazdzewski K, Li W, Liyanarachchi S, Nagy R, Volinia S, Calin GA, Liu CG, Franssila K, Suster S, Kloos RT, Croce CM, de la Chapelle A. The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci U S A 102(52):19075-80, 2005. e-Pub 2005. PMID: 16365291.
500. Felli N, Fontana L, Pelosi E, Botta R, Bonci D, Facchiano F, Liuzzi F, Lulli V, Morsilli O, Santoro S, Valtieri M, Calin GA, Liu CG, Sorrentino A, Croce CM, Peschle C. MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation. Proc Natl Acad Sci U S A 102(50):18081-6, 2005. e-Pub 2005. PMID: 16330772.
501. Michaille JJ, Tili E, Calin GA, Garin J, Louwagie M, Croce CM. Cloning and characterization of cDNAs expressed during chick development and encoding different isoforms of a putative zinc finger transcriptional regulator. Biochimie 87(11):939-49, 2005. e-Pub 2005. PMID: 16023281.
502. Calin GA, Ferracin M, Cimmino A, Di Leva G, Shimizu M, Wojcik SE, Iorio MV, Visone R, Sever NI, Fabbri M, Iuliano R, Palumbo T, Pichiorri F, Roldo C, Garzon R, Sevignani C, Rassenti L, Alder H, Volinia S, Liu CG, Kipps TJ, Negrini M, Croce CM. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 353(17):1793-801, 2005. e-Pub 2005. PMID: 16251535.
503. Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M, Wojcik SE, Aqeilan RI, Zupo S, Dono M, Rassenti L, Alder H, Volinia S, Liu CG, Kipps TJ, Negrini M, Croce CM. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A 102(39):13944-9, 2005. e-Pub 2005. PMID: 16166262.
504. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M, Ménard S, Palazzo JP, Rosenberg A, Musiani P, Volinia S, Nenci I, Calin GA, Querzoli P, Negrini M, Croce CM. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65(16):7065-70, 2005. e-Pub 2005. PMID: 16103053.
505. Zanesi N, Mancini R, Sevignani C, Vecchione A, Kaou M, Valtieri M, Calin GA, Pekarsky Y, Gnarra JR, Croce CM, Huebner K. Lung cancer susceptibility in Fhit-deficient mice is increased by Vhl haploinsufficiency. Cancer Res 65(15):6576-82, 2005. e-Pub 2005. PMID: 16061637.
506. De Brakeleer S, Teugels E, De Greve J, Frank B, Klaes R, Burwinkel B, Calin GA, Croce CM, Neuberg D. Familial cancer and ARLTS1 [1] (multiple letters). New England Journal of Medicine 353(3):313-314, 2005. e-Pub 2005.
507. Calin GA, Trapasso F, Shimizu M, Dumitru CD, Yendamuri S, Godwin AK, Ferracin M, Bernardi G, Chatterjee D, Baldassarre G, Rattan S, Alder H, Mabuchi H, Shiraishi T, Hansen LL, Overgaard J, Herlea V, Mauro FR, Dighiero G, Movsas B, Rassenti L, Kipps T, Baffa R, Fusco A, Mori M, Russo G, Liu CG, Neuberg D, Bullrich F, Negrini M, Croce CM. Familial cancer associated with a polymorphism in ARLTS1. N Engl J Med 352(16):1667-76, 2005. e-Pub 2005. PMID: 15843669.
508. Sarti M, Sevignani C, Calin GA, Aqeilan R, Shimizu M, Pentimalli F, Picchio MC, Godwin A, Rosenberg A, Drusco A, Negrini M, Croce CM. Adenoviral transduction of TESTIN gene into breast and uterine cancer cell lines promotes apoptosis and tumor reduction in vivo. Clin Cancer Res 11(2 Pt 1):806-13, 2005. e-Pub 2005. PMID: 15701871.
509. Miotto E, Sabbioni S, Veronese A, Calin GA, Gullini S, Liboni A, Gramantieri L, Bolondi L, Ferrazzi E, Gafà R, Lanza G, Negrini M. Frequent aberrant methylation of the CDH4 gene promoter in human colorectal and gastric cancer. Cancer Res 64(22):8156-9, 2004. e-Pub 2004. PMID: 15548679.
510. Calin GA, Liu CG, Sevignani C, Ferracin M, Felli N, Dumitru CD, Shimizu M, Cimmino A, Zupo S, Dono M, Dell'Aquila ML, Alder H, Rassenti L, Kipps TJ, Bullrich F, Negrini M, Croce CM. MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc Natl Acad Sci U S A 101(32):9740-4, 2004. e-Pub 2004. PMID: 15284443.
511. Liu CG, Calin GA, Meloon B, Gamliel N, Sevignani C, Ferracin M, Dumitru CD, Shimizu M, Zupo S, Dono M, Alder H, Bullrich F, Negrini M, Croce CM. An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. Proc Natl Acad Sci U S A 101(26):9740-4, 2004. e-Pub 2004. PMID: 15210942.
512. Prisco M, Maiorana A, Guerzoni C, Calin G, Calabretta B, Voit R, Grummt I, Baserga R. Role of pescadillo and upstream binding factor in the proliferation and differentiation of murine myeloid cells. Mol Cell Biol 24(12):5421-33, 2004. e-Pub 2004. PMID: 15169904.
513. Picchio MC, Martin ES, Cesari R, Calin GA, Yendamuri S, Kuroki T, Pentimalli F, Sarti M, Yoder K, Kaiser LR, Fishel R, Croce CM. Alterations of the tumor suppressor gene Parkin in non-small cell lung cancer. Clin Cancer Res 10(8):2720-4, 2004. e-Pub 2004. PMID: 15102676.
514. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M, Croce CM. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A 101(9):2999-3004, 2004. e-Pub 2004. PMID: 14973191.
515. Thakur S, Nakamura T, Calin G, Russo A, Tamburrino JF, Shimizu M, Baldassarre G, Battista S, Fusco A, Wassell RP, Dubois G, Alder H, Croce CM. Regulation of BRCA1 transcription by specific single-stranded DNA binding factors. Mol Cell Biol 23(11):3774-87, 2003. e-Pub 2003. PMID: 12748281.
516. Cesari R, Martin ES, Calin GA, Pentimalli F, Bichi R, McAdams H, Trapasso F, Drusco A, Shimizu M, Masciullo V, D'Andrilli G, Scambia G, Picchio MC, Alder H, Godwin AK, Croce CM. Parkin, a gene implicated in autosomal recessive juvenile parkinsonism, is a candidate tumor suppressor gene on chromosome 6q25-q27. Proc Natl Acad Sci U S A 100(10):5956-61, 2003. e-Pub 2003. PMID: 12719539.
517. Calin GA, Calin S, Ionescu R, Croitoru M, Diculescu M, Oproiu A. Successful local fibrinolytic treatment and balloon angioplasty in superior mesenteric arterial embolism: a case report and literature review. Hepatogastroenterology 50(51):732-4, 2003. e-Pub 2003. PMID: 12828073.
518. Sevignani C, Calin GA, Cesari R, Sarti M, Ishii H, Yendamuri S, Vecchione A, Trapasso F, Croce CM. Restoration of fragile histidine triad (FHIT) expression induces apoptosis and suppresses tumorigenicity in breast cancer cell lines. Cancer Res 63(6):1183-7, 2003. e-Pub 2003. PMID: 12649173.
519. Calin GA, Vasilescu C, Negrini M, Barbanti-Brodano G. Genetic chaos and antichaos in human cancers. Med Hypotheses 60(2):258-62, 2003. e-Pub 2003. PMID: 12606244.
520. Sabbioni S, Miotto E, Veronese A, Sattin E, Gramantieri L, Bolondi L, Calin GA, Gafà R, Lanza G, Carli G, Ferrazzi E, Feo C, Liboni A, Gullini S, Negrini M. Multigene methylation analysis of gastrointestinal tumors: TPEF emerges as a frequent tumor-specific aberrantly methylated marker that can be detected in peripheral blood. Mol Diagn 7(3-4):201-7, 2003. e-Pub 2003. PMID: 15068392.
521. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K, Rassenti L, Kipps T, Negrini M, Bullrich F, Croce CM. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 99(24):15524-9, 2002. e-Pub 2002. PMID: 12434020.
522. Bichi R, Shinton SA, Martin ES, Koval A, Calin GA, Cesari R, Russo G, Hardy RR, Croce CM. Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression. Proc Natl Acad Sci U S A 99(10):6955-60, 2002. e-Pub 2002. PMID: 12011454.
523. Scelfo RA, Schwienbacher C, Veronese A, Gramantieri L, Bolondi L, Querzoli P, Nenci I, Calin GA, Angioni A, Barbanti-Brodano G, Negrini M. Loss of methylation at chromosome 11p15.5 is common in human adult tumors. Oncogene 21(16):2564-72, 2002. e-Pub 2002. PMID: 11971191.
524. Bullrich F, Fujii H, Calin G, Mabuchi H, Negrini M, Pekarsky Y, Rassenti L, Alder H, Reed JC, Keating MJ, Kipps TJ, Croce CM. Characterization of the 13q14 tumor suppressor locus in CLL: identification of ALT1, an alternative splice variant of the LEU2 gene. Cancer Res 61(18):6640-8, 2001. e-Pub 2001. PMID: 11559527.
525. Mabuchi H, Fujii H, Calin G, Alder H, Negrini M, Rassenti L, Kipps TJ, Bullrich F, Croce CM. Cloning and characterization of CLLD6, CLLD7, and CLLD8, novel candidate genes for leukemogenesis at chromosome 13q14, a region commonly deleted in B-cell chronic lymphocytic leukemia. Cancer Res 61(7):2870-7, 2001. e-Pub 2001. PMID: 11306461.
526. Calin G, Ranzani GN, Amadori D, Herlea V, Matei I, Barbanti-Brodano G, Negrini M. Somatic frameshift mutations in the Bloom syndrome BLM gene are frequent in sporadic gastric carcinomas with microsatellite mutator phenotype. BMC Genet 2:14, 2001. e-Pub 2001. PMID: 11532193.
527. Calin GA, Gafà R, Tibiletti MG, Herlea V, Becheanu G, Cavazzini L, Barbanti-Brodano G, Nenci I, Negrini M, Lanza G. Genetic progression in microsatellite instability high (MSI-H) colon cancers correlates with clinico-pathological parameters: A study of the TGRbetaRII, BAX, hMSH3, hMSH6, IGFIIR and BLM genes. Int J Cancer 89(3):230-5, 2000. e-Pub 2000. PMID: 10861498.
528. Schwienbacher C, Gramantieri L, Scelfo R, Veronese A, Calin GA, Bolondi L, Croce CM, Barbanti-Brodano G, Negrini M. Gain of imprinting at chromosome 11p15: A pathogenetic mechanism identified in human hepatocarcinomas. Proc Natl Acad Sci U S A 97(10):5445-9, 2000. e-Pub 2000. PMID: 10779553.
529. Schwienbacher C, Angioni A, Scelfo R, Veronese A, Calin GA, Massazza G, Hatada I, Barbanti-Brodano G, Negrini M. Abnormal RNA expression of 11p15 imprinted genes and kidney developmental genes in Wilms' tumor. Cancer Res 60(6):1521-5, 2000. e-Pub 2000. PMID: 10749116.
530. Calin GA, di Iasio MG, Caprini E, Vorechovsky I, Natali PG, Sozzi G, Croce CM, Barbanti-Brodano G, Russo G, Negrini M. Low frequency of alterations of the alpha (PPP2R1A) and beta (PPP2R1B) isoforms of the subunit A of the serine-threonine phosphatase 2A in human neoplasms. Oncogene 19(9):1191-5, 2000. e-Pub 2000. PMID: 10713707.
531. Wilkinson ML, Hodgson SH, Calin GA, Fodde R. FAP and Marfanoid habitus (multiple letters). European Journal of Human Genetics 8(2):153, 2000. e-Pub 2000.
532. Calin G, Ivan M, Stefanescu D. The difference between p53 mutation frequency in haematological and non-haematological malignancies: possible explanations. Med Hypotheses 53(4):326-8, 1999. e-Pub 1999. PMID: 10608267.
533. Calin G, Wijnen J, van der Klift H, Ionita A, Mulder A, Breukel C, Smits R, Dauwerse H, Hansson K, Calin S, Stefanescu D, Oproiu A, Fodde R. Marfan-like habitus and familial adenomatous polyposis in two unrelated males: a significant association. Eur J Hum Genet 7(5):609-14, 1999. e-Pub 1999. PMID: 10439970.
534. di Iasio MG, Calin G, Tibiletti MG, Vorechovsky I, Benediktsson KP, Taramelli R, Barbanti-Brodano G, Negrini M. Refinement of the LOH region 1 at 11q23.1 deleted in human breast carcinomas and sublocalization of 11 expressed sequence tags within the refined region. Oncogene 18(8):1635-8, 1999. e-Pub 1999. PMID: 10102634.
535. Calin G, Herlea V, Barbanti-Brodano G, Negrini M. The coding region of the Bloom syndrome BLM gene and of the CBL proto-oncogene is mutated in genetically unstable sporadic gastrointestinal tumors. Cancer Res 58(17):3777-81, 1998. e-Pub 1998. PMID: 9731483.
536. Maximilian C, Stefanescu D, Calin G. Genetic services in Romania. Eur J Hum Genet 5 Suppl 2:145-7, 1997. e-Pub 1997. PMID: 9450213.
537. Calin G, Stefanescu D. Can the loss of negative regulation theory be compatible with the development of hematological malignancies - (review). Oncol Rep 2(5):875-8, 1995. e-Pub 1995. PMID: 21597834.
538. Calin G. Oncogenes and tumor-suppressor genes - 2 different looks of the same gene. Oncol Rep 1(5):987-91, 1994. e-Pub 1994. PMID: 21607481.
539. Stefanescu D, Colita D, Calin G. A complex translocation t(1-12-11) in a patient with hodgkins-disease. Oncol Rep 1(4):837-9, 1994. e-Pub 1994. PMID: 21607451.
540. Stefanescu DT, Colita D, Nicoara S, Calin G. t(1;7)(p36;q32): a new recurring abnormality in primary myelodysplastic syndrome. Cancer Genet Cytogenet 75(2):103-5, 1994. e-Pub 1994. PMID: 8055471.
541. Stefanescu DT, Colita D, Motoiu I, Calin G. T-cell malignant lymphoma with a complex unbalanced translocation (8;11;14). Cancer Genet Cytogenet 70(1):71-3, 1993. e-Pub 1993. PMID: 8221616.
542. Calin G. Oncogenes and tumor suppressor genes--two different looks of the same gene. Roum Arch Microbiol Immunol 51(4):271-3, 1992. e-Pub 1992. PMID: 1304831.

Review Articles

1. Turk, A, Čeh, E, Calin, GA, Kunej, T. Multiple omics levels of chronic lymphocytic leukemia. Cell Death Discovery 10(1), 2024. e-Pub 2024. PMID: 38906881.
2. Jurj, A, Fontana, B, Varani, G, Calin, GA. Small molecules targeting microRNAs. Trends in Cancer 10(9):809-824, 2024. e-Pub 2024. PMID: 39107162.
3. Bohosova, J, Ashraf, NS, Slaby, O, Calin, GA. Non-Coding RNAs in Peritoneal Carcinomatosis. Cancers 16(17), 2024. e-Pub 2024. PMID: 39272819.
4. Nemeth K, Bayraktar R, Ferracin M, Calin GA. Non-coding RNAs in disease: from mechanisms to therapeutics. Nat Rev Genet 25(3):211-232, 2024. e-Pub 2023. PMID: 37968332.
5. Huang W, Paul D, Calin GA, Bayraktar R. miR-142: A Master Regulator in Hematological Malignancies and Therapeutic Opportunities. Cells 13(1), 2023. e-Pub 2023. PMID: 38201290.
6. Pisignano G, Michael DC, Visal TH, Pirlog R, Ladomery M, Calin GA. Going circular: history, present, and future of circRNAs in cancer. Oncogene 42(38):2783-2800, 2023. e-Pub 2023. PMID: 37587333.
7. Vitale I, Pietrocola F, Guilbaud E, Aaronson SA, Abrams JM, Adam D, Agostini M, Agostinis P, Alnemri ES, Altucci L, Amelio I, Andrews DW, Aqeilan RI, Arama E, Baehrecke EH, Balachandran S, Bano D, Barlev NA, Bartek J, Bazan NG, Becker C, Bernassola F, Bertrand MJM, Bianchi ME, Blagosklonny MV, Blander JM, Blandino G, Blomgren K, Borner C, Bortner CD, Bove P, Boya P, Brenner C, Broz P, Brunner T, Damgaard RB, Calin GA, Campanella M, Candi E, Carbone M, Carmona-Gutierrez D, Cecconi F, Chan FK, Chen GQ, Chen Q, Chen YH, Cheng EH, Chipuk JE, Cidlowski JA, Ciechanover A, Ciliberto G, Conrad M, Cubillos-Ruiz JR, Czabotar PE, D'Angiolella V, Daugaard M, Dawson TM, Dawson VL, De Maria R, De Strooper B, Debatin KM, Deberardinis RJ, Degterev A, Del Sal G, Deshmukh M, Di Virgilio F, Diederich M, Dixon SJ, Dynlacht BD, El-Deiry WS, Elrod JW, Engeland K, Fimia GM, Galassi C, Ganini C, Garcia-Saez AJ, Garg AD, Garrido C, Gavathiotis E, Gerlic M, Ghosh S, Green DR, Greene LA, Gronemeyer H, Häcker G, Hajnóczky G, Hardwick JM, Haupt Y, He S, Heery DM, Hengartner MO, Hetz C, Hildeman DA, Ichijo H, Inoue S, Jäättelä M, Janic A, Joseph B, Jost PJ, Kanneganti TD, Karin M, Kashkar H, Kaufmann T, Kelly GL, Kepp O, Kimchi A, Kitsis RN, Klionsky DJ, Kluck R, Krysko DV, Kulms D, Kumar S, Lavandero S, Lavrik IN, Lemasters JJ, Liccardi G, Linkermann A, Lipton SA, Lockshin RA, López-Otín C, Luedde T, MacFarlane M, Madeo F, Malorni W, Manic G, Mantovani R, Marchi S, Marine JC, Martin SJ, Martinou JC, Mastroberardino PG, Medema JP, Mehlen P, Meier P, Melino G, Melino S, Miao EA, Moll UM, Muñoz-Pinedo C, Murphy DJ, Niklison-Chirou MV, Novelli F, Núñez G, Oberst A, Ofengeim D, Opferman JT, Oren M, Pagano M, Panaretakis T, Pasparakis M, Penninger JM, Pentimalli F, Pereira DM, Pervaiz S, Peter ME, Pinton P, Porta G, Prehn JHM, Puthalakath H, Rabinovich GA, Rajalingam K, Ravichandran KS, Rehm M, Ricci JE, Rizzuto R, Robinson N, Rodrigues CMP, Rotblat B, Rothlin CV, Rubinsztein DC, Rudel T, Rufini A, R. Apoptotic cell death in disease-Current understanding of the NCCD 2023. Cell Death Differ 30(5):1097-1154, 2023. e-Pub 2023. PMID: 37100955.
8. Aprile M, Costa V, Cimmino A, Calin GA. Emerging role of oncogenic long noncoding RNA as cancer biomarkers. Int J Cancer 152(5):822-834, 2023. e-Pub 2023. PMID: 36082440.
9. Mohapatra S, Winkle M, Ton AN, Nguyen D, Calin GA. The Role of Non-Coding RNAs in Chromosomal Instability in Cancer. J Pharmacol Exp Ther 384(1):10-19, 2023. e-Pub 2023. PMID: 36167417.
10. Cismaru CA, Pirlog R, Calin GA, Berindan-Neagoe I. Stem Cells in the Tumor Immune Microenvironment -Part of the Cure or Part of the Disease? Ontogeny and Dichotomy of Stem and Immune Cells has Led to better Understanding. Stem Cell Rev Rep 18(8):2549-2565, 2022. e-Pub 2022. PMID: 35841518.
11. Kara G, Arun B, Calin GA, Ozpolat B. miRacle of microRNA-Driven Cancer Nanotherapeutics. Cancers (Basel) 14(15), 2022. e-Pub 2022. PMID: 35954481.
12. Balihodzic A, Prinz F, Dengler MA, Calin GA, Jost PJ, Pichler M. Non-coding RNAs and ferroptosis: potential implications for cancer therapy. Cell Death Differ 29(6):1094-1106, 2022. e-Pub 2022. PMID: 35422492.
13. Dragomir MP, Knutsen E, Calin GA. Classical and noncanonical functions of miRNAs in cancers. Trends Genet 38(4):379-394, 2022. e-Pub 2021. PMID: 34728089.
14. Kara G, Calin GA, Ozpolat B. RNAi-based therapeutics and tumor targeted delivery in cancer. Adv Drug Deliv Rev 182:114113, 2022. e-Pub 2022. PMID: 35063535.
15. Kara G, Calin GA, Ozpolat B. RNAi-based therapeutics and tumor targeted delivery in cancer. Adv Drug Deliv Rev 182:114113, 2022. e-Pub 2022. PMID: 35063535.
16. Minciuna CE, Tanase M, Manuc TE, Tudor S, Herlea V, Dragomir MP, Calin GA, Vasilescu C. The seen and the unseen: Molecular classification and image based-analysis of gastrointestinal cancers. Comput Struct Biotechnol J 20:5065-5075, 2022. e-Pub 2022. PMID: 36187924.
17. Pirlog R, Drula R, Nutu A, Calin GA, Berindan-Neagoe I. The Roles of the Colon Cancer Associated Transcript 2 (CCAT2) Long Non-Coding RNA in Cancer: A Comprehensive Characterization of the Tumorigenic and Molecular Functions. Int J Mol Sci 22(22), 2021. e-Pub 2021. PMID: 34830370.
18. Winkle M, El-Daly SM, Fabbri M, Calin GA. Noncoding RNA therapeutics - challenges and potential solutions. Nat Rev Drug Discov 20(8):629-651, 2021. e-Pub 2021. PMID: 34145432.
19. Mohapatra S, Pioppini C, Ozpolat B, Calin GA. Non-coding RNAs regulation of macrophage polarization in cancer. Mol Cancer 20(1):24, 2021. e-Pub 2021. PMID: 33522932.
20. Wei J, Gilboa E, Calin GA, Heimberger AB. Immune Modulatory Short Noncoding RNAs Targeting the Glioblastoma Microenvironment. Front Oncol 11:682129, 2021. e-Pub 2021. PMID: 34532286.
21. Dragomir MP, Moisoiu V, Manaila R, Pardini B, Knutsen E, Anfossi S, Amit M, Calin GA. A Holistic Perspective: Exosomes Shuttle between Nerves and Immune Cells in the Tumor Microenvironment. J Clin Med 9(11), 2020. e-Pub 2020. PMID: 33142779.
22. Fabris L, Juracek J, Calin G. Non-Coding RNAs as Cancer Hallmarks in Chronic Lymphocytic Leukemia. Int J Mol Sci 21(18), 2020. e-Pub 2020. PMID: 32937758.
23. Barth DA, Juracek J, Slaby O, Pichler M, Calin GA. lncRNA and Mechanisms of Drug Resistance in Cancers of the Genitourinary System. Cancers (Basel) 12(8), 2020. e-Pub 2020. PMID: 32756406.
24. Drula R, Ott LF, Berindan-Neagoe I, Pantel K, Calin GA. MicroRNAs from Liquid Biopsy Derived Extracellular Vesicles: Recent Advances in Detection and Characterization Methods. Cancers (Basel) 12(8), 2020. e-Pub 2020. PMID: 32707943.
25. El-Daly SM, Bayraktar R, Anfossi S, Calin GA. The Interplay between MicroRNAs and the Components of the Tumor Microenvironment in B-Cell Malignancies. Int J Mol Sci 21(9), 2020. e-Pub 2020. PMID: 32403283.
26. Jonas K, Calin GA, Pichler M. RNA-Binding Proteins as Important Regulators of Long Non-Coding RNAs in Cancer. Int J Mol Sci 21(8), 2020. e-Pub 2020. PMID: 32340118.
27. Pereira Zambalde E, Mathias C, Rodrigues AC, de Souza Fonseca Ribeiro EM, Fiori Gradia D, Calin GA, Carvalho de Oliveira J. Highlighting transcribed ultraconserved regions in human diseases. Wiley Interdiscip Rev RNA 11(2):e1567, 2020. e-Pub 2020. PMID: 31489780.
28. Tran AM, Chalbatani GM, Berland L, Cruz De Los Santos M, Raj P, Jalali SA, Gharagouzloo E, Ivan C, Dragomir MP, Calin GA. A New World of Biomarkers and Therapeutics for Female Reproductive System and Breast Cancers: Circular RNAs. Front Cell Dev Biol 8:50, 2020. e-Pub 2020. PMID: 32211400.
29. Barth DA, Drula R, Ott L, Fabris L, Slaby O, Calin GA, Pichler M. Circulating Non-coding RNAs in Renal Cell Carcinoma-Pathogenesis and Potential Implications as Clinical Biomarkers. Front Cell Dev Biol 8:828, 2020. e-Pub 2020. PMID: 33042985.
30. Chen B, Li J, Chi D, Sahnoune I, Calin S, Girnita L, Calin GA. Non-Coding RNAs in IGF-1R Signaling Regulation: The Underlying Pathophysiological Link between Diabetes and Cancer. Cells 8(12), 2019. e-Pub 2019. PMID: 31847392.
31. Iqbal MA, Arora S, Prakasam G, Calin GA, Syed MA. MicroRNA in lung cancer: role, mechanisms, pathways and therapeutic relevance. Mol Aspects Med 70:3-20, 2019. e-Pub 2019. PMID: 30102929.
32. Huang GL, Sun J, Lu Y, Liu Y, Cao H, Zhang H, Calin GA. MiR-200 family and cancer: From a meta-analysis view. Mol Aspects Med 70:57-71, 2019. e-Pub 2019. PMID: 31558294.
33. Smolle MA, Prinz F, Calin GA, Pichler M. Current concepts of non-coding RNA regulation of immune checkpoints in cancer. Mol Aspects Med 70:117-126, 2019. e-Pub 2019. PMID: 31582259.
34. Barth DA, Slaby O, Klec C, Juracek J, Drula R, Calin GA, Pichler M. Current Concepts of Non-Coding RNAs in the Pathogenesis of Non-Clear Cell Renal Cell Carcinoma. Cancers (Basel) 11(10), 2019. e-Pub 2019. PMID: 31627266.
35. Crudden C, Song D, Cismas S, Trocmé E, Pasca S, Calin GA, Girnita A, Girnita L. Below the Surface: IGF-1R Therapeutic Targeting and Its Endocytic Journey. Cells 8(10), 2019. e-Pub 2019. PMID: 31600876.
36. Farooqi AA, Fuentes-Mattei E, Fayyaz S, Raj P, Goblirsch M, Poltronieri P, Calin GA. Interplay between epigenetic abnormalities and deregulated expression of microRNAs in cancer. Semin Cancer Biol 58:47-55, 2019. e-Pub 2019. PMID: 30742906.
37. Pardini B, Sabo AA, Birolo G, Calin GA. Noncoding RNAs in Extracellular Fluids as Cancer Biomarkers: The New Frontier of Liquid Biopsies. Cancers (Basel) 11(8), 2019. e-Pub 2019. PMID: 31416190.
38. Petrescu GED, Sabo AA, Torsin LI, Calin GA, Dragomir MP. MicroRNA based theranostics for brain cancer: basic principles. J Exp Clin Cancer Res 38(1):231, 2019. e-Pub 2019. PMID: 31142339.
39. Cortez MA, Anfossi S, Ramapriyan R, Menon H, Atalar SC, Aliru M, Welsh J, Calin GA. Role of miRNAs in Immune Responses and Immunotherapy in Cancer. Genes Chromosomes Cancer 58(4):244-253, 2019. e-Pub 2019. PMID: 30578699.
40. Pardini B, Calin GA. MicroRNAs and Long Non-Coding RNAs and Their Hormone-Like Activities in Cancer. Cancers (Basel) 11(3), 2019. e-Pub 2019. PMID: 30884898.
41. Braicu C, Gulei D, Cojocneanu R, Raduly L, Jurj A, Knutsen E, Calin GA, Berindan-Neagoe I. MiRNAs-181a/b therapy in lung cancer: reality or myth?. Mol Oncol 13(1):9-25, 2019. e-Pub 2019. PMID: 30548184.
42. Bayraktar R, Bertilaccio MTS, Calin GA. The Interaction Between Two Worlds: MicroRNAs and Toll-Like Receptors. Front Immunol 10:1053, 2019. e-Pub 2019. PMID: 31139186.
43. Zimta AA, Tomuleasa C, Sahnoune I, Calin GA, Berindan-Neagoe I. Long Non-coding RNAs in Myeloid Malignancies. Front Oncol 9:1048, 2019. e-Pub 2019. PMID: 31681586.
44. Anfossi S, Babayan A, Pantel K, Calin GA. Clinical utility of circulating non-coding RNAs - an update. Nat Rev Clin Oncol 15(9):541-563, 2018. e-Pub 2018. PMID: 29784926.
45. Ultimo S, Martelli AM, Zauli G, Vitale M, Calin GA, Neri LM. ROLES AND CLINICAL IMPLICATIONS OF MicroRNAs IN ACUTE LYMPHOBLASTIC LEUKEMIA. J Cell Physiol 233(8):5642-5654, 2018. e-Pub 2018. PMID: 29154447.
46. Dragomir M, Mafra ACP, Dias SMG, Vasilescu C, Calin GA. Using microRNA Networks to Understand Cancer. Int J Mol Sci 19(7), 2018. e-Pub 2018. PMID: 29949872.
47. Ferreira AF, Calin GA, Picanço-Castro V, Kashima S, Covas DT, de Castro FA. Hematopoietic stem cells from induced pluripotent stem cells - considering the role of microRNA as a cell differentiation regulator. J Cell Sci 131(4), 2018. e-Pub 2018. PMID: 29467236.
48. Dragomir M, Calin GA. Circular RNAs in Cancer - Lessons Learned From microRNAs. Front Oncol 8:179, 2018. e-Pub 2018. PMID: 29911069.
49. Bayraktar R, Van Roosbroeck K, Calin GA. Cell to cell communication: microRNAs as hormones. Mol Oncol 11(12):1673-1686, 2017. e-Pub 2017. PMID: 29024380.
50. Terracciano D, Terreri S, de Nigris F, Costa V, Calin GA, Cimmino A. The role of a new class of long noncoding RNAs transcribed from ultraconserved regions in cancer. Biochim Biophys Acta Rev Cancer 1868(2):449-455, 2017. e-Pub 2017. PMID: 28916343.
51. Shen P, Pichler M, Chen M, Calin GA, Ling H. To Wnt or Lose: The Missing Non-Coding Linc in Colorectal Cancer. Int J Mol Sci 18(9), 2017. e-Pub 2017. PMID: 28930145.
52. Smolle MA, Calin HN, Pichler M, Calin GA. Noncoding RNAs and immune checkpoints: clinical implications as cancer therapeutics. FEBS J 284(13):1952-1966, 2017. e-Pub 2017. PMID: 28132417.
53. Gladek I, Ferdin J, Horvat S, Calin GA, Kunej T. HIF1A gene polymorphisms and human diseases: Graphical review of 97 association studies. Genes Chromosomes Cancer 56(6):439-452, 2017. e-Pub 2017. PMID: 28165644.
54. Gomes CC, de Sousa SF, Calin GA, Gomez RS. The emerging role of long noncoding RNAs in oral cancer. Oral Surg Oral Med Oral Pathol Oral Radiol 123(2):235-241, 2017. e-Pub 2017. PMID: 27989708.
55. Smolle MA, Bauernhofer T, Pummer K, Calin GA, Pichler M. Current Insights into Long Non-Coding RNAs (LncRNAs) in Prostate Cancer. Int J Mol Sci 18(2), 2017. e-Pub 2017. PMID: 28241429.
56. Giza DE, Fuentes-Mattei E, Bullock MD, Tudor S, Goblirsch MJ, Fabbri M, Lupu F, Yeung SJ, Vasilescu C, Calin GA. Cellular and viral microRNAs in sepsis: mechanisms of action and clinical applications. Cell Death Differ 23(12):1906-1918, 2016. e-Pub 2016. PMID: 27740627.
57. Shah MY, Ferrajoli A, Sood AK, Lopez-Berestein G, Calin GA. microRNA Therapeutics in Cancer - An Emerging Concept. EBioMedicine 12:34-42, 2016. e-Pub 2016. PMID: 27720213.
58. Cerk S, Schwarzenbacher D, Adiprasito JB, Stotz M, Hutterer GC, Gerger A, Ling H, Calin GA, Pichler M. Current Status of Long Non-Coding RNAs in Human Breast Cancer. Int J Mol Sci 17(9), 2016. e-Pub 2016. PMID: 27608009.
59. Fabris L, Ceder Y, Chinnaiyan AM, Jenster GW, Sorensen KD, Tomlins S, Visakorpi T, Calin GA. The Potential of MicroRNAs as Prostate Cancer Biomarkers. Eur Urol 70(2):312-22, 2016. e-Pub 2016. PMID: 26806656.
60. Paladini L, Fabris L, Bottai G, Raschioni C, Calin GA, Santarpia L. Targeting microRNAs as key modulators of tumor immune response. J Exp Clin Cancer Res 35(1):103, 2016. e-Pub 2016. PMID: 27349385.
61. Van Roosbroeck K, Calin GA. MicroRNAs in chronic lymphocytic leukemia: miRacle or miRage for prognosis and targeted therapies?. Semin Oncol 43(2):209-14, 2016. e-Pub 2016. PMID: 27040698.
62. Fabris L, Calin GA. Circulating free xeno-microRNAs - The new kids on the block. Mol Oncol 10(3):503-8, 2016. e-Pub 2016. PMID: 26860056.
63. Rupaimoole R, Calin GA, Lopez-Berestein G, Sood AK. miRNA Deregulation in Cancer Cells and the Tumor Microenvironment. Cancer Discov 6(3):235-46, 2016. e-Pub 2016. PMID: 26865249.
64. Tuna M, Machado AS, Calin GA. Genetic and epigenetic alterations of microRNAs and implications for human cancers and other diseases. Genes Chromosomes Cancer 55(3):193-214, 2016. e-Pub 2016. PMID: 26651018.
65. Park JH, Theodoratou E, Calin GA, Shin JI. From cell biology to immunology: Controlling metastatic progression of cancer via microRNA regulatory networks. Oncoimmunology 5(11):e1230579, 2016. e-Pub 2016. PMID: 27999740.
66. Schwarzenbach H, da Silva AM, Calin G, Pantel K. Data Normalization Strategies for MicroRNA Quantification. Clin Chem 61(11):1333-42, 2015. e-Pub 2015. PMID: 26408530.
67. Silva A, Bullock M, Calin G. The Clinical Relevance of Long Non-Coding RNAs in Cancer. Cancers (Basel) 7(4):2169-82, 2015. e-Pub 2015. PMID: 26516918.
68. Chira S, Jackson CS, Oprea I, Ozturk F, Pepper MS, Diaconu I, Braicu C, Raduly LZ, Calin GA, Berindan-Neagoe I. Progresses towards safe and efficient gene therapy vectors. Oncotarget 6(31):30675-703, 2015. e-Pub 2015. PMID: 26362400.
69. Ling H, Vincent K, Pichler M, Fodde R, Berindan-Neagoe I, Slack FJ, Calin GA. Junk DNA and the long non-coding RNA twist in cancer genetics. Oncogene 34(39):5003-11, 2015. e-Pub 2015. PMID: 25619839.
70. Ohtsuka M, Ling H, Doki Y, Mori M, Calin GA. MicroRNA Processing and Human Cancer. J Clin Med 4(8):1651-1667, 2015. e-Pub 2015. PMID: 26308063.
71. Bullock MD, Silva AM, Kanlikilicer-Unaldi P, Filant J, Rashed MH, Sood AK, Lopez-Berestein G, Calin GA. Exosomal Non-Coding RNAs: Diagnostic, Prognostic and Therapeutic Applications in Cancer. Noncoding RNA 1(1):53-68, 2015. e-Pub 2015. PMID: 29861415.
72. Monroig Pdel C, Chen L, Zhang S, Calin GA. Small molecule compounds targeting miRNAs for cancer therapy. Adv Drug Deliv Rev 81:104-16, 2015. e-Pub 2015. PMID: 25239236.
73. Catana CS, Calin GA, Berindan-Neagoe I. Inflamma-miRs in Aging and Breast Cancer: Are They Reliable Players?. Front Med (Lausanne) 2:85, 2015. e-Pub 2015. PMID: 26697428.
74. Ciccone M, Calin GA, Perrotti D. From the Biology of PP2A to the PADs for Therapy of Hematologic Malignancies. Front Oncol 5:21, 2015. e-Pub 2015. PMID: 25763353.
75. Berindan-Neagoe I, Monroig Pdel C, Pasculli B, Calin GA. MicroRNAome genome: a treasure for cancer diagnosis and therapy. CA Cancer J Clin 64(5):311-36, 2014. e-Pub 2014. PMID: 25104502.
76. Ling H, Fabbri M, Calin GA. MicroRNAs and other non-coding RNAs as targets for anticancer drug development. Nat Rev Drug Discov 12(11):847-65, 2013. e-Pub 2013. PMID: 24172333.
77. Cortez MA, Welsh JW, Calin GA. Circulating microRNAs as noninvasive biomarkers in breast cancer. Recent Results Cancer Res 195:151-61, 2012. e-Pub 2012. PMID: 22527502.
78. Ferracin M, Querzoli P, Calin GA, Negrini M. MicroRNAs: toward the clinic for breast cancer patients. Semin Oncol 38(6):764-75, 2011. e-Pub 2011. PMID: 22082762.
79. Pecot CV, Calin GA, Coleman RL, Lopez-Berestein G, Sood AK. RNA interference in the clinic: challenges and future directions. Nat Rev Cancer 11(1):59-67, 2011. e-Pub 2011. PMID: 21160526.
80. Setoyama T, Ling H, Natsugoe S, Calin GA. Non-coding RNAs for medical practice in oncology. Keio J Med 60(4):106-13, 2011. e-Pub 2011. PMID: 22200634.
81. Fabbri M, Calin GA. Epigenetics and miRNAs in human cancer. Adv Genet 70:87-99, 2010. e-Pub 2010. PMID: 20920746.
82. Cortez MA, Ivan C, Zhou P, Wu X, Ivan M, Calin GA. microRNAs in cancer: from bench to bedside. Adv Cancer Res 108:113-57, 2010. e-Pub 2010. PMID: 21034967.
83. Barbarotto E, Schmittgen TD, Calin GA. MicroRNAs and cancer: profile, profile, profile. Int J Cancer 122(5):969-77, 2008. e-Pub 2008. PMID: 18098138.
84. Caporaso N, Goldin L, Plass C, Calin G, Marti G, Bauer S, Raveche E, McMaster ML, Ng D, Landgren O, Slager S. Chronic lymphocytic leukaemia genetics overview. Br J Haematol 139(5):630-4, 2007. e-Pub 2007. PMID: 18021078.
85. Nicoloso MS, Kipps TJ, Croce CM, Calin GA. MicroRNAs in the pathogeny of chronic lymphocytic leukaemia. Br J Haematol 139(5):709-16, 2007. e-Pub 2007. PMID: 18021085.
86. Tili E, Michaille JJ, Gandhi V, Plunkett W, Sampath D, Calin GA. miRNAs and their potential for use against cancer and other diseases. Future Oncol 3(5):521-37, 2007. e-Pub 2007. PMID: 17927518.
87. Calin GA, Pekarsky Y, Croce CM. The role of microRNA and other non-coding RNA in the pathogenesis of chronic lymphocytic leukemia. Best Pract Res Clin Haematol 20(3):425-37, 2007. e-Pub 2007. PMID: 17707831.
88. Calin GA, Croce CM. Chromosomal rearrangements and microRNAs: a new cancer link with clinical implications. J Clin Invest 117(8):2059-66, 2007. e-Pub 2007. PMID: 17671640.
89. Fabbri M, Ivan M, Cimmino A, Negrini M, Calin GA. Regulatory mechanisms of microRNAs involvement in cancer. Expert Opin Biol Ther 7(7):1009-19, 2007. e-Pub 2007. PMID: 17665990.
90. Kulshreshtha R, Ferracin M, Negrini M, Calin GA, Davuluri RV, Ivan M. Regulation of microRNA expression: the hypoxic component. Cell Cycle 6(12):1426-31, 2007. e-Pub 2007. PMID: 17582223.
91. Garzon R, Fabbri M, Cimmino A, Calin GA, Croce CM. MicroRNA expression and function in cancer. Trends Mol Med 12(12):580-7, 2006. e-Pub 2006. PMID: 17071139.
92. Calin GA, Croce CM. MicroRNa signatures in human cancers. Nat Rev Cancer 6(11):857-66, 2006. e-Pub 2006. PMID: 17060945.
93. Calin GA, Croce CM. MicroRNAs and chromosomal abnormalities in cancer cells. Oncogene 25(46):6202-10, 2006. e-Pub 2006. PMID: 17028600.
94. Calin GA, Croce CM. MicroRNA-cancer connection: the beginning of a new tale. Cancer Res 66(15):7390-4, 2006. e-Pub 2006. PMID: 16885332.
95. Di Leva G, Calin GA, Croce CM. MicroRNAs: fundamental facts and involvement in human diseases. Birth Defects Res C Embryo Today 78(2):180-9, 2006. e-Pub 2006. PMID: 16847883.
96. Calin GA, Croce CM. Genomics of chronic lymphocytic leukemia microRNAs as new players with clinical significance. Semin Oncol 33(2):167-73, 2006. e-Pub 2006. PMID: 16616063.
97. Sevignani C, Calin GA, Siracusa LD, Croce CM. Mammalian microRNAs: a small world for fine-tuning gene expression. Mamm Genome 17(3):189-202, 2006. e-Pub 2006. PMID: 16518686.
98. Croce CM, Calin GA. miRNAs, cancer, and stem cell division. Cell 122(1):6-7, 2005. e-Pub 2005. PMID: 16009126.
99. Pekarsky Y, Calin GA, Aqeilan R. Chronic lymphocytic leukemia: molecular genetics and animal models. Curr Top Microbiol Immunol 294:51-70, 2005. e-Pub 2005. PMID: 16323427.

Other Articles

1. Kanlikilicer, P, Bayraktar, R, Denizli, M, Rashed, MH, Ivan, C, Aslan, B, Mitra, R, Karagoz, K, Bayraktar, E, Zhang, X, Rodriguez-Aguayo, C, El-Arabey, AA, Kahraman, N, Baydogan, S, Ozkayar, O, Gatza, ML, Ozpolat, B, Calin, GA, Sood, AK, Lopez Berestein, G Corrigendum to Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer (eBioMedicine (2018) 38 (100–112), (S2352396418304973), (10.1016/j.ebiom.2018.11.004)). EBioMedicine 111, 2025. PMID: 39637523.
2. Rodrigues, AC, Zambalde, EP, Bellan, DL, Trindade, ES, De Souza Fonseca Ribeiro, EM, Calin, GA, Fiori Gradia, D, Carvalho de Oliveira, J Lnc-uc.147 Is Associated with Disease Stage of Liver, Gastric, and Renal Cancer. Biomolecules 13(2), 2023. PMID: 36830634.

Editorials

1. Calin, GA, Hubé, F, Ladomery, M, Delihas, N, Ferracin, M, Poliseno, L, Agnelli, L, Alahari, SK, Yu, A, Zhong, XB. The 2024 Nobel Prize in Physiology or Medicine. Non-coding RNA 10(6), 2024. PMID: 39728607.

Abstracts

1. De Sousa SF, Diniz MG, França JA, Vilas-Boas FAS, Souza FTA, Calin GA, Gomez RS, Gomes CC. The long noncoding RNA KIAA0125 is aberrantly expressed in ameloblastomas. 2019 AACR Annual Meeting, 2019. e-Pub 2019.
2. Harada K, Song S, Xu Y, Bagewell BD, Pizzi MP, Jin J, Wang Y, Scott AW, Ma L, Amlashi FG, Kobayashi M, Vykoukal JV, Ivan C, Estrella JS, Chowdhuri SR, Calin GA, Hanash S, J-S L, Liu B, Ajani JA. Genomic profiling of metastatic gastric adenocarcinoma. 2018 AACR Annual Meeting, 2018. e-Pub 2018.
3. Mokhlis HA, Bayraktar R, Kabil NN, Kahraman N, Bouchard R, Abdelghany T, Ashour A, Abdel-Aziz AAH, Calin GA, Lopez-Berestein G, Ozpolat B. MiR-873 functions as a potential tumor suppressor in pancreatic cancer by targeting KRAS. 2018 AACR Annual Meeting, 2018. e-Pub 2018.
4. Ruiz Calderon JF, Cruz-Correa M, Calin GA, Castillo-Pichardo L, Dharmawardhane S. New targeted therapeutics for gastric cancer. 2018 AACR Annual Meeting, 2018. e-Pub 2018.
5. Kabil NN, Bayraktar R, Ivan C, Kahraman N, Mokhlis HA, Calin GA, Lopez-Berestein G, Ozpolat B. miR-484 acts as an “oncomiR” in triple negative breast cancer cells to promote tumor growth and progression by targeting HOXA5. 2018 AACR Annual Meeting, 2018. e-Pub 2018.
6. Kanlikilicer P, Bayraktar R, Rashed M, Aslan B, Calin GA, Sood AK, Lopez-Berestein G. Exosome-mediated ovarian cancer tumorigenesis mediated by miR1246/Rb/Cav1 axis. 2017 AACR Annual Meeting, 2017. e-Pub 2017.
7. Jacobs DI, Liu Y, Gabrusiewicz K, Tsavachidis S, Amirian ES, Armstrong GN, Zhou R, Wei J, Ivan C, Calin G, Scheurer M, Dahlin A, Rice T, Bracci PM, Hansen HM, Wiencke JK, Wrensch MR, Melin B, Heimberger AB, Bondy ML. Evaluation of polymorphisms in myeloid-associated genes and glioma survival. 2017 AACR Annual Meeting, 2017. e-Pub 2017.
8. Cortez MA, Niknam S, Cuko E, Schoenhals JE, Barsoumian H, Younes AIA, Li A, Vykoukal JV, Ivan C, Calin GA, Hwu P, Welsh JW. Lipid metabolic reprogramming drives resistance to PD1 blockage. 2017 AACR Annual Meeting, 2017. e-Pub 2017.
9. Ling H, Ohtsuka M, Ivan C, Pichler M, Chen M, Slaby O, Goel A, Radovich M, Calin G. Oncogenic function and molecular mechanism of H19 noncoding RNA in colorectal cancer. 2017 AACR Annual Meeting, 2017. e-Pub 2017.

Book Chapters

1. Monroig, PC, Calin, GA. Drug–MicroRNA Cross-Talk, 837-862, 2023.
2. Oncul, S, Amero, P, Rodriguez-Aguayo, C, Sood, AK, Calin, GA, Lopez Berestein, G. RNA delivery for cancer gene therapy, 375-424, 2022.
3. Drula, R, Mohapatra, S, Calin, GA. microRNA in cancer, 21-28, 2022.
4. Rosenlund, IA, Calin, GA, Dragomir, M, Knutsen, E. CRISPR/Cas9 to Silence Long Non-Coding RNAs, 175-187, 2021.
5. Zhang, X, Calin, GA. Profiling Long Non-coding RNA expression Using Custom-Designed Microarray, 43-51, 2021.
6. Rosenlund, IA, Calin, GA, Dragomir, M, Knutsen, E. CRISPR/Cas9 to Silence Long Non-Coding RNAs, 175-187, 2021.
7. Fabris L, Calin GA. Understanding the Genomic Ultraconservations: T-UCRs and Cancer. In: Int Rev Cell Mol Biol, 159-172, 2017.
8. Zhang X, Lopez-Berestein G, Sood AK, Calin GA. Profiling Long Noncoding RNA Expression Using Custom-Designed. In: Long Non-Coding RNAs: Methods and Protocols, Methods in Molecular Biology. Humana Press, 33-41, 2016.
9. Ling H, Calin GA. The role of microRNAs and ultraconserved non-coding RNAs in cancer. In: Cancer Genomics: From Bench to Personalized Medicine. Academic Press/Elsevier, 2014.
10. Ling H, Calin GA. MicroRNAs as drugs and drug targets. In: Translational Oncology: Cancer Gene Therapy by Viral and Non-viral Vectors. John Wiley & Sons, Inc, 2014.
11. Rossi S, Calin GA. Bioinformatics, non-coding RNAs and its possible application in personalized medicine. In: Adv Exp Med Biol. Springer, 21-37, 2013.
12. Fabbri M, Calore F, Paone A, Galli R, Calin GA. Epigenetic regulation of miRNAs in cancer. In: Adv Exp Med Biol. Springer, New York, 137-48, 2013.
13. Fabbri M, Calin G. Noncoding RNAs: Identification of Cancer-Associated microRNAs. In: RNA Technologies (Springer series) From Nucleic Acids Sequences to Molecular Medicine. Springer, 2012.
14. Nicoloso M, Calin G. In: Small RNAs. in Molecular Oncology: Causes of Cancer and Targets for Treatment. Cambridge University press, 2011.
15. Fabbri M, Calin G. MicroRNAs in Hematologic malignancies, in Hematopathology. In: Genomic Mechanisms of Neoplastic Diseases. Springer Science+Business Media, LLC, 2010.
16. Nicoloso MS, Jasra B, Calin GA. MicroRNAs: new players in AML pathogenesis. In: Cancer Treat Res. Springer, 169-81, 2010.
17. Fabbri M, Spizzo R, Calin GA. Highthroughput profiling in the hematopoietic system. In: Methods Mol Biol. Humana, 79-91, 2010.
18. Barbarotto E, Calin, G. MicroRNA and Drug Resistance. In: MicroRNA and Drug Resistance. Springer: New York, 2009.
19. Fabbri M, Garzon R, Cimmino A, Calin GA, Croce CM. High throughput microRNAs profiling in cancers. In: microRNAs. From basic science to disease biology. Cambridge University Press, 2008.
20. Calin GA, Croce CM. RNA Inhibition. In: deVita textbook of Oncology. 8th, 2008.
21. Bottoni A, Croce CM, Calin GA. Chapter 3: Molecular Pathogenesis. In: Chronic Lymphocytic leukemia. 1. Informa Healthcare USA INC, 2008.
22. Calin GA, Croce CM. RNA as a therapeutic molecule. In: The Molecular Basis of Cancer. 3rd, 2008.
23. C-g L, Lui X, Calin GA. MicroRNoma genome-wide profiling by microarray. In: Bioformatic: A Practical Approach. Taylor & Francis Group LLC, 2007.
24. Calin GA, Croce CM. MicroRNA Involvement in Human Cancers. In: American Society of clinical Oncology 2007 Educational Book --43rd Annual Meeting June 1-5, 2007, Chicago, IL. Lisa Greaves, 720-723, 2007.
25. Calin GA, Lui C, Ferracin M, Volinia S, Negrini M, Croce CM. Significance of Aberrant Expression of MicroRNAs. In: In Cancer Cells Bioinformatics in Cancer and Cancer Therapy, 2006.
26. Oproiu A, Calin G. Colorectal cancer. In: Internal Medicine. The Medical Publishing House, 1998.
27. Stefanescu DT, Calin GA. Genetic markers in the diagnosis of cancers. In: Advances in Pediatry. The Romanian Medical Life Publishing House, 1996.

Books (edited and written)

1. Negrini, M, Calin, GA, Croce, CM. MicroRNA in Human Malignancies, 2022.
2. Calin GA. Primitive gastric Lymphoma, 2002.
3. Stefanescu DT, Calin GA. Advances in Human Genetics. The Technical Publishing House, 1998.

Patents

1. Diagnosis and treatment of cancers with microRNA located in or near cancer associated chromosomal features. Patent Number: U.S. Patent App. No. 20060105360.
2. Croce CM, Liu C, Calin GA, Sevignani C. Diagnosis and treatment of cancers with microRNA located in or near cancer-associated chromosomal features. Patent Number: Intl. App. No. WO 2005/078239 A2.
3. Croce CM, Calin GA. Compositions and methods for cancer diagnosis and therapy. Patent Number: Intl. App. No. WO 2004/043387 A2.
4. Calin MicroRNA Signatures Associated with Human Chronic Lymphocytic Leukemia (CCL) and Uses Thereof. Patent Number: US Patent App. No. 2011/0052502 A1.
5. Croce CM, Calin GA. MicroRNA Expression Abnormalities In Pancreatic Endocrine And Acinar Tumors. Patent Number: EP Patent No. 1968622 B1.
6. Croce CM, Calin GA. Compositions For The Therapy of Bcl2-Associated Cancers. Patent Number: EP Patent No. 1937280 B1.
7. Calin GA, Davuluri R, Nicoloso M, Sun H. Diagnostic Methods of Tumor Susceptibility With Single Nucleotide Polymorphisms Inside Microrna Target Sites. Patent Number: PCT/US11/25826.
8. Novel tumor suppressor gene and compositions and methods for making and using the same. Patent Number: US Patent App. No. 2005/0266443.
9. Compositions and methods for cancer diagnosis and therapy. Patent Number: U.S. Patent App. No. 20060165659.
10. Croce CM, Calin GA, Volinia S. Methods for Diagnosing Lung Cancer Using microRNA Signatures. Patent Number: US Patent No. 9,051,618 B2.
11. Croce CM, Liu C, Calin GA. Compositions and methods for cancer diagnosis and therapy. Patent Number: U.S. Patent App. No. 2004052112.
12. Micro-RNA expression abnormalities of pancreatic, endocrine and acinar tumors. Patent Number: US Patent App. No. 7670840.
13. Croce CM, Garzon R, Calin GA. MicroRNA Fingerprints During Human Megakaryocytopoiesis. Patent Number: US Patent App. No. 8,492,083 B2.
14. MicroRNA-based methods and compositions for the diagnosis, prognosis, and treatment of solid cancers. Patent Number: US Patent App. No. 8148069.